0001641751-19-000027.txt : 20191113 0001641751-19-000027.hdr.sgml : 20191113 20191113133237 ACCESSION NUMBER: 0001641751-19-000027 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 52 CONFORMED PERIOD OF REPORT: 20190930 FILED AS OF DATE: 20191113 DATE AS OF CHANGE: 20191113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vet Online Supply Inc CENTRAL INDEX KEY: 0001641751 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES [5047] IRS NUMBER: 470990750 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-55787 FILM NUMBER: 191212941 BUSINESS ADDRESS: STREET 1: 6500 LIVE OAK DRIVE CITY: KELSEYVILLE STATE: CA ZIP: 95451 BUSINESS PHONE: 503-308-9173 MAIL ADDRESS: STREET 1: 6500 LIVE OAK DRIVE CITY: KELSEYVILLE STATE: CA ZIP: 95451 10-Q 1 form10-q.htm FORM 10-Q
 

 

U.S. SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

 

Mark One

xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2019

 

oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______ to _______ 

 

Commission file number 000-55787

 

 

VET ONLINE SUPPLY, INC.
(Exact name of registrant as specified in its charter)

 

(VET ONLINE SUPPLY INC LOGO)

 

Florida 47-0990750 5047
(State or Other Jurisdiction of IRS Employer Primary Standard Industrial
Incorporation or Organization) Identification Number Classification Code Number
     

6500 Live Oak Drive

Kelseyville, CA 95451

Tel: 415-756-4057

(Address and telephone number of principal executive offices)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

  Yes   x No   o

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files

 

  Yes   x No   o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer o Accelerated filer o
Non-accelerated filer o (Do not check if a smaller reporting company) Smaller reporting company x
  Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. o

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 

  Yes   o No   x

 

As of November 8, 2019, there were 1,943,330 shares of the registrant’s $0.001 par value common stock issued and outstanding.

 

 

CONTENTS

 

    Page
  PART I – FINANCIAL INFORMATION  
     
Item 1. Financial Statements   3
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 19
     
Item 3. Quantitative and Qualitative Disclosure about Market Risk 22
     
Item 4. Controls and Procedures 22
     
  PART II – OTHER INFORMATION  
     
Item 1. Legal Proceedings 23
     
Item 1A. Risk Factors 23
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 23
     
Item 3. Defaults Upon Senior Securities 23
     
Item 4. Mine Safety Disclosures 23
     
Item 5. Other Information 23
     
Item 6. Exhibits 24
     
  SIGNATURES 25

 

FORWARD LOOKING STATEMENTS

 

Statements made in this Form 10-Q that are not historical or current facts are “forward-looking statements.”. These statements often can be identified by the use of terms such as “may,” “will,” “expect,” “believe,” “anticipate,” “estimate,” “approximate” or “continue,” or the negative thereof. We intend that such forward-looking statements be subject to the safe harbors for such statements. We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Any forward-looking statements represent management’s best judgment as to what may occur in the future. However, forward-looking statements are subject to risks, uncertainties and important factors beyond our control that could cause actual results and events to differ materially from historical results of operations and events and those presently anticipated or projected. We disclaim any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statement or to reflect the occurrence of anticipated or unanticipated events.

2

 

PART I - FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

The accompanying unaudited financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions for Form 10-Q and Article 210 8-03 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal recurring nature. Operating results for the nine months ended September 30, 2019, are not necessarily indicative of the results that may be expected for the year ending December 31, 2019. For further information, refer to the financial statements and footnotes thereto included in our company’s Annual Report on Form 10-K for the year ended December 31, 2018 as filed with the Securities and Exchange Commission on April 15, 2019.

 

REPORTED IN UNITED STATES DOLLARS

 

    Page
Balance Sheets (Unaudited)   4
Statements of Operations and Comprehensive Loss (Unaudited)   5
Statements of Shareholders’ Deficit (Unaudited)   6
Statements of Cash Flows (Unaudited)   7
Notes to Financial Statements   8-18

3

 

VET ONLINE SUPPLY INC.
BALANCE SHEETS

 

   September 30,   December 31, 
   2019   2018 
   (Unaudited) 
ASSETS          
Current Assets          
Cash  $5,468   $10,640 
Inventory   17,375    17,960 
Prepaid expenses       3,000 
Other current assets   156     
Total Current Assets   22,999    31,600 
           
TOTAL ASSETS  $22,999   $31,600 
           
LIABILITIES          
Current Liabilities:          
Accounts payable  $569,519   $567,250 
Convertible notes payable, interest   189,143    61,586 
Convertible notes payable, net of discount   826,820    555,224 
Deferred revenue       82 
Derivative liabilities   1,322,116    1,426,982 
Liability for unissued shares   150,825    150,825 
Related party liabilities   82,032    29,267 
Sales tax payable   51    35 
Total Current Liabilities   3,140,506    2,791,251 
           
Total Liabilities   3,140,506    2,791,251 
           
Commitments and contingencies        
           
SHAREHOLDERS’ EQUITY (DEFICIT)          
Preferred stock, Series A: $0.001 par value; 30,000,000 shares authorized        
0 shares issued and outstanding at September 30, 2019 and December 31, 2018          
Preferred stock, Series B: $0.001 par value; 10,000,000 shares authorized   1    1 
1,000 shares issued and outstanding at September 30, 2019          
1,000 shares issued and outstanding at December 31, 2018          
Common stock, $0.001 par value; 50,000,000,000 authorized   1,942    1,498 
1,942,319 shares issued and outstanding at September 30, 2019 (1)          
1,498,038 shares issued and outstanding at December 31, 2018 (1)          
Additional paid in capital   6,858,915    6,672,064 
Accumulated deficit   (9,978,365)   (9,433,214)
Total Shareholders’ Equity (Deficit)   (3,117,507)   (2,759,651)
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT)  $22,999   $31,600 

 

(1)All common share amounts and per share amounts in the financial statements reflect the one-for-three thousand reverse stock split that was made effective on April 22, 2019. See Note 7.

 

The accompanying notes are an integral part of these financial statements

4

 

VET ONLINE SUPPLY INC.
STATEMENT OF OPERATIONS
(Unaudited)

 

   Three months ended   Nine months ended 
   September 30,   September 30, 
   2019   2018   2019   2018 
Sales  $156   $1,295   $1,521   $4,309 
Cost of sales   73    675    920    2,200 
Gross profit   83    620    601    2,109 
                     
Operating expenses:                    
Consulting fees   13,000    165,180    39,228    771,773 
G&A expenses   3,357    7,323    16,482    53,528 
Professional fees   10,749    8,400    54,446    75,329 
Salaries and wages   9,000    9,000    27,000    27,000 
Total operating expenses   36,106    189,903    137,156    927,630 
                     
Loss from operations   (36,023)   (189,283)   (136,555)   (925,521)
                     
Other income (expense):                    
Gain (loss) on derivative liability valuation   (100,370)   814,310    78,541    (1,930,886)
Interest expenses   (126,202)   (374,760)   (487,137)   (1,088,949)
Total other income (expense)   (226,572)   439,550    (408,596)   (3,019,835)
                     
Net income (loss) before income taxes   (262,595)   250,267    (545,151)   (3,945,356)
Income tax expense                
Net income (loss)  $(262,595)  $250,267   $(545,151)  $(3,945,356)
                     
Per share information                    
Weighted number of common shares outstanding, basic (1)   1,942,319    888,127    1,874,134    670,913 
Net income (loss) per common share   (0.13520)   0.2818    (0.29088)   (5.8806)
Weighted number of common shares outstanding, diluted (1)       2,301,072         
Net income (loss) per common share       0.1088         

 

The accompanying notes are an integral part of these financial statements

5

 

VET ONLINE SUPPLY INC.
STATEMENT OF SHAREHOLDERS’ EQUITY
(Unaudited)

 

   Preferred Stock               Additional       Total 
   Series B   Common Stock (1)   Treasury   Paid-In   Accumulated   Shareholders’ 
   Shares   Amount   Shares   Amount   Stock   Capital   Deficit   Equity 
Balance as of December 31, 2017   1,000   $1    223,070   $223   $19   $3,904,473   $(4,864,606)  $(959,890)
                                         
Conversion of promissory notes to stock           435,214    435        1,597,489        1,597,924 
Preferred shares returned to treasury cancelled                   (19)   19         
Common stock warrants issued by cashless exercise           66,508    67        (67)        
Common stock issued for services           7,158    7        38,646        38,653 
Net loss                           (3,954,104)   (3,954,104)
Balance as of March 31, 2018   1,000    1    731,950    732        5,540,560    (8,818,710)   (3,277,417)
                                         
Conversion of promissory notes to stock           113,769    114        385,083        385,197 
Common stock issued for services           90    0        486        486 
Net loss                           (241,519)   (241,519)
Balance as of June 30, 2018   1,000   $1    845,809   $846   $   $5,926,129   $(9,060,229)  $(3,133,253)
                                         
Conversion of promissory notes to stock           72,150    72        168,306        168,378 
Net income                           250,267    250,267 
Balance as of September 30, 2018   1,000   $1    917,959   $918   $   $6,094,435   $(8,809,962)  $(2,714,608)
                                         
                                         
                                         
Balance as of December 31, 2018   1,000   $1    1,498,038   $1,498   $   $6,672,064   $(9,433,214)  $(2,759,651)
                                         
Conversion of promissory notes to stock           444,281    444        308,426        308,870 
Derivative settlements                       (121,575)       (121,575)
Net loss                           (200,093)   (200,093)
Balance as of March 31, 2019   1,000    1    1,942,319    1,942        6,858,915    (9,633,307)   (2,772,449)
                                         
Net loss                           (82,463)   (82,463)
Balance as of June 30, 2019   1,000   $1    1,942,319   $1,942   $   $6,858,915   $(9,715,770)  $(2,854,912)
                                         
Net loss                           (262,595)   (262,595)
Balance as of September 30, 2019   1,000   $1    1,942,319   $1,942   $   $6,858,915   $(9,978,365)  $(3,117,507)

 

(1)All common share amounts and per share amounts in the financial statements reflect the one-for-three thousand reverse stock split that was made effective on April 22, 2019. See Note 7.

 

The accompanying notes are an integral part of these financial statements

6

 

VET ONLINE SUPPLY INC.
STATEMENTS OF CASH FLOWS
(Unaudited)

 

   For the nine months ended 
   September 30, 
   2019   2018 
Increase (decrease) in cash and cash equivalents:          
Cash flows from operating activities:          
Net profit (loss)  $(545,151)  $(3,945,356)
Adjustments to reconcile net income to net cash provided by operating activities:          
Amortization of convertible debt discount   352,879    976,978 
New derivatives recorded as loan fees   70,313    4,058,576 
Change in derivative liability   (148,855)   (2,127,690)
Common stock issued for services       39,139 
Liability for unissued shares due to agreements       25,000 
Decrease (increase) in operating assets          
Inventory   585    (38,332)
Prepaid expenses   3,000     
Other assets   (156)    
Increase (decrease) in operating liabilities          
Accounts payable   2,269    108,041 
Accrued interest   133,995    111,972 
Deferred revenue   (82)    
Sales tax payable   16    35 
Net cash used in operating activities   (131,187)   (791,637)
           
Cash flows from investing activities          
           
Cash flows from financing activities:          
Proceeds from convertible notes payable, net   73,250    774,500 
Proceeds from (payments to) related parties, net   52,765    9,918 
Proceeds from promissory notes payable        
Net cash provided (used) by financing activities   126,015    784,418 
           
Net increase (decrease) in cash   (5,172)   (7,219)
           
Cash, beginning of year   10,640    16,820 
Cash, end of year  $5,468   $9,601 
           
Supplemental disclosures of cash flow information:          
Stock issued for debt conversion  $64,220   $406,330 

 

The accompanying notes are an integral part of these financial statements

7

 

VET ONLINE SUPPLY INC.
NOTES TO UNAUDITED FINANCIAL STATEMENTS
(Unaudited)
 
1.BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Organization and Description of Business

 

Vet Online Supply Inc. (the “Company”) is a Florida corporation incorporated on May 31, 2014. The Company engages in the online sale of its own holistic product line for pets, as well as targeting the larger Big-Box Pet retail suppliers, and during the first quarter of 2018, discontinued its legacy veterinarian supplies lines. The company discontinued its legacy line of products to increase margins and profitability with its own brand-name holistic products. These new holistic pet products are designed to help with arthritis, compromised immune systems, stress responses, aggression and digestive issues and may also be useful in treating acute ailments like sprains and strains, torn ligaments, bone breaks and even during post-operative care to reduce swelling, pain and stiffness. The Company’s web-based eCommerce platform with our products is on our website, www.vetonlinesupplies.com. The website gives our potential clients the ability to purchase quality pet products by placing their order any time of day at their convenience.

 

Distribution channels include its existing online retail sales platform and fulfillment, and direct sales through its global manufacturing sales representative network. Although selling pet products online is not entirely new to the company, we anticipate that this medium will continue to grow as our brand continues to achieve recognition. We believe that by providing high quality holistic pet products at competitive prices and to customers online, Vet Online Supply hopes to become a ‘go-to’ solution for pet owners everywhere. In addition, online vs. catalogue has the benefit of, among other things, search tools and accounts that remember previous purchases, and expedited ordering.

 

On April 22, 2019, the Company approved the authorization of a 1 for 3,000 reverse stock split of the Company’s outstanding shares of common stock. The Company’s financial statements have been retroactively adjusted for this stock split for all periods presented.

 

On July 1, 2019, the Company filed a Certificate of Amendment to increase the number of authorized Series A Preferred Stock to 30,000,000, with a par value of $0.001. Each share of Preferred Series A Stock shall have a value of $10 per share and will convert into common stock at the closing price of the common stock on the date of conversion. The Series A stock shall have no voting rights on corporate matters, unless and until the Series A shares are converted into Common Shares, at which time they will have the same voting rights as all Common Shareholders have; their consent shall not be required for taking any corporate action.

 

To date, our activities have been limited to formation, the raising of equity capital, and the initial stages of implementation of our business plan. We filed a Form S-1 Registration Statement with the U.S. Securities and Exchange Commission, received a notice of effect and trade on the OTC Markets, PINK under the symbol VTNL. We are continuing to explore additional sources of capital. We anticipate incurring operating losses as we continue to implement our business plan.

 

Financial Statement Presentation

 

The audited financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).

 

Fiscal year end

 

The Company has selected December 31 as its fiscal year end.

8

 

Use of Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported therein. Due to the inherent uncertainty involved in making estimates, actual results reported in future periods may be based upon amounts that differ from these estimates.

 

Cash Equivalents

 

The Company considers all highly liquid investments with maturities of 90 days or less from the date of purchase to be cash equivalents.

 

Revenue Recognition and Related Allowances

 

The Company adopted ASU No. 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”) as amended, as of January 1, 2018 with no material impact. The Company primarily generates net revenue through product sales to distributors and to retail customers on its website. Revenue is recognized upon transfer of control of promised products to customers which is generally upon shipment in an amount that reflects the consideration we expect to receive in exchange for those products or services. Revenue is recognized net of allowances for returns and any taxes collected from customers, which are subsequently remitted to governmental authorities.

 

Accounts Receivable and Allowance for Doubtful Accounts

 

Accounts receivable are stated at the amount that management expects to collect from outstanding balances. Bad debts and allowances are provided based on historical experience and management’s evaluation of outstanding accounts receivable. Management evaluates past due or delinquency of accounts receivable based on the open invoices aged on due date basis. The allowance for doubtful accounts at September 30, 2019 and December 31, 2018 is $0.

 

Inventories

 

The Company is a manufacturer of premium CBD infused holistic pet products and as such will maintain inventory on site. The company directly drop ships to customers when ordered. The Company has wholesale distributors that purchase products in bulk inventory.

 

Warranty

 

The Company is a manufacturer of products which are shipped to our customers directly from the company and as a result, there are costs that may be incurred by the Company under the terms of the limited warranty provided by the company directly to the purchasers. We provide provisions for obligations which may arise under manufacturer’s warranties and therefore incur liabilities. We warranty the product for packaging and shipping.

 

Advertising and Marketing Costs

 

The company provides website online marketing of its products, as well as wholesalers who market the product. The company also utilises various public press releases to provide public information about its product line and future products under development. Advertising and marketing costs are expensed as incurred for the three and nine months ended September 30, 2019 were $200 and $4,000, respectively. ($5,850 – December 31, 2018).

 

Fair Value of Financial Instruments

 

Fair value is defined as the price that would be received upon sale of an asset or paid upon transfer of a liability in an orderly transaction between market participants at the measurement date and in the principal or most advantageous market for that asset or liability. The fair value should be calculated based on assumptions that market participants would use in pricing the asset or liability, not on assumptions specific to the entity. In addition, the fair value of liabilities should include consideration of non-performance risk including our own credit risk.

9

 

In addition to defining fair value, the standard expands the disclosure requirements around fair value and establishes a fair value hierarchy for valuation inputs is expanded. The hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of the three levels and which is determined by the lowest level input that is significant to the fair value measurement in its entirety.

 

These levels are:

 

Level 1 - inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.

 

Level 2 - inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

 

Level 3 - inputs are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. The fair values are therefore determined using model-based techniques that include option pricing models, discounted cash flow models, and similar techniques.

 

Financial assets and liabilities measured at fair value on a recurring basis:

 

   Input  September 30, 2019   December 31, 2018 
   Level  Fair Value   Fair Value 
Derivative Liability  3  $1,322,116   $1,426,982 
Total Financial Liabilities     $1,322,116   $1,426,982 

 

In management’s opinion, the fair value of convertible notes payable and advances payable is approximate to carrying value as the interest rates and other features of these instruments approximate those obtainable for similar instruments in the current market. Unless otherwise noted, it is management’s opinion that the Company is not exposed to significant interest, exchange or credit risks arising from these financial instruments. As of September 30, 2019 and December 31, 2018, the balances reported for cash, accounts receivable, prepaid expenses, accounts payable, and accrued liabilities, approximate the fair value because of their short maturities.

 

Income taxes

 

 The Company has adopted SFAS No. 109 – “Accounting for Income Taxes”. ASC Topic 740 requires the use of the asset and liability method of accounting for income taxes. Under the asset and liability method of ASC Topic 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.

 

Basic and Diluted Loss Per Share

 

In accordance with ASC Topic 280 – “Earnings Per Share”, the basic loss per common share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding. Diluted loss per common share is computed similar to basic loss per common share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive.

 

Recent Accounting Pronouncements

 

In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), which replaces existing revenue recognition guidance. The updated guidance requires companies to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, the new standard requires that reporting companies disclose the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The Company adopted the standard on January 1, 2018, using a modified retrospective approach, with the cumulative effect of initially applying the standard recognized in retained earnings at the date of adoption.

10

 

2.GOING CONCERN

 

The Company has experienced net losses to date, and it has not generated sufficient revenue from operations to meet our operational overhead. We will need additional working capital to service debt and for ongoing operations, which raises substantial doubt about our ability to continue as a going concern. Management of the Company is preparing a strategy to meet operational shortfalls which may include equity funding, short term or long-term financing or debt financing, to enable the Company to reach profitable operations. Historically, the Company’s sole officer and director has provided short term loans to meet working capital shortfalls. We have recently entered into financing agreements with various third parties to meet our capital needs in fiscal 2019.

 

The accompanying financial statements do not include any adjustments related to the recoverability or classification of asset-carrying amounts or the amounts and classification of liabilities that may result should the Company be unable to continue as a going concern.

 

3.PREPAID EXPENSES

 

   September 30,   December 31, 
   2019   2018 
Prepaid expenses  $   $3,000 

 

Prepaid fees represent amounts paid in advance for future contractual benefits to be received. Contracting expenses paid in advance are recorded as a prepaid asset and then amortized to the statements of operations when services are rendered, or over the life of the contract using the straight-line method.

 

During the nine months ended September 30, 2019, the Company reclassed prepaid employee wages that were paid during the year ended December 31, 2018.

 

4.CONVERTIBLE NOTES PAYABLE

 

As of September 30, 2019 and December 31, 2018, notes payable were comprised of the following:

 

   Original  Original  Due  Interest  Conversion  September 30,   December 31, 
   Amount  Note Date  Date  Rate  Rate  2019   2018 
APG Capital #2   31,500  6/25/2018  6/25/2019  24%  Variable   31,500    31,500 
Auctus Fund #2   84,000  1/10/2018  10/10/2018  24%  Variable   31,285    47,373 
Auctus Fund #3   175,000  2/6/2018  11/6/2018  24%  Variable   175,000    175,000 
Auctus Fund #4   90,000  3/6/2018  12/6/2018  24%  Variable   90,000    90,000 
Auctus Fund #5   100,000  6/14/2018  3/14/2019  24%  Variable   100,000    100,000 
Auctus Fund #6   75,000  8/13/2018  5/13/2019  24%  Variable   75,000    75,000 
Auctus Fund #7   25,000  10/11/2018  7/11/2019  24%  Variable   25,000    25,000 
Auctus Fund #8   25,750  12/20/2018  9/20/2019  24%  Variable   25,750    25,750 
Auctus Fund #9   57,000  4/12/2019  1/12/2020  12%  Variable   57,000     
Auctus Fund #10   31,000  7/22/2019  7/22/2020  12%  Variable   31,000     
EMA Financial #2   50,000  12/15/2017  12/15/2018  24%  Variable   8,474    8,474 
EMA Financial #3   100,000  3/5/2018  3/5/2019  24%  Variable   73,305    83,499 
EMA Financial #4   25,000  10/10/2018  7/10/2019  24%  Variable   25,000    25,000 
Emerging Corp #1   83,333  2/12/2018  2/11/2019  22%  Variable   74,933    74,933 
Emerging Corp #2   110,000  10/31/2018  10/31/2019  12%  Variable   110,000    110,000 
Power Up Lending #8   33,000  6/25/2018  4/15/2019  12%  Variable       33,000 
                   933,247    904,529 
Debt discount   (97,416)   (313,258)
Financing costs/Original issue discount   (9,011)   (36,047)
Notes payable, net of discount  $826,820   $555,224 

11

 

During the nine months ending September 30, 2019, the Company received proceeds from new convertible notes of $73,250. The Company recorded no payments on their convertible notes, and conversions of $59,282 of convertible note principal. The Company recorded loan fees on new convertible notes of $14,750, which increased the debt discounts recorded on the convertible notes during the nine months ending September 30, 2018. All of the Company’s convertible notes have a conversion rate that is variable, and therefore, the Company has accounted for their conversion features as derivative instruments (see Note 5). The Company also recorded amortization of $352,879 on their convertible note debt discounts and loan fees. As of September 30, 2019, the convertible notes payable are convertible into 21,183,475,536  shares of the Company’s common stock.

 

During the nine months ending September 30, 2018, the Company received proceeds from new convertible notes of $774,500. The Company recorded no payments on their convertible notes, and conversions of $390,478 of convertible note principal. The Company recorded penalties of $47,727, of which $32,762 was converted into the Company’s common stock. The Company recorded loan fees on new convertible notes of $127,833, which increased the debt discounts recorded on the convertible notes during the nine months ending September 30, 2018. All of the Company’s convertible notes have a conversion rate that is variable, and therefore, the Company has accounted for their conversion features as derivative instruments (see Note 5). The Company also recorded amortization of $976,978 on their convertible note debt discounts and loan fees.  

 

During the three months ended September 30, 2019 and 2018, the Company recorded interest expense of $48,741 and $23,461, respectively, on its convertible notes payable. During the three months ended September 30,2019 and 2018, the Company recorded conversions of $0 and $6,964, respectively of convertible note interest.

 

During the nine months ended September 30, 2019 and 2018, the Company recorded interest expense of $132,495 and $52,495, respectively, on its convertible notes payable. During the nine months ended September 30, 2019 and 2018, the Company recorded conversions of $4,938 and $15,852, respectively of convertible note interest.  As of September 30, 2019 and 2018, the accrued interest balance was $189,143 and $42,876, respectively.

 

As of September 30, 2019, we have not attained profitable operations and are dependent upon obtaining financing to pursue any extensive acquisitions and activities.

 

5.DERIVATIVE LIABILITIES

 

The following table represents the Company’s derivative liability activity for the embedded conversion features for the periods ending September 30, 2019 and December 31, 2018:

 

   September 30,   December 31, 
   2019   2018 
Balance, beginning of period  $1,426,982   $625,214 
Initial recognition of derivative liability   165,563    5,441,395 
Conversion of derivative instruments to Common Stock   (121,575)   (1,958,802)
Mark-to-Market adjustment to fair value   (148,854)   (2,680,825)
Balance, end of period  $1,322,116   $1,426,982 

 

During the nine months ended September 30, 2019 and 2018, the Company recorded derivative liabilities for embedded conversion features related to convertible notes payable of $165,563 and $5,049,659, respectively.

12

 

During the nine months ended September 30, 2019 and 2018, in conjunction with convertible notes payable principal and accrued interest being converted into common stock of the Company, derivative liabilities were reduced by $121,575 and $1,733,419, respectively.

 

For the nine months ended September 30, 2019 and 2018, the Company performed a final mark-to-market adjustment for the derivative liability related to the convertible notes and the carrying amount of the derivative liability related to the conversion feature and recognized a gain on the derivative liability valuation of $148,854 and $2,127,690, respectively.

 

During the three months ended September 30, 2019 and 2018, the Company recorded derivative liabilities for embedded conversion features related to convertible notes payable of $57,365 and $183,148, respectively.

 

During the three months ended September 30, 2019 and 2018, in conjunction with convertible notes payable principal and accrued interest being converted into common stock of the Company, derivative liabilities were reduced by $0 and $99,317, respectively.

 

For the three months ended September 30, 2019 and 2018, the Company performed a final mark-to-market adjustment for the derivative liability related to the convertible notes and the carrying amount of the derivative liability related to the conversion feature and recognized a loss(gain) on the derivative liability valuation of $75,555 and $(888,709), respectively.

 

The Company uses the Black-Scholes option pricing model to estimate fair value for those instruments convertible into common shares at inception, at conversion or extinguishment date, and at each reporting date. During the nine months ended September 30, 2019, the company used the following assumptions in their Black-Scholes model: (1) risk free interest rate 1.71% - 2.44%, (2) term of 0.12 years – 5 years, (3) expected stock volatility of 185.7% - 568.21%, (4) expected dividend rate of 0%, (5) common stock price of $0.0001, and (6) exercise price of $0.00005 - $0.03.

 

These instruments were not issued with the intent of effectively hedging any future cash flow, fair value of any asset, liability or any net investment in a foreign operation. The instruments do not qualify for hedge accounting, and as such, all future changes in the fair value will be recognized in earnings until such time as the instruments are exercised, converted or expire.

 

6.PREFERRED STOCK

 

On March 28, 2017, the Company filed an amendment to its articles of incorporation designating 20,000 shares of its authorized preferred stock, par value $0.001 as Series B Voting Preferred Stock. The Series B Voting Preferred Stock shall have the right to vote the shares on any matter requiring shareholder approval on the basis of 4 times the votes of all the issued and outstanding shares of common stock, as well as any issued and outstanding preferred stock.

 

On March 1, 2018, 1,000 shares of Series B Voting Preferred Stock were issued to Daniel Rushford.

 

On October 25, 2018, the Company’s Board of Directors authorized the creation of 2,000,000 shares of Series A Preferred Stock with a par value of $0.001, and on October 30, 2018 a Certificate of Designation was filed with the Florida Secretary of State. Upon written notice to the Corporation, the holder of Series A Preferred stock may convert their shares into ten (10) shares of fully paid and nonassessable shares of Common Stock of the Corporation. The holders shall have no voting rights on corporate matters, unless and until they convert their Series A shares into Common Shares, at which time they will have the same voting rights as all Common Shareholders have; their consent shall not be required for taking any corporate action.

 

On July 1, 2019, the Company filed a Certificate of Amendment to increase the number of authorized Series A Preferred Stock to 30,000,000, with a par value of $0.001. Each share of Preferred Series A Stock shall have a value of $10 per share and will convert into common stock at the closing price of the common stock on the date of conversion. The Series A stock shall have no voting rights on corporate matters, unless and until the Series A shares are converted into Common Shares, at which time they will have the same voting rights as all Common Shareholders have; their consent shall not be required for taking any corporate action.

13

 

As of September 30, 2019, 30,000,000 Series A Preferred shares and 10,000,000 Series B Preferred shares were authorized, of which 0 Series A shares were issued and outstanding, (0 shares as of December 31, 2018) and 1,000 Series B shares were issued and outstanding (1,000 shares as of December 31, 2018).

 

7.COMMON STOCK

 

On March 15, 2018, the Company announced that its Board of Directors has determined that it is in the best interests of the Corporation to initiate a program  to reacquire certain shares of stock from its stockholders, and to thereafter retire said shares as non-voting Treasury stock. The Corporation has approved a Share Repurchase Program (the “Program”) to accomplish this. The Corporation hereby will make an offer of redemption to its shareholders in accordance with the terms of the Program. The specific timing, price and size of purchases will depend on prevailing stock prices, general economic and market conditions, and other considerations. The Program does not obligate the Company to acquire any particular amount of stock, and the Program may be suspended or discontinued at any time at the Company’s discretion. The Company discontinued this program on June 30, 2019.

 

On March 27, 2018, the Company approved the issuance of 7,248 shares of the Company’s common stock for services provided by a consultant, in the form of stock awards which shall vest as of the date of grant. The shares were valued at the fair market value on the date of grant totaling $39,139, which has been expensed as stock-based compensation as part of consulting expenses.

 

On April 30, 2018, the Company filed a Certificate of Amendment to increase the number of authorized common shares from 25,000,000,000 to 50,000,000,000 with a par value of $0.001.

 

During the year ended December 31, 2018, the holders of convertible notes converted a total of $560,907 of principal, accrued interest, note fees and penalties into 1,201,212  shares of common stock. The common stock was valued at $2,519,708 based on the market price of the Company’s stock on the date of conversion. The issuance extinguished $1,958,802 worth of derivative liabilities, and $(1,083,929) was recorded as additional paid in capital.

 

On April 22, 2019, the Majority Preferred Series B Shareholders of the Company, owning a majority of the Company’s voting securities, approved a resolution authorizing the Company to amend the Articles of Incorporation to accomplish the Reverse Split of the Corporation’s issued and outstanding shares of 1 for 3,000 of Common Stock having a par value of $0.001 per share. The Company filed a Certificate of Amendment with an effective date of September 16, 2019.

 

During the nine months ended September 30, 2019, the holders of convertible notes converted a total of $64,220 of principal and accrued interest, and $1,500 in note fees into 444,281  shares of common stock. The common stock was valued at $308,870 based on the market price of the Company’s stock on the date of conversion. The issuance extinguished $121,575 worth of derivative liabilities and $1,267,126 was recorded as additional paid in capital.

 

As of September 30, 2019 and December 31, 2018 there were 1,942,319 and 1,498,038  shares issued and outstanding, respectively.

 

Warrants

 

The following table summarizes the activity related to warrants of the Company as of September 30, 2019:

 

Issue  Number of  Exercise Price  Remaining Life
Date  Warrants  per Share  (Years)
6/19/2017  17  0.03  2.72
6/4/2018  16,667  0.001  3.71
8/13.18  12,500  0.001  3.87
10/11/2018  8,333  0.001  4.03
12/20/2018  8,583  0.001  4.22
4/12/2019  19,000  0.001  4.53
7/22/2019  15,500,000  0.001  4.81

14

 

During the three months ended September 30, 2019, the Company issued 15,500,000 warrants, with an exercise price of $.001 in connection with a convertible note originating on July 22, 2019. If the market price of one share of common stock is greater than the Exercise Price, the holder may elect to receive warrant shares pursuant to cashless exercise. The warrants vest immediately and expire five years from the date of issuance.

 

During the three months ended September 30, 2018, the Company issued 12,500 warrants, with an exercise price of $.001 in connection with a convertible note originating on August 13, 2018. If the market price of one share of common stock is greater than the Exercise Price, the holder may elect to receive warrant shares pursuant to cashless exercise. The warrants vest immediately and expire five years from the date of issuance.

 

During the three months ended September 30, 2019 and 2018, there were no warrants exercised.

 

During the nine months ended September 30, 2019, the Company issued an aggregate of 15,519,000 warrants, with an exercise price of $.001 in connection with convertible notes executed on April 12, 2019 and July 22, 2019. If the market price of one share of common stock is greater than the Exercise Price, the holder may elect to receive warrant shares pursuant to cashless exercise. The warrants vest immediately and expire five years from the date of issuance.

 

During the nine months ended September 30, 2018, the Company issued an aggregate of 29,167 warrants, with an exercise price of $.001 in connection with convertible notes executed on June 4, 2018 and August 13, 2018. If the market price of one share of common stock is greater than the Exercise Price, the holder may elect to receive warrant shares pursuant to cashless exercise. The warrants vest immediately and expire five years from the date of issuance.

 

During the nine months ended September 30, 2019 and 2018, the Company issued 0 and 66,508, respectively, shares of common stock through a cashless exercise of the warrants.

 

We account for common stock purchase warrants as derivative liabilities and debt issuance costs on the balance sheet at fair value, and changes in fair value during the periods presented in the statement of operations, which is revalued at each balance sheet date subsequent to the initial issuance of the warrant.

 

8.RELATED PARTY TRANSACTIONS

 

Mr. Matthew C. Scott, Director

 

On April 1, 2017, the Company expanded its board of directors to include Matthew C. Scott. Concurrently, the Company entered into a consulting agreement with Mr. Scott for a term of one year, whereby Mr. Scott shall receive an annual fee of $100,000 payable in quarterly installments. Furthermore, effective April 1, 2017 the Company agreed to issue Mr. Scott 667 shares of restricted common stock for his services as a director. The shares upon issue will be held by the Company for a term of six months and are cancelable should Mr. Scott not serve in his capacity as director for a minimum term of six months.

 

The Company recorded $140,000 in share-based compensation in respect of the 667 shares issuable based on the fair market value on April 1, 2017, which has been recorded on the balance sheet as liabilities for unissued shares. Furthermore, a total of $140,000 has been expensed in the year ending December 31, 2017 as stock-based compensation as part of consulting expenses. As of the date of this report, the shares have not been issued.

 

On October 15, 2017, the Board of Directors of the Company approved the issuance of 25,000 restricted common shares to Matthew Scott to satisfy accrued fees of $50,000, pursuant his agreement dated April 1, 2017. The shares were issued on November 13, 2017 and were valued at $1,200,000, based on the market value on the date the shares were approved for issuance, and $1,150,000 was recorded as a loss on settlement of debt of the statement of operations.

15

 

On April 1, 2018, the Company agreed to renew the Consulting Agreement dated April 1, 2017 for one year.

 

On November 8, 2018, Mr. Scott resigned as a Director and agreed to forfeit all stock and outstanding debts owed to him pursuant to his Consulting Agreement. The Company recorded a reduction of $210,000 to accounts payable and unissued shares with a corresponding entry to additional paid in capital.

 

Mr. Samuel Berry, Director

 

On June 19, 2017, the Company entered into a Consulting Agreement with Mr. Samuel Berry. Mr. Berry will receive an annual salary of $50,000, payable in quarterly installments at $12,500 per quarter.

 

On June 19, 2017 the Board of Directors appointed Mr. Samuel Berry as Director. For accepting the position of Director, Mr. Berry will receive 333 Shares of the Company’s common stock. Additionally, Mr. Berry will be paid $500 for each board meeting for which he is physically present.

 

The Company recorded $50,000 in respect to the value of 333 unissued shares as liabilities for unissued shares and expensed $50,000 as stock-based compensation as part of consulting expenses in the period ended September 30, 2017. As of the date of this report, the shares have not been issued.

 

On October 15, 2017, the Board of Directors of the Company approved the issuance of 25,000  restricted common to Samuel Berry to satisfy consulting fees of $50,000, pursuant his agreement dated June 19, 2017. The shares were issued on November 13, 2017 and were valued at $1,200,000 based on the market value on the date the shares were approved for issuance, and $1,150,000 was recorded as a loss on settlement of debt on the statement of operations.

 

On June 19, 2019, the Company agreed to renew the Consulting Agreement dated June 19, 2017 for one year .

 

During the nine months ended September 30, 2019, the Company accrued $37,500 in consulting fees in connection to his agreement and made payments of $1,000.

 

On July 22, 2019, the Company appointed Samuel Berry as the Chief Financial Officer of the company. Mr. Berry was appointed as a Director on June 19, 2017. For accepting the position of CFO, Mr. Berry will receive $45,000 annual salary. On September 1, 2019, the agreement was voided, and therefore no fees were accrued.

 

Daniel Rushford, President, CEO, Secretary, Treasurer and Director

 

On August 28, 2017, the Company entered into an Employment Agreement with Mr. Daniel Rushford with regard to being appointed as the new Chief Executive Officer, President, Secretary, Treasurer and Member of the Board of Directors. Mr. Rushford will receive a monthly salary of $2,000 to be paid at the end of each month. Unpaid amounts will accrue annual interest of 6%. The term of the Consulting Agreement is for two years; renewable upon mutual consent.

 

On November 13, 2017, the Company issued 8,333 restricted common shares for $25,000 in share-based compensation that were valued at $95,000 based on the market value on the date of issuance, and $70,000 was recorded as a loss on settlement of debt. 

 

On January 2, 2018, the Company approved an increase in salary to $3,000 per month.

 

During the nine months ended September 30, 2019, the Company accrued wages and interest of $27,265 in connection with his agreement and made payments of $8,000.

16

 

9.INCOME TAXES

 

Deferred income taxes are determined using the liability method for the temporary differences between the financial reporting basis and income tax basis of the Company’s assets and liabilities. Deferred income taxes are measured based on the tax rates expected to be in effect when the temporary differences are included in the Company’s tax return. Deferred tax assets and liabilities are recognized based on anticipated future tax consequences attributable to differences between financial statement carrying amounts of assets and liabilities and their respective tax bases.

 

Operating loss carry forwards generated during the period from May 25, 2014 (date of inception) through September 30, 2019 of approximately $9,978,365 will begin to expire in 2034. The Company applies a statutory income tax rate of 21%. Accordingly, deferred tax assets related to net operating loss carry-forwards total approximately $2,095,457 at September 30, 2019.

 

All tax years since inception are open to examination by the Internal Revenue Service.

 

10.COMMITMENTS AND CONTINGENCIES

 

(1).IR Agreement

 

On March 28, 2017, the Company entered into an investor relations agreement with a third party, whereby the third party will provide advertising, promotional and marketing services for the Company between April 1, 2017 and July 1, 2017. In consideration of the foregoing services performed by the third party, the Company will pay a fee of 640 restricted shares on or before April 1, 2017. In addition, the third party will remain the owner of at least 1% of the company’s outstanding shares for a 1-year period. On April 1, 2018, the Company shall issue additional shares as necessary to bring the total number of shares paid to the third party to equal 1% of the outstanding shares of common stock as of 4/1/2018. In the event the Company does not issue the shares as required under this provision, the Company will be subject to a penalty of $5,000 per month until the shares are issued.

 

640 shares were issued on March 28, 2017 and valued at the fair market value on the date of grant totaling $96,000, which amount has been expensed as stock-based compensation as part of consulting expenses.

 

7,248 shares were issued on March 27, 2018 and valued at the fair market value on the date of grant totaling $39,139, which amount has been expensed as stock-based compensation as part of consulting expenses.

 

In respect to the investor relations agreement, 5 additional shares have been allocated for issuance effective May 16, 2017, and $825 has been expensed as stock-based compensation as part of consulting expenses due to 500 shares of common stock issued to a consultant.

 

The 5 shares were not issued as of September 30, 2019, and $825 is recorded on the balance sheet as liabilities for unissued shares.

 

(2).Consultant Agreement

 

On January 24, 2018, the Company entered into a Consulting Agreement with BAS1. The Company has agreed to pay BAS1 a fee of $10,000 for a 30-day marketing awareness program.

 

As of September 30, 2019, the Company paid of $7,500 to the advisor in respect to this agreement.

 

(3).Distribution Agreement

 

On February 23, 2018, the Company entered into an Exclusive Agreement for Distribution with a west coast distributor, whereby the distributor will exclusively distribute all Pet CDB Products owned by the Company. Furthermore, the distributor will purchase $3,000,000  of product at negotiable prices for a period of 24 months for distribution. As of September 30, 2019, this agreement is in affect.

17

 

On April 3, 2018, the Company agreed to enter in to a 12-month exclusive agreement with a west coast distributor, whereas the distributor has agreed to purchase $6.5M on Oral Pet Sprays from Vet Online Supply Inc. during the next 12 months. Vet Online Supply is allowing an exclusive agreement to purchase and place our CBD Pet products in California marijuana dispensaries through April 3, 2019. On April 3, 2019, the Company chose not to extend the agreement.

 

(4).Consultant Agreement

 

On March 1, 2018, the Company executed a Consulting Agreement whereby the Consultant will receive a retainer of $50,000 per month for nine months to revise an online retail website, Private-Label product contract and distribution for veterinarian supplies and holistic based pet products.

 

On March 15, 2018, the Company agreed to engage in an additional contract with the consultant for $200,000.

 

On October 1, 2018, the Company executed an additional Consulting Agreement whereby the Consultant will receive a fee of $350,000  to expand the business product sales, marketing and new product development, develop new distribution channels, and the development of a new subsidiary providing services in Cryptocurrency. This involves negotiating contracts, raising capital with new funding partners, and establishing the criteria to expand the Company’s business model.

 

During the nine months ended of September 30, 2019 and 2018, the Company paid $550 and $337,500, respectively, to the advisor in respect of these agreements.

 

As of September 30, 2019, the Company paid of $448,050 to the advisor in respect of these agreements. The balance due on these agreements is $151,950 and is due on or before December 31, 2019.

 

(5).Consultant Agreement

 

On August 1, 2018, the Company entered into a National Sales Rep Agreement for a period of three years, to recruit and manage new sales representatives. In consideration of services performed, the Company will pay a commission of 25% of gross proceeds to be paid in cash, and 10% of gross proceeds to be paid in restricted common stock. In addition, the Company has agreed to pay a fee of $25,000 in the form of restricted common stock upon signing of the Agreement.

 

The Company recorded $25,000 in respect to the value of unissued shares as liabilities for unissued shares and expensed $25,000 as stock-based compensation as part of consulting expenses. At September 30, 2019 the shares remained unissued.

 

11.SUBSEQUENT EVENTS

 

None.

18

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION

 

The following discussion and analysis summarizes the significant factors affecting our consolidated results of operations, financial condition and liquidity position for the three and nine months ended September 30, 2019. This discussion and analysis should be read in conjunction with our audited financial statements and notes thereto included in our Annual Report on Form 10-K for our year-ended December 31, 2018 and the consolidated unaudited financial statements and related notes included elsewhere in this filing. The following discussion and analysis contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements.

 

FORWARD-LOOKING STATEMENTS

 

This quarterly report contains forward-looking statements relating to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may”, “should”, “intends”, “expects”, “plans”, “anticipates”, “believes”, “estimates”, “predicts”, “potential”, or “continue” or the negative of these terms or other comparable terminology. These statements are only predictions and involve known and unknown risks, uncertainties and other factors which may cause our or our industry’s actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements.

 

Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity or performance. You should not place undue reliance on these statements, which speak only as of the date that they were made. These cautionary statements should be considered with any written or oral forward-looking statements that we may issue in the future. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to actual results, later events or circumstances or to reflect the occurrence of unanticipated events.

 

In this report unless otherwise specified, all dollar amounts are expressed in United States dollars and all references to “common shares” refer to the common shares of our capital stock.

 

The management’s discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”).

 

As used in this quarterly report, the terms “we”, “us”, “our”, and “our company” means Vet Online Supply, Inc., unless otherwise indicated.

 

Corporate Information

 

Vet Online Supply Inc. (the “Company”) is a Florida corporation incorporated on May 31, 2014. The Company engages in the online sale of its own holistic product line for pets, as well as targeting the larger Big-Box Pet retail suppliers, and during the first quarter of 2018, discontinued its legacy veterinarian supplies lines. The company discontinued its legacy line of products to increase margins and profitability with its own brand-name holistic products. These new holistic pet products are designed to help with arthritis, compromised immune systems, stress responses, aggression and digestive issues and may also be useful in treating acute ailments like sprains and strains, torn ligaments, bone breaks and even during post-operative care to reduce swelling, pain and stiffness. The Company’s web-based eCommerce platform with our products is on our website, www.vetonlinesupplies.com. The website gives our potential clients the ability to purchase quality pet products by placing their order any time of day at their convenience.

 

Distribution channels include its existing online retail sales platform and fulfillment, and direct sales through its global manufacturing sales representative network. Although selling pet products online is not entirely new to the company, we anticipate that this medium will continue to grow as our brand continues to achieve recognition. We believe that by providing high quality holistic pet products at competitive prices and to customers online, Vet Online Supply hopes to become a ‘go-to’ solution for pet owners everywhere. In addition, online vs. catalogue has the benefit of, among other things, search tools and accounts that remember previous purchases, and expedited ordering.

 

We hope to realize our full plan of operations by raising additional capital through the sale of our securities, and other financing strategies to fully implement our marketing plan. While we have designed a full marketing strategy to gain brand awareness, with a goal of developing a large opt-in customer base we have not yet raised sufficient capital to implement this strategy.

 

Other than as set out herein, we have not been involved in any bankruptcy, receivership or similar proceedings, nor have we been a party to any material reclassification, merger, consolidation or purchase or sale of a significant amount of assets not in the ordinary course of our business.

 

Liquidity and Capital Resources

 

The following discussion of our financial condition and results of operations should be read in conjunction with our unaudited financial statements for the nine months ended September 30, 2019 and audited financial statements for the year ended December 31, 2018, along with the accompanying notes, as filed with the Securities and Exchange Commission on Form 10-K on April 15, 2019.

19

 

Results for the Three Months Ended September 30, 2019 Compared to the Three Months Ended September 30, 2018

 

Revenues:

 

The Company’s revenues were $156 for the three months ended September 30, 2019 compared to $1,295 for the three months ended September 30, 2018.

 

Cost of Sales:

 

The Company’s cost of sales was $73 for the three months ended September 30, 2019 compared to $675 for the three months ended September 30, 2018. The decrease was due to fewer customer orders.

 

Operating Expenses:

 

Operating expenses consisted primarily of consulting fees, professional fees, salaries and wages, office expenses and fees associated with preparing reports and SEC filings relating to being a public company. Operating expenses for the three months ended September 30, 2019, and September 30, 2018 were $36,106 and $189,903, respectively. The decrease was primarily attributable to consulting fees accrued during the three months ended September 30, 2018. There were no new consulting agreements executed during the three months ended September 30, 2019.

 

Other Income (Expense):

 

Other income (expense) for the three months ended September 30, 2019 and September 30, 2018 was $(226,572) and $439,550, respectively. Other income (expense) consisted of gain or loss on derivative valuation and interest expense. The gain or loss on derivative valuation is directly attributable to the change in fair value of the derivative liability. Interest expense is primarily attributable the initial interest expense associated with the valuation of derivative instruments at issuance and the accretion of the convertible debentures over their respective terms. The variance primarily resulted from the fluctuation of the Company’s stock price which impacted the valuation of the derivative liabilities on the convertible debt.

 

Net Income (Loss):

 

Net income (loss) for the three months ended September 30, 2019 was $(262,595) compared with $250,267 for the three months ended September 30, 2018. The increased net loss can be explained by the loss in fair value of the derivative instruments in the three months ended September 30, 2019.

 

Results for the Nine Months Ended September 30, 2019 Compared to the Nine Months Ended September 30, 2018

 

Revenues:

 

The Company’s revenues were $1,521 for the nine months ended September 30, 2019 compared to $4,309 the nine months ended September 30, 2018.

 

Cost of Sales:

 

The Company’s cost of sales was $920 for the nine months ended September 30, 2019 compared to $2,200 for the nine months ended September 30, 2018.

20

 

Operating Expenses:

 

Operating expenses consisted primarily of consulting fees, professional fees, salaries and wages, office expenses and fees associated with preparing reports and SEC filings relating to being a public company. Operating expenses for the nine months ended September 30, 2019 and September 30, 2018 were $137,156 and $927,630, respectively. The decrease was primarily attributable to consulting fees accrued during the nine months ended September 30, 2018. There were no new consulting agreements executed during the nine months ended September 30, 2019.

 

Other Income (Expense):

 

Other income (expense) for the nine months ended September 30, 2019 and September 30, 2018 was $(408,596) and $(3,019,835), respectively. Other income (expense) consisted of gain or loss on derivative valuation and interest expense. The gain or loss on derivative valuation is directly attributable to the change in fair value of the derivative liability. Interest expense is primarily attributable the initial interest expense associated with the valuation of derivative instruments at issuance and the accretion of the convertible debentures over their respective terms. The variance primarily resulted from the fluctuation of the Company’s stock price which impacted the valuation of the derivative liabilities on the convertible debt.

 

Net Loss:

 

Net loss for the nine months ended September 30, 2019 was $545,151 compared with $3,945,356 for the nine months ended September 30, 2018. The decreased net loss can be explained by the decrease in operating expenses, and the gain in fair value of the derivative instruments in the nine months ended September 30, 2019.

 

Impact of Inflation

 

We believe that the rate of inflation has had a negligible effect on our operations.

 

Liquidity and Capital Resources

 

   September 30, 2019   December 31, 2018 
   $   $ 
Current Assets   22,999    31,600 
Current Liabilities   3,140,506    2,791,251 
Working Capital (Deficit)   (3,117,507)   (2,759,651)

 

As of September 30, 2019, we had $5,468 and $22,999 in cash and total assets, as well as $3,140,506 in total liabilities as compared to $10,640 and $31,600 in cash and total assets, and $2,791,251 in total liabilities as of December 31, 2018. The decrease in cash was due to a decrease in customer orders. The increase in total liabilities was primarily attributed to the increase in accounts payable and note payable accrued interest.

 

The Company requires additional capital to fully execute its marketing program and increase revenues. Presently we are relying on short term loans from our sole officer and director to meet operational shortfalls. There can be no assurance that continued funding will be available on satisfactory terms. We intend to raise additional capital through the sale of equity, loans or other short-term financing options.

 

   September 30, 2019
$
   September 30, 2018
$
 
Cash Flows from (used in) Operating Activities   (131,187)   (791,637)
Cash Flows from (used in) Investing Activities        
Cash Flows from (used in) Financing Activities   126,015    784,418 
Net Increase (decrease) in Cash During Period   (5,172)   (7,219)

21

 

During the nine months ended September 30, 2019, cash used in operating activities was $(131,187) compared to $(791,637) for the nine months ended September 30, 2018. The decrease primarily resulted from a decrease in consulting fees and interest expenses in 2019.  

 

During the nine months ended September 30, 2019 cash used in investing activities was $0 compared to $0 for the nine months ended September 30, 2018.

 

During the nine months ended September 30, 2019, cash from financing activity was $126,015 compared to $784,418 for the nine months ended September 30, 2018. The decrease in cash from financing activity primarily resulted from a decrease in the proceeds from convertible debt during the nine months ended September 30, 2019.

 

Contractual Obligations

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

 

Off-Balance Sheet Arrangements

 

We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to stockholders.

 

Critical Accounting Policies and Estimates

 

The preparation of our financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an on-going basis, management evaluates its estimates and judgments which are based on historical experience and on various other factors that are believed to be reasonable under the circumstances. The results of their evaluation form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions and circumstances. Our significant accounting policies are more fully discussed in the Notes to our Financial Statements, included herein.

 

Recent Accounting Pronouncements

 

The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

A smaller reporting company is not required to provide the information required by this Item.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Management’s Report on Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports filed under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our president and chief financial officer (our principal executive officer, principal financial officer and principal accounting officer) to allow for timely decisions regarding required disclosure.

22

 

As of the end of the quarter covered by this report, we carried out an evaluation, under the supervision and with the participation of our president and chief financial officer (our principal executive officer, principal financial officer and principal accounting officer), of the effectiveness of the design and operation of our disclosure controls and procedures. Based on the foregoing, our president and chief financial officer (our principal executive officer, principal financial officer and principal accounting officer) concluded that our disclosure controls and procedures were not effective as of the end of the period covered by this quarterly report. Our company is in the process of adopting specific internal control mechanisms to ensure effectiveness as we grow, and we will work to retain additional qualified individuals to ensure a proper segregation of duties. We have engaged an outside consultant to assist in adopting new measures to improve upon our internal controls. Future controls, among other things, will include more checks and balances and communication strategies between the management and the board, once we are able to secure additional board members, to ensure efficient and effective oversight over company activities as well as more stringent accounting policies to track and update our financial reporting.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting during the quarterly period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

PART II – OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

We know of no material, existing or pending legal proceedings against us, nor are we involved as a plaintiff in any material proceeding or pending litigation. There are no proceedings in which any of our directors, officers or affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our company.

 

ITEM 1A. RISK FACTORS

 

A smaller reporting company is not required to provide the information required by this Item.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

Quarterly Issuances

 

None.

 

In respect of the aforementioned convertible loan agreement(s) and the underlying shares, as well as shares issued to a director and consultant, the Company will claim an exemption from the registration requirements of the Securities Act of 1933, as amended, for the issuance of the shares pursuant to Section 4(2) of the Act and/or Rule 506 of Regulation D promulgated thereunder since, among other things, the transaction does not involve a public offering, the purchasers are “accredited investors” and/or qualified institutional buyers, the purchasers have access to information about the Company and its purchase, the purchasers will take the securities for investment and not resale.

 

Other than as disclosed above, there were no unregistered securities to report which were sold or issued by the Company without the registration of these securities under the Securities Act of 1933 in reliance on exemptions from such registration requirements, within the period covered by this report, which have not been previously included in a Quarterly Report on Form 10-Q or a Current Report on Form 8-K.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not Applicable.

 

ITEM 5. OTHER INFORMATION

 

None.

23

 

ITEM 6. EXHIBITS

 

Exhibit
Number
  Description
10.1   Securities Purchase Agreement and Convertible Note with EMA Financial, LLC, dated May 1, 2017
10.2   Securities Purchase Agreement and Convertible Note with Crown Bridge Partners LLC dated May 8, 2017
10.3   Securities Purchase Agreement and Convertible Note with Power Up Lending Group dated May 22, 2017
10.4   Securities Purchase Agreement and Convertible Note with LG Capital dated May 25, 2017
10.5   Securities Purchase Agreement and Convertible Note with Auctus Fund LLC dated June 16, 2017
10.6   Securities Purchase Agreement and Back End Convertible Note with Crown Bridge Partners LLC dated June 19, 2017
10.7   Convertible Promissory Note with LG Capital dated August 10, 2017
10.8   Convertible Promissory Note with APG Capital Holdings LLC dated November 20, 2017
10.9   Convertible Promissory Note with Power Up Lending Group dated November 20, 2017
10.10   Convertible Promissory Note with EMA Financial, LLC dated December 15, 2017
10.11   Convertible Promissory Note with Auctus Fund LLC dated January 1, 2018
10.12   Convertible Promissory Note with Auctus Fund LLC dated February 6, 2018
10.13   Convertible Promissory Note with Emerging Corporate Capital Financing, Inc. dated February 12, 2018
10.14   Convertible Promissory Note with Power Up Lending Group dated February 28, 2018
10.15   Convertible Promissory Note with EMA Financial, LLC dated March 5, 2018
10.16   Convertible Promissory Note with Power Up Lending Group dated April 12, 2018
10.17   Convertible Promissory Note with Power Up Lending Group dated May 3, 2018
10.18   Convertible Promissory Note with Auctus Fund LLC dated June 14, 2018
10.19   Convertible Promissory Note with Power Up Lending Group dated June 25, 2018
10.20   Convertible Promissory Note with APG Capital Holdings dated June 25, 2018
10.21   Convertible Promissory Note with Auctus Fund LLC dated August 13, 2018
31.1   Certification of the Chief Executive Officer required under Rule 13a-14(a)/15d-14(a) of the Exchange Act*
31.2   Certification of the Chief Financial Officer required under Rule 13a-14(a)/15d-14(a) of the Exchange Act*
32.1   Certification of the Chief Executive Officer and Chief Financial Officer required under Section 1350 of the Exchange Act*
101.INS   XBRL Instance Document*
101.SCH   XBRL Taxonomy Extension Schema*
101.CAL   XBRL Taxonomy Extension Calculation Linkbase*
101.DEF   XBRL Taxonomy Extension Definition Linkbase*
101.LAB   XBRL Taxonomy Extension Label Linkbase*
101.PRE   XBRL Taxonomy Extension Presentation Linkbase*

 

*Filed herewith

24

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

    VET ONLINE SUPPLY, INC.
       
Date:   November 13, 2019 By: /s/ Daniel Rushford
    Name:  Daniel Rushford
    Title: President, Chief Executive Officer, Chief Financial Officer, Director

25

EX-31 2 ex31-1.htm CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER REQUIRED UNDER RULE 13A-14(A)/15D-14(A) OF THE EXCHANGE ACT
 

Exhibit 31.1

 

CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO RULE 13a-14

 

I, Daniel Rushford, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of Vet Online Supply Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

  Date: November 13, 2019
  /s/ Daniel Rushford
  By: Daniel Rushford
  Its: Principal Executive Officer

 

EX-31 3 ex31-2.htm CERTIFICATION OF THE CHIEF FINANCIAL OFFICER REQUIRED UNDER RULE 13A-14(A)/15D-14(A) OF THE EXCHANGE ACT
 

Exhibit 31.2

 

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULE 13a-14

 

I, Daniel Rushford, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of Vet Online Supply Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

  Date: November 13, 2019
  /s/ Daniel Rushford
  By: Daniel Rushford
  Its: Principal Financial Officer

 

EX-32 4 ex32-1.htm CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER REQUIRED UNDER SECTION 1350 OF THE EXCHANGE ACT
 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Vet Online Supply Inc. (the “Company”) on Form 10-Q for the period ending September 30, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Daniel Rushford, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

/s/ Daniel Rushford  
By: Daniel Rushford
Principal Executive Officer and Principal Financial Officer
Dated: November 13, 2019

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

GRAPHIC 5 vo001_v1.jpg GRAPHIC begin 644 vo001_v1.jpg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end EX-101.INS 6 vtnl-20190930.xml XBRL INSTANCE FILE 0001641751 2019-01-01 2019-09-30 0001641751 2018-12-31 0001641751 2019-09-30 0001641751 2018-09-30 0001641751 2017-12-31 0001641751 us-gaap:RetainedEarningsMember 2019-09-30 0001641751 us-gaap:RetainedEarningsMember 2018-12-31 0001641751 us-gaap:CommonStockMember 2019-09-30 0001641751 us-gaap:CommonStockMember 2018-12-31 0001641751 us-gaap:TreasuryStockMember 2019-09-30 0001641751 us-gaap:TreasuryStockMember 2018-12-31 0001641751 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0001641751 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001641751 us-gaap:CommonStockMember 2017-12-31 0001641751 us-gaap:CommonStockMember 2018-09-30 0001641751 us-gaap:TreasuryStockMember 2017-12-31 0001641751 us-gaap:TreasuryStockMember 2018-09-30 0001641751 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001641751 us-gaap:AdditionalPaidInCapitalMember 2018-09-30 0001641751 us-gaap:RetainedEarningsMember 2017-12-31 0001641751 us-gaap:RetainedEarningsMember 2018-09-30 0001641751 us-gaap:SeriesAPreferredStockMember 2018-12-31 0001641751 us-gaap:SeriesAPreferredStockMember 2019-09-30 0001641751 us-gaap:SeriesBPreferredStockMember 2018-12-31 0001641751 us-gaap:SeriesBPreferredStockMember 2019-09-30 0001641751 us-gaap:SeriesBPreferredStockMember srt:PresidentMember 2018-03-01 0001641751 2018-04-30 0001641751 2018-01-01 2018-09-30 0001641751 vtnl:MrEdwardArudaMember 2019-01-01 2019-09-30 0001641751 vtnl:ConsultantAgreementMember srt:DirectorMember 2019-01-01 2019-09-30 0001641751 vtnl:ConsultantAgreementMember vtnl:DirectorOneMember 2017-06-01 2017-10-15 0001641751 vtnl:ConsultantAgreementMember vtnl:DirectorOneMember 2019-01-01 2019-09-30 0001641751 us-gaap:ConvertibleDebtMember 2019-01-01 2019-09-30 0001641751 us-gaap:ConvertibleDebtMember 2018-01-01 2018-09-30 0001641751 2019-07-01 2019-07-02 0001641751 vtnl:ConsultantAgreementMember 2017-05-16 0001641751 us-gaap:LiabilitiesTotalMember srt:MinimumMember 2019-01-01 2019-09-30 0001641751 us-gaap:LiabilitiesTotalMember srt:MaximumMember 2019-01-01 2019-09-30 0001641751 vtnl:ConsultantAgreementMember 2017-05-09 2017-05-16 0001641751 vtnl:InvestorRelationsAgreementMember 2017-05-09 2017-05-16 0001641751 vtnl:InvestorRelationsAgreementMember 2017-03-02 2017-03-28 0001641751 2017-03-02 2017-03-28 0001641751 srt:DirectorMember us-gaap:RestrictedStockMember 2017-03-22 2017-04-03 0001641751 vtnl:ConsultantAgreementMember vtnl:DirectorOneMember 2017-06-01 2017-06-19 0001641751 vtnl:MrEdwardArudaMember 2017-04-02 2017-04-07 0001641751 vtnl:ConsultantAgreementMember vtnl:DirectorOneMember 2017-09-01 2017-09-30 0001641751 vtnl:ConsultantAgreementMember srt:DirectorMember 2017-01-01 2017-11-13 0001641751 vtnl:ConsultantAgreementMember vtnl:DirectorOneMember us-gaap:RestrictedStockMember 2017-06-18 2017-06-19 0001641751 vtnl:ConsultantAgreementMember srt:DirectorMember 2017-03-22 2017-04-03 0001641751 2018-01-01 2018-12-31 0001641751 us-gaap:LiabilitiesTotalMember 2019-09-30 0001641751 us-gaap:LiabilitiesTotalMember srt:MinimumMember 2019-09-30 0001641751 us-gaap:LiabilitiesTotalMember srt:MaximumMember 2019-09-30 0001641751 us-gaap:LiabilitiesTotalMember 2019-01-01 2019-09-30 0001641751 vtnl:ConsultantAgreementMember vtnl:DirectorOneMember us-gaap:RestrictedStockMember 2017-06-19 0001641751 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeMember us-gaap:FairValueInputsLevel3Member 2018-12-31 0001641751 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeMember us-gaap:FairValueInputsLevel3Member 2019-09-30 0001641751 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeMember 2019-09-30 0001641751 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeMember 2018-12-31 0001641751 vtnl:ConsultantAgreementMember 2018-01-01 2018-09-30 0001641751 vtnl:APGCapital2Member 2018-12-31 0001641751 vtnl:APGCapital2Member 2019-09-30 0001641751 vtnl:AuctusFund2Member 2018-12-31 0001641751 vtnl:AuctusFund2Member 2019-09-30 0001641751 vtnl:AuctusFund3Member 2018-12-31 0001641751 vtnl:AuctusFund3Member 2019-09-30 0001641751 vtnl:AuctusFund4Member 2018-12-31 0001641751 vtnl:AuctusFund4Member 2019-09-30 0001641751 vtnl:AuctusFund5Member 2018-12-31 0001641751 vtnl:AuctusFund5Member 2019-09-30 0001641751 vtnl:AuctusFund6Member 2018-12-31 0001641751 vtnl:AuctusFund6Member 2019-09-30 0001641751 vtnl:EMAFinancial2Member 2018-12-31 0001641751 vtnl:EMAFinancial2Member 2019-09-30 0001641751 vtnl:EMAFinancial3Member 2018-12-31 0001641751 vtnl:EMAFinancial3Member 2019-09-30 0001641751 vtnl:EmergingCorpCapitalMember 2018-12-31 0001641751 vtnl:EmergingCorpCapitalMember 2019-09-30 0001641751 vtnl:PowerUpLending8Member 2018-12-31 0001641751 vtnl:PowerUpLending8Member 2019-09-30 0001641751 vtnl:AuctusFund7Member 2018-12-31 0001641751 vtnl:AuctusFund7Member 2019-09-30 0001641751 vtnl:AuctusFund8Member 2018-12-31 0001641751 vtnl:AuctusFund8Member 2019-09-30 0001641751 vtnl:EMAFinancial4Member 2018-12-31 0001641751 vtnl:EMAFinancial4Member 2019-09-30 0001641751 vtnl:EmergingCorpCapital2Member 2018-12-31 0001641751 vtnl:EmergingCorpCapital2Member 2019-09-30 0001641751 vtnl:APGCapital2Member 2019-01-01 2019-09-30 0001641751 vtnl:AuctusFund2Member 2019-01-01 2019-09-30 0001641751 vtnl:AuctusFund3Member 2019-01-01 2019-09-30 0001641751 vtnl:AuctusFund4Member 2019-01-01 2019-09-30 0001641751 vtnl:AuctusFund5Member 2019-01-01 2019-09-30 0001641751 vtnl:AuctusFund6Member 2019-01-01 2019-09-30 0001641751 vtnl:EMAFinancial2Member 2019-01-01 2019-09-30 0001641751 vtnl:EMAFinancial3Member 2019-01-01 2019-09-30 0001641751 vtnl:EmergingCorpCapitalMember 2019-01-01 2019-09-30 0001641751 vtnl:PowerUpLending8Member 2019-01-01 2019-09-30 0001641751 vtnl:AuctusFund7Member 2019-01-01 2019-09-30 0001641751 vtnl:AuctusFund8Member 2019-01-01 2019-09-30 0001641751 vtnl:EMAFinancial4Member 2019-01-01 2019-09-30 0001641751 vtnl:EmergingCorpCapital2Member 2019-01-01 2019-09-30 0001641751 2019-11-08 0001641751 2019-07-01 2019-09-30 0001641751 2018-07-01 2018-09-30 0001641751 us-gaap:CommonStockMember 2018-07-01 2018-09-30 0001641751 us-gaap:CommonStockMember 2019-07-01 2019-09-30 0001641751 us-gaap:CommonStockMember 2018-06-30 0001641751 us-gaap:CommonStockMember 2019-06-30 0001641751 us-gaap:TreasuryStockMember 2018-07-01 2018-09-30 0001641751 us-gaap:TreasuryStockMember 2019-07-01 2019-09-30 0001641751 us-gaap:TreasuryStockMember 2018-06-30 0001641751 us-gaap:TreasuryStockMember 2019-06-30 0001641751 us-gaap:AdditionalPaidInCapitalMember 2018-07-01 2018-09-30 0001641751 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0001641751 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0001641751 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001641751 us-gaap:RetainedEarningsMember 2018-07-01 2018-09-30 0001641751 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0001641751 us-gaap:RetainedEarningsMember 2018-06-30 0001641751 us-gaap:RetainedEarningsMember 2019-06-30 0001641751 2018-06-30 0001641751 2019-06-30 0001641751 us-gaap:SeriesBPreferredStockMember 2017-03-28 0001641751 us-gaap:SeriesBPreferredStockMember 2017-03-27 2017-03-28 0001641751 us-gaap:SeriesAPreferredStockMember 2018-10-24 2018-10-25 0001641751 us-gaap:SeriesAPreferredStockMember 2018-10-25 0001641751 2018-03-26 2018-03-27 0001641751 us-gaap:ConvertibleDebtMember 2019-07-01 2019-09-30 0001641751 us-gaap:ConvertibleDebtMember 2018-07-01 2018-09-30 0001641751 vtnl:AuctusFund9Member 2019-01-01 2019-09-30 0001641751 vtnl:AuctusFund9Member 2019-09-30 0001641751 vtnl:AuctusFund9Member 2018-12-31 0001641751 us-gaap:PreferredStockMember 2019-01-01 2019-03-31 0001641751 us-gaap:PreferredStockMember 2019-04-01 2019-06-30 0001641751 us-gaap:PreferredStockMember 2019-07-01 2019-09-30 0001641751 us-gaap:PreferredStockMember 2018-07-01 2018-09-30 0001641751 us-gaap:PreferredStockMember 2018-04-01 2018-06-30 0001641751 us-gaap:PreferredStockMember 2018-01-01 2018-03-31 0001641751 us-gaap:PreferredStockMember 2018-12-31 0001641751 us-gaap:PreferredStockMember 2019-03-31 0001641751 us-gaap:PreferredStockMember 2019-06-30 0001641751 us-gaap:PreferredStockMember 2019-09-30 0001641751 us-gaap:PreferredStockMember 2018-06-30 0001641751 us-gaap:PreferredStockMember 2018-09-30 0001641751 us-gaap:PreferredStockMember 2018-03-31 0001641751 us-gaap:PreferredStockMember 2017-12-31 0001641751 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001641751 us-gaap:CommonStockMember 2019-04-01 2019-06-30 0001641751 us-gaap:CommonStockMember 2018-04-01 2018-06-30 0001641751 us-gaap:CommonStockMember 2018-01-01 2018-03-31 0001641751 us-gaap:CommonStockMember 2019-03-31 0001641751 us-gaap:CommonStockMember 2018-03-31 0001641751 us-gaap:TreasuryStockMember 2019-01-01 2019-03-31 0001641751 us-gaap:TreasuryStockMember 2019-04-01 2019-06-30 0001641751 us-gaap:TreasuryStockMember 2018-04-01 2018-06-30 0001641751 us-gaap:TreasuryStockMember 2018-01-01 2018-03-31 0001641751 us-gaap:TreasuryStockMember 2019-03-31 0001641751 us-gaap:TreasuryStockMember 2018-03-31 0001641751 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001641751 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0001641751 us-gaap:AdditionalPaidInCapitalMember 2018-04-01 2018-06-30 0001641751 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-03-31 0001641751 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001641751 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0001641751 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001641751 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001641751 us-gaap:RetainedEarningsMember 2018-04-01 2018-06-30 0001641751 us-gaap:RetainedEarningsMember 2018-01-01 2018-03-31 0001641751 us-gaap:RetainedEarningsMember 2019-03-31 0001641751 us-gaap:RetainedEarningsMember 2018-03-31 0001641751 2019-01-01 2019-03-31 0001641751 2019-04-01 2019-06-30 0001641751 2018-04-01 2018-06-30 0001641751 2018-01-01 2018-03-31 0001641751 2019-03-31 0001641751 2018-03-31 0001641751 2019-04-21 2019-04-22 0001641751 vtnl:AuctusFund10Member 2019-01-01 2019-09-30 0001641751 vtnl:AuctusFund10Member 2018-12-31 0001641751 vtnl:AuctusFund10Member 2019-09-30 0001641751 us-gaap:SeriesAPreferredStockMember 2019-07-02 0001641751 vtnl:Warrant1Member 2019-01-01 2019-09-30 0001641751 vtnl:Warrant1Member 2019-09-30 0001641751 vtnl:Warrant2Member 2019-01-01 2019-09-30 0001641751 vtnl:Warrant2Member 2019-09-30 0001641751 vtnl:Warrant3Member 2019-01-01 2019-09-30 0001641751 vtnl:Warrant3Member 2019-09-30 0001641751 vtnl:Warrant4Member 2019-01-01 2019-09-30 0001641751 vtnl:Warrant4Member 2019-09-30 0001641751 vtnl:Warrant5Member 2019-01-01 2019-09-30 0001641751 vtnl:Warrant5Member 2019-09-30 0001641751 vtnl:Warrant6Member 2019-01-01 2019-09-30 0001641751 vtnl:Warrant6Member 2019-09-30 0001641751 vtnl:Warrant7Member 2019-01-01 2019-09-30 0001641751 vtnl:Warrant7Member 2019-09-30 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure 10640 5468 9601 31600 22999 31600 22999 567250 569519 29267 82032 555224 826820 61586 189143 1426982 1322116 625214 150825 150825 2791251 3140506 2791251 3140506 1498 1942 6672064 6858915 -9433214 -9978365 -2759651 -3117507 -2714608 -959890 -9978365 -9433214 1942 1498 6858915 6672064 223 918 19 3904473 6094435 -4864606 -8809962 846 1942 5926129 6858915 -9060229 -9715770 -3133253 -2854912 1 1 1 1 1 1 1 1 1942 732 6858915 5540560 -9633307 -8818710 -2772449 -3277417 31600 22999 0 0 1000 1000 1000 0.001 0.001 50000000000 50000000000 50000000000 1498038 1942319 1498038 1942319 1942319 1498038 223070 917959 845809 1942319 1000 1000 1000 1000 1000 1000 1000 1000 1942319 731950 601 2109 83 620 16482 53528 3357 7323 54446 75329 10749 8400 39228 771773 40000 75000 50000 16667 13000 165180 137156 927630 36106 189903 -136555 -925521 -36023 -189283 487137 1088949 132495 52495 126202 374760 48741 23461 78541 -1930886 -100370 814310 -408596 -3019835 -226572 439550 -545151 -3945356 -262595 250267 250267 -262595 -200093 -82463 -241519 -3954104 -200093 -82463 -241519 -3954104 352879 976978 2269 108041 -131187 -791637 73250 774500 126015 784418 -5172 -7219 10640 16820 On July 1, 2019, the Company filed a Certificate of Amendment to increase the number of authorized Series A Preferred Stock to 30,000,000, with a par value of $0.001. Each share of Preferred Series A Stock shall have a value of $10 per share and will convert into common stock at the closing price of the common stock on the date of conversion. The Series A stock shall have no voting rights on corporate matters, unless and until the Series A shares are converted into Common Shares, at which time they will have the same voting rights as all Common Shareholders have; their consent shall not be required for taking any corporate action. 0.01 1.857 5.6821 P1M13D P5Y 0.0171 0.0244 67500 825 39139 In consideration of the foregoing services performed by the third party, the Company will pay a fee of 1,920,000 restricted shares on or before April 1, 2017. In addition, the third party will remain the owner of at least 1% of the company's outstanding shares for a 1 year period. On April 1, 2018, the Company shall issue additional shares as necessary to bring the total number of shares paid to the third party to equal 1% of the outstanding shares of common stock as of 4/1/2018. In the event the Company does not issue the shares as required under this provision, the Company will be subject to a penalty of $5,000 per month until the shares are issued. 1920000 2000000 1000000 7248 90 7158 140000 96000 21000 50000 2034-12-31 0.21 2095457 1500000 1500000 14760 1150000 1150000 39139 50000 15000 50000 50000 0 7 486 38646 486 38653 0.055 82500 1200000 15000 Entered into a consulting agreement with Mr. Scott for a term of one year, where under Mr. Scott shall receive an annual fee of $100,000 payable in quarterly installments 50000 12500 5000 P1Y -545151 -3945356 -262595 250267 165563 5441395 -121575 -1958802 -121575 -121575 -148854 -2680825 0.0001 0.00005 0.03 27000 27000 9000 9000 70313 4058576 -133995 -111972 52765 9918 P90D -97416 14750 127833 -313258 .0000 2000000 25000 140000 0.05 75000000 1000000 25000000 1200000 1200000 9978365 -148855 -2127690 35 51 17960 17375 1521 4309 156 1295 920 2200 73 675 16 35 585 -38332 1426982 1322116 1322116 1426982 -82 64220 406330 59282 390478 168378 72 168306 444 114 435 308426 385083 1597489 308870 385197 1597924 352879 976978 14475 500 904529 933247 31500 31500 47373 31285 175000 175000 90000 90000 100000 100000 75000 75000 8474 8474 83499 73305 74933 74933 33000 25000 25000 25750 25750 25000 25000 110000 110000 57000 31000 0.24 0.24 0.24 0.24 0.24 0.24 0.24 0.24 0.22 0.12 0.24 0.24 0.24 0.12 0.12 0.12 2019-06-25 2018-10-10 2018-11-06 2018-12-06 2019-03-14 2019-05-13 2018-12-15 2019-03-05 2019-02-11 2019-04-15 2019-07-11 2019-09-20 2019-07-10 2019-10-31 2020-01-12 2020-07-22 2018-06-25 2018-01-10 2018-02-06 2018-03-06 2018-06-14 2018-08-13 2017-12-15 2018-03-05 2018-02-12 2018-06-25 2018-10-11 2018-12-20 2018-10-10 2018-10-31 2019-04-12 2019-07-22 31500 84000 175000 90000 100000 75000 50000 100000 83333 33000 25000 25750 25000 110000 57000 31000 -9011 -36047 82 3000 1 1 0.001 0.001 0.001 0.001 0.001 0.001 0.001 30000000 30000000 10000000 10000000 20000 2000000 30000000 0 0 1000 1000 72150 444281 113769 435214 -19 19 67 -67 66508 3000 156 -156 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial assets and liabilities measured at fair value on a recurring basis:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="text-align: center; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">Input</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">September 30, 2019</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">December 31, 2018</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="text-align: center; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">Level</td> <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">Fair Value</td> <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">Fair Value</td> <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="width: 59%; text-align: justify; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">Derivative Liability</td> <td style="width: 2%; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 11%; text-align: center; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">3</td> <td style="width: 2%; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">$</td> <td style="width: 10%; text-align: right; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">1,322,116</td> <td style="width: 1%; text-align: left; padding-bottom: 1pt; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 2%; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">$</td> <td style="width: 10%; text-align: right; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">1,426,982</td> <td style="width: 1%; text-align: left; padding-bottom: 1pt; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="text-align: justify; padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif">Total Financial Liabilities</td> <td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; border-bottom: black 2.5pt double; font: 10pt Times New Roman, Times, Serif">$</td> <td style="text-align: right; border-bottom: black 2.5pt double; font: 10pt Times New Roman, Times, Serif">1,322,116</td> <td style="text-align: left; padding-bottom: 2.5pt; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; border-bottom: black 2.5pt double; font: 10pt Times New Roman, Times, Serif">$</td> <td style="text-align: right; border-bottom: black 2.5pt double; font: 10pt Times New Roman, Times, Serif">1,426,982</td> <td style="text-align: left; padding-bottom: 2.5pt; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> </table> 4000 5850 200 The Series B Voting Preferred Stock shall have the right to vote the shares on any matter requiring shareholder approval on the basis of 4 times the votes of all the issued and outstanding shares of common stock, as well as any issued and outstanding preferred stock. The holders shall have no voting rights on corporate matters, unless and until they convert their Series A shares into Common Shares, at which time they will have the same voting rights as all Common Shareholders have; their consent shall not be required for taking any corporate action. 4938 15852 0 6964 2019-09-30 --12-31 Vet Online Supply Inc 0001641751 Yes Non-accelerated Filer true true false 1943330 10-Q false 2019 Q3 000-55787 47-0990750 FL 6500 Live Oak Drive Kelseyville CA 95451 415 756-4057 Yes 1874134 670913 1942319 888127 -0.29088 -5.8806 -0.1352 0.2818 0.1088 2301072 25000 5047 <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0px; margin-bottom: 0pt; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <td style="width: 0.3in; text-align: left; font: 10pt Times New Roman, Times, Serif"><b>1.</b></td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><b>BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Organization and Description of Business</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Vet Online Supply Inc. (the &#8220;Company&#8221;) is a Florida corporation incorporated on May 31, 2014. The Company engages in the online sale of its own holistic product line for pets, as well as targeting the larger Big-Box Pet retail suppliers, and during the first quarter of 2018, discontinued its legacy veterinarian supplies lines. The company discontinued its legacy line of products to increase margins and profitability with its own brand-name holistic products. These new holistic pet products are designed to help with arthritis, compromised immune systems, stress responses, aggression and digestive issues and may also be useful in treating acute ailments like sprains and strains, torn ligaments, bone breaks and even during post-operative care to reduce swelling, pain and stiffness. The Company&#8217;s web-based eCommerce platform with our products is on our website, www.vetonlinesupplies.com. The website gives our potential clients the ability to purchase quality pet products by placing their order any time of day at their convenience.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Distribution channels include its existing online retail sales platform and fulfillment, and direct sales through its global manufacturing sales representative network. Although selling pet products online is not entirely new to the company, we anticipate that this medium will continue to grow as our brand continues to achieve recognition. We believe that by providing high quality holistic pet products at competitive prices and to customers online, Vet Online Supply hopes to become a &#8216;go-to&#8217; solution for pet owners everywhere. In addition, online vs. catalogue has the benefit of, among other things, search tools and accounts that remember previous purchases, and expedited ordering.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 22, 2019, the Company approved the authorization of a 1 for 3,000 reverse stock split of the Company&#8217;s outstanding shares of common stock. The Company&#8217;s financial statements have been retroactively adjusted for this stock split for all periods presented.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 1, 2019, the Company filed a Certificate of Amendment to increase the number of authorized Series A Preferred Stock to 30,000,000, with a par value of $0.001. Each share of Preferred Series A Stock shall have a value of $10 per share and will convert into common stock at the closing price of the common stock on the date of conversion. The Series A stock shall have no voting rights on corporate matters, unless and until the Series A shares are converted into Common Shares, at which time they will have the same voting rights as all Common Shareholders have; their consent shall not be required for taking any corporate action.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">To date, our activities have been limited to formation, the raising of equity capital, and the initial stages of implementation of our business plan. We filed a Form S-1 Registration Statement with the U.S. Securities and Exchange Commission, received a notice of effect and trade on the OTC Markets, PINK under the symbol VTNL. We are continuing to explore additional sources of capital. We anticipate incurring operating losses as we continue to implement our business plan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Financial Statement Presentation</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The audited financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Fiscal year end</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has selected December 31 as its fiscal year end.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Use of Estimates</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported therein. Due to the inherent uncertainty involved in making estimates, actual results reported in future periods may be based upon amounts that differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Cash Equivalents</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company considers all highly liquid investments with maturities of 90 days or less from the date of purchase to be cash equivalents.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Revenue Recognition and Related Allowances</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company adopted ASU No. 2014-09, &#8220;Revenue from Contracts with Customers&#8221; (&#8220;ASU 2014-09&#8221;) as amended, as of January 1, 2018 with no material impact. The Company primarily generates net revenue through product sales to distributors and to retail customers on its website. Revenue is recognized upon transfer of control of promised products to customers which is generally upon shipment in an amount that reflects the consideration we expect to receive in exchange for those products or services. Revenue is recognized net of allowances for returns and any taxes collected from customers, which are subsequently remitted to governmental authorities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Accounts Receivable and Allowance for Doubtful Accounts</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts receivable are stated at the amount that management expects to collect from outstanding balances. Bad debts and allowances are provided based on historical experience and management&#8217;s evaluation of outstanding accounts receivable. Management evaluates past due or delinquency of accounts receivable based on the open invoices aged on due date basis. The allowance for doubtful accounts at September 30, 2019 and December 31, 2018 is $0.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Inventories</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is a manufacturer of premium CBD infused holistic pet products and as such will maintain inventory on site. The company directly drop ships to customers when ordered. The Company has wholesale distributors that purchase products in bulk inventory.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Warranty</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is a manufacturer of products which are shipped to our customers directly from the company and as a result, there are costs that may be incurred by the Company under the terms of the limited warranty provided by the company directly to the purchasers. We provide provisions for obligations which may arise under manufacturer&#8217;s warranties and therefore incur liabilities. We warranty the product for packaging and shipping.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Advertising and Marketing Costs</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The company provides website online marketing of its products, as well as wholesalers who market the product. The company also utilises various public press releases to provide public information about its product line and future products under development. Advertising and marketing costs are expensed as incurred for the three and nine months ended September 30, 2019 were $200 and $4,000, respectively. ($5,850 &#8211; December 31, 2018).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Fair Value of Financial Instruments</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fair value is defined as the price that would be received upon sale of an asset or paid upon transfer of a liability in an orderly transaction between market participants at the measurement date and in the principal or most advantageous market for that asset or liability. The fair value should be calculated based on assumptions that market participants would use in pricing the asset or liability, not on assumptions specific to the entity. In addition, the fair value of liabilities should include consideration of non-performance risk including our own credit risk.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition to defining fair value, the standard expands the disclosure requirements around fair value and establishes a fair value hierarchy for valuation inputs is expanded. The hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of the three levels and which is determined by the lowest level input that is significant to the fair value measurement in its entirety.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">These levels are:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 1 - inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 2 - inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 3 - inputs are generally unobservable and typically reflect management&#8217;s estimates of assumptions that market participants would use in pricing the asset or liability. The fair values are therefore determined using model-based techniques that include option pricing models, discounted cash flow models, and similar techniques.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial assets and liabilities measured at fair value on a recurring basis:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="text-align: center; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">Input</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">September 30, 2019</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">December 31, 2018</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="text-align: center; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">Level</td> <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">Fair Value</td> <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">Fair Value</td> <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="width: 59%; text-align: justify; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">Derivative Liability</td> <td style="width: 2%; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 11%; text-align: center; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">3</td> <td style="width: 2%; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">$</td> <td style="width: 10%; text-align: right; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">1,322,116</td> <td style="width: 1%; text-align: left; padding-bottom: 1pt; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 2%; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">$</td> <td style="width: 10%; text-align: right; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">1,426,982</td> <td style="width: 1%; text-align: left; padding-bottom: 1pt; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="text-align: justify; padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif">Total Financial Liabilities</td> <td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; border-bottom: black 2.5pt double; font: 10pt Times New Roman, Times, Serif">$</td> <td style="text-align: right; border-bottom: black 2.5pt double; font: 10pt Times New Roman, Times, Serif">1,322,116</td> <td style="text-align: left; padding-bottom: 2.5pt; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; border-bottom: black 2.5pt double; font: 10pt Times New Roman, Times, Serif">$</td> <td style="text-align: right; border-bottom: black 2.5pt double; font: 10pt Times New Roman, Times, Serif">1,426,982</td> <td style="text-align: left; padding-bottom: 2.5pt; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In management&#8217;s opinion, the fair value of convertible notes payable and advances payable is approximate to carrying value as the interest rates and other features of these instruments approximate those obtainable for similar instruments in the current market. Unless otherwise noted, it is management&#8217;s opinion that the Company is not exposed to significant interest, exchange or credit risks arising from these financial instruments. As of September 30, 2019 and December 31, 2018, the balances reported for cash, accounts receivable, prepaid expenses, accounts payable, and accrued liabilities, approximate the fair value because of their short maturities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Income taxes</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;The Company has adopted SFAS No. 109 &#8211; &#8220;Accounting for Income Taxes&#8221;. ASC Topic 740 requires the use of the asset and liability method of accounting for income taxes. Under the asset and liability method of ASC Topic 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Basic and Diluted Loss Per Share</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with ASC Topic 280 &#8211; &#8220;Earnings Per Share&#8221;, the basic loss per common share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding. Diluted loss per common share is computed similar to basic loss per common share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Recent Accounting Pronouncements</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In May 2014, the FASB issued ASU No. 2014-09, <i>Revenue from Contracts with Customers (Topic 606)</i>, which replaces existing revenue recognition guidance. The updated guidance requires companies to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, the new standard requires that reporting companies disclose the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The Company adopted the standard on January 1, 2018, using a modified retrospective approach, with the cumulative effect of initially applying the standard recognized in retained earnings at the date of adoption.</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0px; margin-bottom: 0pt; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <td style="width: 0.3in; text-align: left; font: 10pt Times New Roman, Times, Serif"><b>2.</b></td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><b>GOING CONCERN</b></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0px; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">The Company has experienced net losses to date, and it has not generated sufficient revenue from operations to meet our operational overhead. We will need additional working capital to service debt and for ongoing operations, which raises substantial doubt about our ability to continue as a going concern. Management of the Company is preparing a strategy to meet operational shortfalls which may include equity funding, short term or long-term financing or debt financing, to enable the Company to&#160;reach profitable operations. Historically, the Company&#8217;s sole officer and director has provided short term loans to meet working capital shortfalls. We have recently entered into financing agreements with various third parties to meet our capital needs in fiscal 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">The accompanying financial statements do not include any adjustments related to the recoverability or classification of asset-carrying amounts or the amounts and classification of liabilities that may result should the Company be unable to continue as a going concern.</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0px; margin-bottom: 0pt; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <td style="width: 0.3in; text-align: left; font: 10pt Times New Roman, Times, Serif"><b>3.</b></td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><b>PREPAID EXPENSES</b></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="text-align: center; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">September 30,</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">December 31,</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="text-align: center; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">2019</td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">2018</td> <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="width: 72%; text-align: left; font: 10pt Times New Roman, Times, Serif">Prepaid expenses</td> <td style="width: 2%; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif">$</td> <td style="width: 10%; text-align: right; font: 10pt Times New Roman, Times, Serif">&#8212;</td> <td style="width: 1%; text-align: left; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 2%; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif">$</td> <td style="width: 10%; text-align: right; font: 10pt Times New Roman, Times, Serif">3,000</td> <td style="width: 1%; text-align: left; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">Prepaid fees represent amounts paid in advance for future contractual benefits to be received. Contracting expenses paid in advance are recorded as a prepaid asset and then amortized to the statements of operations when services are rendered, or over the life of the contract using the straight-line method.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">During the nine months ended September 30, 2019, the Company reclassed prepaid employee wages that were paid during the year ended December 31, 2018.</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0px; margin-bottom: 0pt; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <td style="width: 0.3in; text-align: left; font: 10pt Times New Roman, Times, Serif"><b>4.</b></td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><b>CONVERTIBLE NOTES PAYABLE</b></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0px; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0px; text-align: justify">As of September 30, 2019 and December 31, 2018, notes payable were comprised of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0px; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="text-align: center; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">Original</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">Original</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">Due</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">Interest</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">Conversion</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">September 30,</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">December 31,</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="text-align: center; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">Amount</td> <td style="text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">Note Date</td> <td style="text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">Date</td> <td style="text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">Rate</td> <td style="text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">Rate</td> <td style="text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">2019</td> <td style="text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">2018</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="width: 24%; text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">APG Capital #2</td> <td style="width: 3%; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 9%; text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;31,500</td> <td style="width: 1%; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 9%; text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">6/25/2018</td> <td style="width: 1%; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 9%; text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">6/25/2019</td> <td style="width: 1%; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 9%; text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">24%</td> <td style="width: 1%; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 9%; text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Variable</td> <td style="width: 1%; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 9%; text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">31,500</td> <td style="width: 1%; text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 9%; text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">31,500</td> <td style="width: 1%; text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Auctus Fund #2</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;84,000</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">1/10/2018</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">10/10/2018</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">24%</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Variable</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">31,285</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">47,373</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Auctus Fund #3</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;175,000</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">2/6/2018</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">11/6/2018</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">24%</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Variable</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">175,000</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">175,000</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Auctus Fund #4</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;90,000</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">3/6/2018</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">12/6/2018</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">24%</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Variable</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">90,000</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">90,000</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Auctus Fund #5</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;100,000</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">6/14/2018</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">3/14/2019</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">24%</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Variable</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">100,000</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">100,000</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Auctus Fund #6</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;75,000</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">8/13/2018</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">5/13/2019</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">24%</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Variable</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">75,000</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">75,000</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Auctus Fund #7</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;25,000</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">10/11/2018</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">7/11/2019</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">24%</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Variable</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">25,000</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">25,000</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Auctus Fund #8</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;25,750</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">12/20/2018</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">9/20/2019</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">24%</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Variable</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">25,750</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">25,750</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Auctus Fund #9</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;57,000</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">4/12/2019</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">1/12/2020</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">12%</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Variable</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">57,000</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#8212;</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Auctus Fund #10</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;31,000</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">7/22/2019</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">7/22/2020</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">12%</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Variable</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">31,000</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#8212;</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">EMA Financial #2</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;50,000</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">12/15/2017</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">12/15/2018</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">24%</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Variable</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">8,474</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">8,474</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">EMA Financial #3</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;100,000</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">3/5/2018</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">3/5/2019</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">24%</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Variable</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">73,305</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">83,499</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">EMA Financial #4</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;25,000</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">10/10/2018</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">7/10/2019</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">24%</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Variable</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">25,000</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">25,000</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Emerging Corp #1</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;83,333</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">2/12/2018</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">2/11/2019</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">22%</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Variable</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">74,933</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">74,933</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Emerging Corp #2</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;110,000</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">10/31/2018</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">10/31/2019</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">12%</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Variable</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">110,000</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">110,000</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Power Up Lending #8</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;33,000</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">6/25/2018</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">4/15/2019</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">12%</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Variable</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#8212;</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">33,000</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">933,247</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">904,529</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td colspan="11" style="padding-left: 17.3pt; text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Debt discount</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">(97,416</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">)</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">(313,258</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td colspan="11" style="padding-left: 17.3pt; text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Financing costs/Original issue discount</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">(9,011</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">)</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">(36,047</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td colspan="11" style="padding-left: 17.3pt; text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Notes payable, net of discount</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; border-bottom: black 2.5pt double; font: 10pt Times New Roman, Times, Serif">$</td> <td style="text-align: right; text-indent: 0px; border-bottom: black 2.5pt double; font: 10pt Times New Roman, Times, Serif">826,820</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; border-bottom: black 2.5pt double; font: 10pt Times New Roman, Times, Serif">$</td> <td style="text-align: right; text-indent: 0px; border-bottom: black 2.5pt double; font: 10pt Times New Roman, Times, Serif">555,224</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">During the nine months ending September 30, 2019, the Company received proceeds from new convertible notes of $73,250. The Company recorded no payments on their convertible notes, and conversions of $59,282 of convertible note principal. The Company recorded loan fees on new convertible notes of $14,750, which increased the debt discounts recorded on the convertible notes during the nine months ending September 30, 2018. All of the Company&#8217;s convertible notes have a conversion rate that is variable, and therefore, the Company has accounted for their conversion features as derivative instruments (see Note 5). The Company also recorded amortization of $352,879 on their convertible note debt discounts and loan fees. As of September 30, 2019, the convertible notes payable are convertible into 21,183,475,536 &#160;shares of the Company&#8217;s common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">During the nine months ending September 30, 2018, the Company received proceeds from new convertible notes of $774,500. The Company recorded no payments on their convertible notes, and conversions of $390,478 of convertible note principal. The Company recorded penalties of $47,727, of which $32,762 was converted into the Company&#8217;s common stock. The Company recorded loan fees on new convertible notes of $127,833, which increased the debt discounts recorded on the convertible notes during the nine months ending September 30, 2018. All of the Company&#8217;s convertible notes have a conversion rate that is variable, and therefore, the Company has accounted for their conversion features as derivative instruments (see Note 5). The Company also recorded amortization of $976,978 on their convertible note debt discounts and loan fees. &#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">During the three months ended September 30, 2019 and 2018, the Company recorded interest expense of $48,741 and $23,461, respectively, on its convertible notes payable. During the three months ended September 30,2019 and 2018, the Company recorded conversions of $0 and $6,964, respectively of convertible note interest.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">During the nine months ended September 30, 2019 and 2018, the Company recorded interest expense of $132,495 and $52,495, respectively, on its convertible notes payable. During the nine months ended September 30, 2019 and 2018, the Company recorded conversions of $4,938 and $15,852, respectively of convertible note interest. &#160;As of September 30, 2019 and 2018, the accrued interest balance was $189,143 and $42,876, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">As of September 30, 2019, we have not attained profitable operations and are dependent upon obtaining financing to pursue any extensive acquisitions and activities.</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0px; margin-bottom: 0pt; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <td style="width: 0.3in; text-align: left; font: 10pt Times New Roman, Times, Serif"><b>5.</b></td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><b>DERIVATIVE LIABILITIES</b></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">The following table represents the Company&#8217;s derivative liability activity for the embedded conversion features for the periods ending September 30, 2019 and December 31, 2018:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="text-align: center; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">September 30,</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">December 31,</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="text-align: center; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">2019</td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">2018</td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="width: 72%; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Balance, beginning of period</td> <td style="width: 2%; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif">$</td> <td style="width: 10%; text-align: right; font: 10pt Times New Roman, Times, Serif">1,426,982</td> <td style="width: 1%; text-align: left; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 2%; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif">$</td> <td style="width: 10%; text-align: right; font: 10pt Times New Roman, Times, Serif">625,214</td> <td style="width: 1%; text-align: left; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Initial recognition of derivative liability</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">165,563</td> <td style="text-align: left; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">5,441,395</td> <td style="text-align: left; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Conversion of derivative instruments to Common Stock</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">(121,575</td> <td style="text-align: left; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">)</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">(1,958,802</td> <td style="text-align: left; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="text-align: left; text-indent: 0px; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">Mark-to-Market adjustment to fair value</td> <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">(148,854</td> <td style="text-align: left; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">)</td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">(2,680,825</td> <td style="text-align: left; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="text-indent: 0px; padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif">Balance, end of period</td> <td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; border-bottom: black 2.5pt double; font: 10pt Times New Roman, Times, Serif">$</td> <td style="text-align: right; border-bottom: black 2.5pt double; font: 10pt Times New Roman, Times, Serif">1,322,116</td> <td style="text-align: left; border-bottom: black 2.5pt double; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&#160;</td> <td style="border-bottom: black 2.5pt double; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; border-bottom: black 2.5pt double; font: 10pt Times New Roman, Times, Serif">$</td> <td style="text-align: right; border-bottom: black 2.5pt double; font: 10pt Times New Roman, Times, Serif">1,426,982</td> <td style="text-align: left; border-bottom: black 2.5pt double; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">During the nine months ended September 30, 2019 and 2018, the Company recorded derivative liabilities for embedded conversion features related to convertible notes payable of $165,563 and $5,049,659, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">During the nine months ended September 30, 2019 and 2018, in conjunction with convertible notes payable principal and accrued interest being converted into common stock of the Company, derivative liabilities were reduced by $121,575 and $1,733,419, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">For the nine months ended September 30, 2019 and 2018, the Company performed a final mark-to-market adjustment for the derivative liability related to the convertible notes and the carrying amount of the derivative liability related to the conversion feature and recognized a gain on the derivative liability valuation of $148,854 and $2,127,690, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">During the three months ended September 30, 2019 and 2018, the Company recorded derivative liabilities for embedded conversion features related to convertible notes payable of $57,365 and $183,148, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">During the three months ended September 30, 2019 and 2018, in conjunction with convertible notes payable principal and accrued interest being converted into common stock of the Company, derivative liabilities were reduced by $0 and $99,317, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">For the three months ended September 30, 2019 and 2018, the Company performed a final mark-to-market adjustment for the derivative liability related to the convertible notes and the carrying amount of the derivative liability related to the conversion feature and recognized a loss(gain) on the derivative liability valuation of $75,555 and $(888,709), respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">The Company uses the Black-Scholes option pricing model to estimate fair value for those instruments convertible into common shares at inception, at conversion or extinguishment date, and at each reporting date. During the nine months ended September 30, 2019, the company used the following assumptions in their Black-Scholes model: (1) risk free interest rate 1.71% - 2.44%, (2) term of 0.12 years &#8211; 5 years, (3) expected stock volatility of 185.7% - 568.21%, (4) expected dividend rate of 0%, (5) common stock price of $0.0001, and (6) exercise price of $0.00005 - $0.03.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">These instruments were not issued with the intent of effectively hedging any future cash flow, fair value of any asset, liability or any net investment in a foreign operation. The instruments do not qualify for hedge accounting, and as such, all future changes in the fair value will be recognized in earnings until such time as the instruments are exercised, converted or expire.</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0px; margin-bottom: 0pt; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <td style="width: 0.3in; text-align: left; font: 10pt Times New Roman, Times, Serif"><b>6.</b></td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><b>PREFERRED STOCK</b></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0px; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">On March 28, 2017, the Company filed an amendment to its articles of incorporation designating 20,000 shares of its authorized preferred stock, par value $0.001 as Series B Voting Preferred Stock. The Series B Voting Preferred Stock shall have the right to vote the shares on any matter requiring shareholder approval on the basis of 4 times the votes of all the issued and outstanding shares of common stock, as well as any issued and outstanding preferred stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">On March 1, 2018, 1,000 shares of Series B Voting Preferred Stock were issued to Daniel Rushford.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">On October 25, 2018, the Company&#8217;s Board of Directors authorized the creation of 2,000,000 shares of Series A Preferred Stock with a par value of $0.001, and on October 30, 2018 a Certificate of Designation was filed with the Florida Secretary of State. Upon written notice to the Corporation, the holder of Series A Preferred stock may convert their shares into ten (10) shares of fully paid and nonassessable shares of Common Stock of the Corporation. The holders shall have no voting rights on corporate matters, unless and until they convert their Series A shares into Common Shares, at which time they will have the same voting rights as all Common Shareholders have; their consent shall not be required for taking any corporate action.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">On July 1, 2019, the Company filed a Certificate of Amendment to increase the number of authorized Series A Preferred Stock to 30,000,000, with a par value of $0.001. Each share of Preferred Series A Stock shall have a value of $10 per share and will convert into common stock at the closing price of the common stock on the date of conversion. The Series A stock shall have no voting rights on corporate matters, unless and until the Series A shares are converted into Common Shares, at which time they will have the same voting rights as all Common Shareholders have; their consent shall not be required for taking any corporate action.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">As of September 30, 2019, 30,000,000 Series A Preferred shares and 10,000,000 Series B Preferred shares were authorized, of which 0 Series A shares were issued and outstanding, (0 shares as of December 31, 2018) and 1,000 Series B shares were issued and outstanding (1,000 shares as of December 31, 2018).</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0px; margin-bottom: 0pt; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <td style="width: 0.3in; text-align: left; font: 10pt Times New Roman, Times, Serif"><b>7.</b></td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><b>COMMON STOCK</b></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0px; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">On March 15, 2018, the Company announced that its Board of Directors has determined that it is in the best interests of the Corporation to initiate a program &#160;to reacquire certain shares of stock from its stockholders, and to thereafter retire said shares as non-voting Treasury stock. The Corporation has approved a Share Repurchase Program (the &#8220;Program&#8221;) to accomplish this. The Corporation hereby will make an offer of redemption to its shareholders in accordance with the terms of the Program. The specific timing, price and size of purchases will depend on prevailing stock prices, general economic and market conditions, and other considerations. The Program does not obligate the Company to acquire any particular amount of stock, and the Program may be suspended or discontinued at any time at the Company&#8217;s discretion. The Company discontinued this program on June 30, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">On March 27, 2018, the Company approved the issuance of 7,248 shares of the Company&#8217;s common stock for services provided by a consultant, in the form of stock awards which shall vest as of the date of grant. The shares were valued at the fair market value on the date of grant totaling $39,139, which has been expensed as stock-based compensation as part of consulting expenses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">On April 30, 2018, the Company filed a Certificate of Amendment to increase the number of authorized common shares from 25,000,000,000 to 50,000,000,000 with a par value of $0.001.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">During the year ended December 31, 2018, the holders of convertible notes converted a total of $560,907 of principal, accrued interest, note fees and penalties into 1,201,212 &#160;shares of common stock. The common stock was valued at $2,519,708 based on the market price of the Company&#8217;s stock on the date of conversion. The issuance extinguished $1,958,802 worth of derivative liabilities, and $(1,083,929) was recorded as additional paid in capital.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">On April 22, 2019, the Majority Preferred Series B Shareholders of the Company, owning a majority of the Company&#8217;s voting securities, approved a resolution authorizing the Company to amend the Articles of Incorporation to accomplish the Reverse Split of the Corporation&#8217;s issued and outstanding shares of 1 for 3,000 of Common Stock having a par value of $0.001 per share. The Company filed a Certificate of Amendment with an effective date of September 16, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">During the nine months ended September 30, 2019, the holders of convertible notes converted a total of $64,220 of principal and accrued interest, and $1,500 in note fees into 444,281 &#160;shares of common stock. The common stock was valued at $308,870 based on the market price of the Company&#8217;s stock on the date of conversion. The issuance extinguished $121,575 worth of derivative liabilities and $1,267,126 was recorded as additional paid in capital.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px"><font style="background-color: white">As of September 30, 2019 and December 31, 2018 there were 1,942,319 and 1,498,038 </font>&#160;<font style="background-color: white">shares issued and outstanding, respectively.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px"><b>Warrants</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">The following table summarizes the activity related to warrants of the Company as of September 30, 2019:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="text-align: center; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">Issue</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">Number of</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">Exercise Price</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">Remaining Life</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="text-align: center; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">Date</td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">Warrants</td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">per Share</td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">(Years)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="width: 27%; text-align: center; font: 10pt Times New Roman, Times, Serif">6/19/2017</td> <td style="width: 2%; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 23%; text-align: right; font: 10pt Times New Roman, Times, Serif">17</td> <td style="width: 2%; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 23%; text-align: right; font: 10pt Times New Roman, Times, Serif">0.03</td> <td style="width: 2%; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 21%; text-align: right; font: 10pt Times New Roman, Times, Serif">2.72</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">6/4/2018</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">16,667</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">0.001</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">3.71</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">8/13.18</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">12,500</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">0.001</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">3.87</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">10/11/2018</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">8,333</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">0.001</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">4.03</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">12/20/2018</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">8,583</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">0.001</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">4.22</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">4/12/2019</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">19,000</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">0.001</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">4.53</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">7/22/2019</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">15,500,000</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">0.001</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">4.81</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">During the three months ended September 30, 2019, the Company issued 15,500,000 warrants, with an exercise price of $.001 in connection with a convertible note originating on July 22, 2019. If the market price of one share of common stock is greater than the Exercise Price, the holder may elect to receive warrant shares pursuant to cashless exercise. The warrants vest immediately and expire five years from the date of issuance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">During the three months ended September 30, 2018, the Company issued 12,500 warrants, with an exercise price of $.001 in connection with a convertible note originating on August 13, 2018. If the market price of one share of common stock is greater than the Exercise Price, the holder may elect to receive warrant shares pursuant to cashless exercise. The warrants vest immediately and expire five years from the date of issuance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">During the three months ended September 30, 2019 and 2018, there were no warrants exercised.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">During the nine months ended September 30, 2019, the Company issued an aggregate of 15,519,000 warrants, with an exercise price of $.001 in connection with convertible notes executed on April 12, 2019 and July 22, 2019. If the market price of one share of common stock is greater than the Exercise Price, the holder may elect to receive warrant shares pursuant to cashless exercise. The warrants vest immediately and expire five years from the date of issuance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">During the nine months ended September 30, 2018, the Company issued an aggregate of 29,167 warrants, with an exercise price of $.001 in connection with convertible notes executed on June 4, 2018 and August 13, 2018. If the market price of one share of common stock is greater than the Exercise Price, the holder may elect to receive warrant shares pursuant to cashless exercise. The warrants vest immediately and expire five years from the date of issuance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">During the nine months ended September 30, 2019 and 2018, the Company issued 0 and 66,508, respectively, shares of common stock through a cashless exercise of the warrants.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">We account for common stock purchase warrants as derivative liabilities and debt issuance costs on the balance sheet at fair value, and changes in fair value during the periods presented in the statement of operations, which is revalued at each balance sheet date subsequent to the initial issuance of the warrant.</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0px; margin-bottom: 0pt; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <td style="width: 0.3in; text-align: left; font: 10pt Times New Roman, Times, Serif"><b>8.</b></td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><b>RELATED PARTY TRANSACTIONS</b></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0px; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px"><i>Mr. Matthew C. Scott<font style="background-color: white">, Director</font></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">On April 1, 2017, the Company expanded its board of directors to include Matthew C. Scott. Concurrently, the Company&#160;entered into a consulting agreement with Mr. Scott for a term of one year, whereby Mr. Scott shall receive an annual fee of $100,000 payable in quarterly installments. Furthermore, effective April 1, 2017 the Company agreed to issue Mr. Scott 667 shares of restricted common stock for his services as a director. The shares upon issue will be held by the Company for a term of six months and are cancelable should Mr. Scott not serve in his capacity as director for a minimum term of six months.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">The Company recorded $140,000 in share-based compensation in respect of the 667 shares issuable based on the fair market value on April 1, 2017, which has been recorded on the balance sheet as liabilities for unissued shares. Furthermore, a total of $140,000 has been expensed in the year ending December 31, 2017 as stock-based compensation as part of consulting expenses. As of the date of this report, the shares have not been issued.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">On October 15, 2017, the Board of Directors of the Company approved the issuance of 25,000 restricted common shares to Matthew Scott to satisfy accrued fees of $50,000, pursuant his agreement dated April 1, 2017. The shares were issued on November 13, 2017 and were valued at $1,200,000, based on the market value on the date the shares were approved for issuance, and $1,150,000 was recorded as a loss on settlement of debt of the statement of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">On April 1, 2018, the Company agreed to renew the Consulting Agreement dated April 1, 2017 for one year.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">On November 8, 2018, Mr. Scott resigned as a Director and agreed to forfeit all stock and outstanding debts owed to him pursuant to his Consulting Agreement. The Company recorded a reduction of $210,000 to accounts payable and unissued shares with a corresponding entry to additional paid in capital.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px"><font style="background-color: white"><i>Mr. Samuel Berry, Director</i></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px"><font style="background-color: white">On June 19, 2017, the Company entered into a Consulting Agreement with Mr. Samuel Berry. Mr. Berry will receive an annual salary of $50,000, payable in quarterly installments at $12,500 per quarter.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px"><font style="background-color: white">On June 19, 2017 the Board of Directors appointed Mr. Samuel Berry as Director. For accepting the position of Director, Mr. Berry will receive 333 Shares of the Company&#8217;s common stock. Additionally, Mr. Berry will be paid $500 for each board meeting for which he is physically present.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">The Company recorded $50,000 in respect to the value of 333 unissued shares as liabilities for unissued shares and expensed $50,000 as stock-based compensation as part of consulting expenses in the period ended September 30, 2017. As of the date of this report, the shares have not been issued.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">On October 15, 2017, the Board of Directors of the Company approved the issuance of 25,000&#160; restricted common to Samuel Berry to satisfy consulting fees of $50,000, pursuant his agreement dated June 19, 2017. The shares were issued on November 13, 2017 and were valued at $1,200,000 based on the market value on the date the shares were approved for issuance, and $1,150,000 was recorded as a loss on settlement of debt on the statement of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">On June 19, 2019, the Company agreed to renew the Consulting Agreement dated June 19, 2017 for one year&#160;.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">During the nine months ended September 30, 2019, the Company accrued $37,500 in consulting fees in connection to his agreement and made payments of $1,000.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">On July 22, 2019, the Company appointed Samuel Berry as the Chief Financial Officer of the company. Mr. Berry was appointed as a Director on June 19, 2017. For accepting the position of CFO, Mr. Berry will receive $45,000 annual salary. On September 1, 2019, the agreement was voided, and therefore no fees were accrued.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px"><i>Daniel Rushford, President, CEO, Secretary, Treasurer and Director</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">On August 28, 2017, the Company entered into an Employment Agreement with Mr. Daniel Rushford with regard to being appointed as the new Chief Executive Officer, President, Secretary, Treasurer and Member of the Board of Directors. Mr. Rushford will receive a monthly salary of $2,000 to be paid at the end of each month. Unpaid amounts will accrue annual interest of 6%. The term of the Consulting Agreement is for two years; renewable upon mutual consent.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">On November 13, 2017, the Company issued 8,333 restricted common shares for $25,000 in share-based compensation that were valued at $95,000 based on the market value on the date of issuance, and $70,000 was recorded as a loss on settlement of debt.&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">On January 2, 2018, the Company approved an increase in salary to $3,000 per month.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">During the nine months ended September 30, 2019, the Company accrued wages and interest of $27,265 in connection with his agreement and made payments of $8,000.</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0px; margin-bottom: 0pt; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <td style="width: 0.3in; text-align: left; font: 10pt Times New Roman, Times, Serif"><b>9.</b></td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><b>INCOME TAXES</b></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0px; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">Deferred income taxes are determined using the liability method for the temporary differences between the financial reporting basis and income tax basis of the Company&#8217;s assets and liabilities. Deferred income taxes are measured based on the tax rates expected to be in effect when the temporary differences are included in the Company&#8217;s tax return. Deferred tax assets and liabilities are recognized based on anticipated future tax consequences attributable to differences between financial statement carrying amounts of assets and liabilities and their respective tax bases.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px"><font style="background-color: white">Operating loss carry forwards generated during the period from May 25, 2014 (date of inception) through September 30, 2019 of approximately $9,978,365 will begin to expire in 2034. The Company applies a statutory income tax rate of 21%. Accordingly, deferred tax assets related to net operating loss carry-forwards total approximately $2,095,457 at September 30, 2019.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px"><font style="background-color: white">All tax years since inception are open to examination by the Internal Revenue Service.</font></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0px; margin-bottom: 0pt; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <td style="width: 0.3in; text-align: left; font: 10pt Times New Roman, Times, Serif"><b>10.</b></td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><b>COMMITMENTS AND CONTINGENCIES</b></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0px; margin-bottom: 0pt; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <td style="width: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 0.3in; text-align: left; font: 10pt Times New Roman, Times, Serif">(1).</td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif">IR Agreement</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0px; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">On March 28, 2017, the Company entered into an investor relations agreement with a third party, whereby the third party will provide advertising, promotional and marketing services for the Company between April 1, 2017 and July 1, 2017. In consideration of the foregoing services performed by the third party, the Company will pay a fee of 640 restricted shares on or before April 1, 2017. In addition, the third party will remain the owner of at least 1% of the company&#8217;s outstanding shares for a 1-year period. On April 1, 2018, the Company shall issue additional shares as necessary to bring the total number of shares paid to the third party to equal 1% of the outstanding shares of common stock as of 4/1/2018. In the event the Company does not issue the shares as required under this provision, the Company will be subject to a penalty of $5,000 per month until the shares are issued.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">640 shares were issued on March 28, 2017 and valued at the fair market value on the date of grant totaling $96,000, which amount has been expensed as stock-based compensation as part of consulting expenses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">7,248 shares were issued on March 27, 2018 and valued at the fair market value on the date of grant totaling $39,139, which amount has been expensed as stock-based compensation as part of consulting expenses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">In respect to the investor relations agreement, 5 additional shares have been allocated for&#160;issuance effective May 16, 2017, and $825 has been expensed as stock-based compensation as part of consulting expenses due to 500 shares of common stock issued to a consultant.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">The 5 shares were not issued as of September 30, 2019, and $825 is recorded on the balance sheet as liabilities for unissued shares.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0px; margin-bottom: 0pt; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <td style="width: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 0.3in; text-align: left; font: 10pt Times New Roman, Times, Serif">(2).</td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif">Consultant Agreement</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0px; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">On January 24, 2018, the Company entered into a Consulting Agreement with BAS1. The Company has agreed to pay BAS1 a fee of $10,000 for a 30-day marketing awareness program.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">As of September 30, 2019, the Company paid&#160;of $7,500 to the&#160;advisor in respect to this agreement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0px; margin-bottom: 0pt; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <td style="width: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 0.3in; text-align: left; font: 10pt Times New Roman, Times, Serif">(3).</td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif">Distribution Agreement</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0px; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">On February 23, 2018, the Company entered into an Exclusive Agreement for Distribution with a west coast distributor, whereby the distributor will exclusively distribute all Pet CDB Products owned by the Company. Furthermore, the distributor will purchase $3,000,000 &#160;of product at negotiable prices for a period of 24 months for distribution. As of September 30, 2019, this agreement is in affect.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">On April 3, 2018, the Company agreed to enter in to a 12-month exclusive agreement with a west coast distributor, whereas the distributor has agreed to purchase $6.5M on Oral Pet Sprays from Vet Online Supply Inc. during the next 12 months. Vet Online Supply is allowing an exclusive agreement to purchase and place our CBD Pet products in California marijuana dispensaries through April 3, 2019. On April 3, 2019, the Company chose not to extend the agreement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0px; margin-bottom: 0pt; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <td style="width: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 0.3in; text-align: left; font: 10pt Times New Roman, Times, Serif">(4).</td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif">Consultant Agreement</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0px; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">On March 1, 2018, the Company executed a Consulting Agreement whereby the Consultant will receive a retainer of $50,000 per month for nine months to revise an online retail website, Private-Label product contract and distribution for veterinarian supplies and holistic based pet products.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">On March 15, 2018, the Company agreed to engage in an additional contract with the consultant for $200,000.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">On October 1, 2018, the Company executed an additional Consulting Agreement whereby the Consultant will receive a fee of $350,000 &#160;to expand the business product sales, marketing and new product development, develop new distribution channels, and the development of a new subsidiary providing services in Cryptocurrency. This involves negotiating contracts, raising capital with new funding partners, and establishing the criteria to expand the Company&#8217;s business model.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">During the nine months ended of September 30, 2019 and 2018, the Company paid&#160;$550 and $337,500, respectively, to the&#160;advisor in respect of these agreements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">As of September 30, 2019, the Company paid&#160;of $448,050 to the&#160;advisor in respect of these agreements. The balance due on these agreements is $151,950 and is due on or before December 31, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0px; margin-bottom: 0pt; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <td style="width: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 0.3in; text-align: left; font: 10pt Times New Roman, Times, Serif">(5).</td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif">Consultant Agreement</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0px; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">On August 1, 2018, the Company entered into a National Sales Rep Agreement for a period of three years, to recruit and manage new sales representatives. In consideration of services performed, the Company will pay a commission of 25% of gross proceeds to be paid in cash, and 10% of gross proceeds to be paid in restricted common stock. In addition, the Company has agreed to pay a fee of $25,000 in the form of restricted common stock upon signing of the Agreement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">The Company recorded $25,000 in respect to the value of unissued shares as liabilities for unissued shares and expensed $25,000 as stock-based compensation as part of consulting expenses. At September 30, 2019 the shares remained unissued.</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0px; margin-bottom: 0pt; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <td style="width: 0.3in; text-align: left; font: 10pt Times New Roman, Times, Serif"><b>11.</b></td> <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><b>SUBSEQUENT EVENTS</b></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">None.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Organization and Description of Business</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Vet Online Supply Inc. (the &#8220;Company&#8221;) is a Florida corporation incorporated on May 31, 2014. The Company engages in the online sale of its own holistic product line for pets, as well as targeting the larger Big-Box Pet retail suppliers, and during the first quarter of 2018, discontinued its legacy veterinarian supplies lines. The company discontinued its legacy line of products to increase margins and profitability with its own brand-name holistic products. These new holistic pet products are designed to help with arthritis, compromised immune systems, stress responses, aggression and digestive issues and may also be useful in treating acute ailments like sprains and strains, torn ligaments, bone breaks and even during post-operative care to reduce swelling, pain and stiffness. The Company&#8217;s web-based eCommerce platform with our products is on our website, www.vetonlinesupplies.com. The website gives our potential clients the ability to purchase quality pet products by placing their order any time of day at their convenience.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Distribution channels include its existing online retail sales platform and fulfillment, and direct sales through its global manufacturing sales representative network. Although selling pet products online is not entirely new to the company, we anticipate that this medium will continue to grow as our brand continues to achieve recognition. We believe that by providing high quality holistic pet products at competitive prices and to customers online, Vet Online Supply hopes to become a &#8216;go-to&#8217; solution for pet owners everywhere. In addition, online vs. catalogue has the benefit of, among other things, search tools and accounts that remember previous purchases, and expedited ordering.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 22, 2019, the Company approved the authorization of a 1 for 3,000 reverse stock split of the Company&#8217;s outstanding shares of common stock. The Company&#8217;s financial statements have been retroactively adjusted for this stock split for all periods presented.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 1, 2019, the Company filed a Certificate of Amendment to increase the number of authorized Series A Preferred Stock to 30,000,000, with a par value of $0.001. Each share of Preferred Series A Stock shall have a value of $10 per share and will convert into common stock at the closing price of the common stock on the date of conversion. The Series A stock shall have no voting rights on corporate matters, unless and until the Series A shares are converted into Common Shares, at which time they will have the same voting rights as all Common Shareholders have; their consent shall not be required for taking any corporate action.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">To date, our activities have been limited to formation, the raising of equity capital, and the initial stages of implementation of our business plan. We filed a Form S-1 Registration Statement with the U.S. Securities and Exchange Commission, received a notice of effect and trade on the OTC Markets, PINK under the symbol VTNL. We are continuing to explore additional sources of capital. We anticipate incurring operating losses as we continue to implement our business plan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Financial Statement Presentation</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The audited financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Fiscal year end</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has selected December 31 as its fiscal year end.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Use of Estimates</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported therein. Due to the inherent uncertainty involved in making estimates, actual results reported in future periods may be based upon amounts that differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Cash Equivalents</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company considers all highly liquid investments with maturities of 90 days or less from the date of purchase to be cash equivalents.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Revenue Recognition and Related Allowances</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company adopted ASU No. 2014-09, &#8220;Revenue from Contracts with Customers&#8221; (&#8220;ASU 2014-09&#8221;) as amended, as of January 1, 2018 with no material impact. The Company primarily generates net revenue through product sales to distributors and to retail customers on its website. Revenue is recognized upon transfer of control of promised products to customers which is generally upon shipment in an amount that reflects the consideration we expect to receive in exchange for those products or services. Revenue is recognized net of allowances for returns and any taxes collected from customers, which are subsequently remitted to governmental authorities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Accounts Receivable and Allowance for Doubtful Accounts</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts receivable are stated at the amount that management expects to collect from outstanding balances. Bad debts and allowances are provided based on historical experience and management&#8217;s evaluation of outstanding accounts receivable. Management evaluates past due or delinquency of accounts receivable based on the open invoices aged on due date basis. The allowance for doubtful accounts at September 30, 2019 and December 31, 2018 is $0.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Inventories</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is a manufacturer of premium CBD infused holistic pet products and as such will maintain inventory on site. The company directly drop ships to customers when ordered. The Company has wholesale distributors that purchase products in bulk inventory.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Warranty</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is a manufacturer of products which are shipped to our customers directly from the company and as a result, there are costs that may be incurred by the Company under the terms of the limited warranty provided by the company directly to the purchasers. We provide provisions for obligations which may arise under manufacturer&#8217;s warranties and therefore incur liabilities. We warranty the product for packaging and shipping.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Advertising and Marketing Costs</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The company provides website online marketing of its products, as well as wholesalers who market the product. The company also utilises various public press releases to provide public information about its product line and future products under development. Advertising and marketing costs are expensed as incurred for the three and nine months ended September 30, 2019 were $200 and $4,000, respectively. ($5,850 &#8211; December 31, 2018).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Fair Value of Financial Instruments</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fair value is defined as the price that would be received upon sale of an asset or paid upon transfer of a liability in an orderly transaction between market participants at the measurement date and in the principal or most advantageous market for that asset or liability. The fair value should be calculated based on assumptions that market participants would use in pricing the asset or liability, not on assumptions specific to the entity. In addition, the fair value of liabilities should include consideration of non-performance risk including our own credit risk.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition to defining fair value, the standard expands the disclosure requirements around fair value and establishes a fair value hierarchy for valuation inputs is expanded. The hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of the three levels and which is determined by the lowest level input that is significant to the fair value measurement in its entirety.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">These levels are:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 1 - inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 2 - inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 3 - inputs are generally unobservable and typically reflect management&#8217;s estimates of assumptions that market participants would use in pricing the asset or liability. The fair values are therefore determined using model-based techniques that include option pricing models, discounted cash flow models, and similar techniques.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial assets and liabilities measured at fair value on a recurring basis:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="text-align: center; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">Input</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">September 30, 2019</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">December 31, 2018</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="text-align: center; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">Level</td> <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">Fair Value</td> <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">Fair Value</td> <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="width: 59%; text-align: justify; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">Derivative Liability</td> <td style="width: 2%; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 11%; text-align: center; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">3</td> <td style="width: 2%; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">$</td> <td style="width: 10%; text-align: right; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">1,322,116</td> <td style="width: 1%; text-align: left; padding-bottom: 1pt; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 2%; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">$</td> <td style="width: 10%; text-align: right; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">1,426,982</td> <td style="width: 1%; text-align: left; padding-bottom: 1pt; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="text-align: justify; padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif">Total Financial Liabilities</td> <td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; border-bottom: black 2.5pt double; font: 10pt Times New Roman, Times, Serif">$</td> <td style="text-align: right; border-bottom: black 2.5pt double; font: 10pt Times New Roman, Times, Serif">1,322,116</td> <td style="text-align: left; padding-bottom: 2.5pt; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; border-bottom: black 2.5pt double; font: 10pt Times New Roman, Times, Serif">$</td> <td style="text-align: right; border-bottom: black 2.5pt double; font: 10pt Times New Roman, Times, Serif">1,426,982</td> <td style="text-align: left; padding-bottom: 2.5pt; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In management&#8217;s opinion, the fair value of convertible notes payable and advances payable is approximate to carrying value as the interest rates and other features of these instruments approximate those obtainable for similar instruments in the current market. Unless otherwise noted, it is management&#8217;s opinion that the Company is not exposed to significant interest, exchange or credit risks arising from these financial instruments. As of September 30, 2019 and December 31, 2018, the balances reported for cash, accounts receivable, prepaid expenses, accounts payable, and accrued liabilities, approximate the fair value because of their short maturities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Income taxes</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;The Company has adopted SFAS No. 109 &#8211; &#8220;Accounting for Income Taxes&#8221;. ASC Topic 740 requires the use of the asset and liability method of accounting for income taxes. Under the asset and liability method of ASC Topic 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Basic and Diluted Loss Per Share</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with ASC Topic 280 &#8211; &#8220;Earnings Per Share&#8221;, the basic loss per common share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding. Diluted loss per common share is computed similar to basic loss per common share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Recent Accounting Pronouncements</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In May 2014, the FASB issued ASU No. 2014-09, <i>Revenue from Contracts with Customers (Topic 606)</i>, which replaces existing revenue recognition guidance. The updated guidance requires companies to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, the new standard requires that reporting companies disclose the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The Company adopted the standard on January 1, 2018, using a modified retrospective approach, with the cumulative effect of initially applying the standard recognized in retained earnings at the date of adoption.</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif"><td style="text-align: center; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">September 30,</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">December 31,</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="text-align: center; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">2019</td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">2018</td> <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="width: 72%; text-align: left; font: 10pt Times New Roman, Times, Serif">Prepaid expenses</td> <td style="width: 2%; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif">$</td> <td style="width: 10%; text-align: right; font: 10pt Times New Roman, Times, Serif">&#8212;</td> <td style="width: 1%; text-align: left; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 2%; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif">$</td> <td style="width: 10%; text-align: right; font: 10pt Times New Roman, Times, Serif">3,000</td> <td style="width: 1%; text-align: left; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0px; text-align: justify">As of September 30, 2019 and December 31, 2018, notes payable were comprised of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0px; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="text-align: center; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">Original</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">Original</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">Due</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">Interest</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">Conversion</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">September 30,</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">December 31,</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="text-align: center; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">Amount</td> <td style="text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">Note Date</td> <td style="text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">Date</td> <td style="text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">Rate</td> <td style="text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">Rate</td> <td style="text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">2019</td> <td style="text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">2018</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="width: 24%; text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">APG Capital #2</td> <td style="width: 3%; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 9%; text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;31,500</td> <td style="width: 1%; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 9%; text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">6/25/2018</td> <td style="width: 1%; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 9%; text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">6/25/2019</td> <td style="width: 1%; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 9%; text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">24%</td> <td style="width: 1%; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 9%; text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Variable</td> <td style="width: 1%; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 9%; text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">31,500</td> <td style="width: 1%; text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 9%; text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">31,500</td> <td style="width: 1%; text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Auctus Fund #2</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;84,000</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">1/10/2018</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">10/10/2018</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">24%</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Variable</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">31,285</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">47,373</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Auctus Fund #3</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;175,000</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">2/6/2018</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">11/6/2018</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">24%</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Variable</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">175,000</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">175,000</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Auctus Fund #4</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;90,000</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">3/6/2018</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">12/6/2018</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">24%</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Variable</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">90,000</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">90,000</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Auctus Fund #5</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;100,000</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">6/14/2018</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">3/14/2019</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">24%</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Variable</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">100,000</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">100,000</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Auctus Fund #6</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;75,000</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">8/13/2018</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">5/13/2019</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">24%</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Variable</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">75,000</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">75,000</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Auctus Fund #7</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;25,000</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">10/11/2018</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">7/11/2019</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">24%</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Variable</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">25,000</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">25,000</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Auctus Fund #8</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;25,750</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">12/20/2018</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">9/20/2019</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">24%</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Variable</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">25,750</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">25,750</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Auctus Fund #9</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;57,000</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">4/12/2019</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">1/12/2020</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">12%</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Variable</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">57,000</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#8212;</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Auctus Fund #10</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;31,000</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">7/22/2019</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">7/22/2020</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">12%</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Variable</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">31,000</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#8212;</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">EMA Financial #2</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;50,000</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">12/15/2017</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">12/15/2018</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">24%</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Variable</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">8,474</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">8,474</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">EMA Financial #3</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;100,000</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">3/5/2018</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">3/5/2019</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">24%</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Variable</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">73,305</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">83,499</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">EMA Financial #4</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;25,000</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">10/10/2018</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">7/10/2019</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">24%</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Variable</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">25,000</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">25,000</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Emerging Corp #1</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;83,333</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">2/12/2018</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">2/11/2019</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">22%</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Variable</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">74,933</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">74,933</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Emerging Corp #2</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;110,000</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">10/31/2018</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">10/31/2019</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">12%</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Variable</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">110,000</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">110,000</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Power Up Lending #8</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;33,000</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">6/25/2018</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">4/15/2019</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">12%</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Variable</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#8212;</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">33,000</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">933,247</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">904,529</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td colspan="11" style="padding-left: 17.3pt; text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Debt discount</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">(97,416</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">)</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">(313,258</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td colspan="11" style="padding-left: 17.3pt; text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Financing costs/Original issue discount</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">(9,011</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">)</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; text-indent: 0px; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">(36,047</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td colspan="11" style="padding-left: 17.3pt; text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Notes payable, net of discount</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; border-bottom: black 2.5pt double; font: 10pt Times New Roman, Times, Serif">$</td> <td style="text-align: right; text-indent: 0px; border-bottom: black 2.5pt double; font: 10pt Times New Roman, Times, Serif">826,820</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-indent: 0px; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; text-indent: 0px; border-bottom: black 2.5pt double; font: 10pt Times New Roman, Times, Serif">$</td> <td style="text-align: right; text-indent: 0px; border-bottom: black 2.5pt double; font: 10pt Times New Roman, Times, Serif">555,224</td> <td style="text-align: left; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">The following table represents the Company&#8217;s derivative liability activity for the embedded conversion features for the periods ending September 30, 2019 and December 31, 2018:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="text-align: center; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">September 30,</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">December 31,</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="text-align: center; text-indent: 0px; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">2019</td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td colspan="2" style="text-align: center; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">2018</td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="width: 72%; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Balance, beginning of period</td> <td style="width: 2%; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif">$</td> <td style="width: 10%; text-align: right; font: 10pt Times New Roman, Times, Serif">1,426,982</td> <td style="width: 1%; text-align: left; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 2%; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; text-align: left; font: 10pt Times New Roman, Times, Serif">$</td> <td style="width: 10%; text-align: right; font: 10pt Times New Roman, Times, Serif">625,214</td> <td style="width: 1%; text-align: left; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Initial recognition of derivative liability</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">165,563</td> <td style="text-align: left; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">5,441,395</td> <td style="text-align: left; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="text-align: left; text-indent: 0px; font: 10pt Times New Roman, Times, Serif">Conversion of derivative instruments to Common Stock</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">(121,575</td> <td style="text-align: left; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">)</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">(1,958,802</td> <td style="text-align: left; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="text-align: left; text-indent: 0px; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">Mark-to-Market adjustment to fair value</td> <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">(148,854</td> <td style="text-align: left; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">)</td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">(2,680,825</td> <td style="text-align: left; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="text-indent: 0px; padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif">Balance, end of period</td> <td style="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; border-bottom: black 2.5pt double; font: 10pt Times New Roman, Times, Serif">$</td> <td style="text-align: right; border-bottom: black 2.5pt double; font: 10pt Times New Roman, Times, Serif">1,322,116</td> <td style="text-align: left; border-bottom: black 2.5pt double; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&#160;</td> <td style="border-bottom: black 2.5pt double; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: left; border-bottom: black 2.5pt double; font: 10pt Times New Roman, Times, Serif">$</td> <td style="text-align: right; border-bottom: black 2.5pt double; font: 10pt Times New Roman, Times, Serif">1,426,982</td> <td style="text-align: left; border-bottom: black 2.5pt double; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">&#160;</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">The following table summarizes the activity related to warrants of the Company as of September 30, 2019:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0px">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="text-align: center; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">Issue</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">Number of</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">Exercise Price</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; white-space: nowrap; font: 10pt Times New Roman, Times, Serif">Remaining Life</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="text-align: center; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">Date</td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">Warrants</td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">per Share</td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: center; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">(Years)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="width: 27%; text-align: center; font: 10pt Times New Roman, Times, Serif">6/19/2017</td> <td style="width: 2%; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 23%; text-align: right; font: 10pt Times New Roman, Times, Serif">17</td> <td style="width: 2%; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 23%; text-align: right; font: 10pt Times New Roman, Times, Serif">0.03</td> <td style="width: 2%; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 21%; text-align: right; font: 10pt Times New Roman, Times, Serif">2.72</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">6/4/2018</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">16,667</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">0.001</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">3.71</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">8/13.18</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">12,500</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">0.001</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">3.87</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">10/11/2018</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">8,333</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">0.001</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">4.03</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">12/20/2018</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">8,583</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">0.001</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">4.22</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">4/12/2019</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">19,000</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">0.001</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">4.53</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204, 238, 255)"> <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">7/22/2019</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">15,500,000</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">0.001</td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="text-align: right; font: 10pt Times New Roman, Times, Serif">4.81</td></tr></table> On April 22, 2019, the Company approved the authorization of a 1 for 3,000 reverse stock split of the Company’s outstanding shares of common stock. The Company’s financial statements have been retroactively adjusted for this stock split for all periods presented. P2Y8M19D P3Y8M16D P3Y10M13D P4Y0M11D P4Y2M19D P4Y6M11D P4Y9M22D 0.03 0.001 0.001 0.001 0.001 0.001 0.001 17 16667 12500 8333 8583 19000 15500000 2017-06-19 2018-06-04 2018-08-13 2018-10-11 2018-12-20 2019-04-12 2019-07-22 All common share amounts and per share amounts in the financial statements reflect the one-for-three thousand reverse stock split that was made effective on April 22, 2019. See Note 7. EX-101.SCH 7 vtnl-20190930.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - BALANCE SHEETS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - BALANCE SHEETS (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - STATEMENT OF OPERATIONS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - STATEMENT OF SHAREHOLDERS' EQUITY (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - STATEMENTS OF CASH FLOWS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - GOING CONCERN link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - PREPAID EXPENSES link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - CONVERTIBLE NOTES PAYABLE link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - DERIVATIVE LIABILITIES link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - PREFERRED STOCK link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - COMMON STOCK link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - COMMITMENTS link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - PREPAID EXPENSES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - CONVERTIBLE NOTES PAYABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - DERIVATIVE LIABIITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - COMMON STOCK (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - PREPAID EXPENSES (Details) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - CONVERTIBLE NOTES PAYABLE (Details) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - CONVERTIBLE NOTES PAYABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - DERIVATIVE LIABIITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - DERIVATIVE LIABIITIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - PREFERRED STOCK (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - COMMON STOCK (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - COMMON STOCK (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - RELATED PARTY TRANSACTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - INCOME TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - COMMITMENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 vtnl-20190930_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 vtnl-20190930_def.xml XBRL DEFINITION FILE EX-101.LAB 10 vtnl-20190930_lab.xml XBRL LABEL FILE Equity Components [Axis] Accumulated Deficit Common Stock Treasury Stock Additional Paid-In Capital Class of Stock [Axis] Series A Preferred Stock [Member] Series B Preferred Stock [Member] Related Party Transaction [Axis] Daniel Rushford Title of Individual [Axis] Mr Edward Aruda [Member] Consultant Agreement [Member] Mr. Matthew C. Scott, Director [Member] Mr. Samuel Berry, Director [Member] Short-term Debt, Type [Axis] Convertible Notes [Member] Concentration Risk Benchmark [Axis] Liabilities, Total [Member] Range [Axis] Minimum [Member] Maximum [Member] Investor Relations Agreement [Member] Award Type [Axis] Restricted Stock [Member] Measurement Frequency [Axis] Fair Value, Measurements, Recurring [Member] Financial Instrument [Axis] Derivative [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 3 [Member] APG Capital #2 Auctus Fund #2 Auctus Fund #3 Auctus Fund #4 Auctus Fund #5 Auctus Fund #6 EMA Financial #2 EMA Financial #3 Emerging Corp Capital #1 Power Up Lending #8 Auctus Fund #7 Auctus Fund #8 EMA Financial #4 Emerging Corp Capital #2 Auctus Fund #9 Preferred Stock Auctus Fund #10 Warrant [Member] Warrant [Member] Warrant [Member] Warrant [Member] Warrant [Member] Warrant [Member] Warrant [Member] Document and Entity Information [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Document Fiscal Period Focus Document Fiscal Year Focus Statement [Table] Statement [Line Items] ASSETS Current assets Cash Inventory Prepaid expenses Other current assets Total current assets TOTAL ASSETS LIABILITIES & STOCKHOLDERS' EQUITY (DEFICIT) Current liabilities Accounts payable Convertible notes payable, interest Convertible notes payable, net of discount Deferred revenue Derivative liabilities Liability for unissued shares Related party liabilities Sales tax payable Total current liabilities Total liabilities Commitments and Contingencies Stockholders' equity (deficit) Preferred stock, Series A: $0.001 par value; 30,000,000 shares authorized 0 shares issued and outstanding at September 30, 2019 and December 31, 2018; Preferred stock, Series B: $0.001 par value; 10,000,000 shares authorized 1,000 shares issued and outstanding at September 30, 2019 1,000 shares issued and outstanding at December 31, 2018 Common stock, $0.001 par value; 50,000,000,000 authorized 1,942,319 shares issued and outstanding at September 30, 2019 1,498,038 shares issued and outstanding at December 31, 2018 Additional paid in capital Accumulated deficit Total stockholder's deficit TOTAL LIABILITIES & EQUITY Preferred stock, par value Preferred stock, authorized Preferred stock, issued Preferred stock, outstanding Common stock, par value Common stock, authorized Common stock, issued Common stock, outstanding Income Statement [Abstract] Net sales Cost of goods sold Gross profit (loss) Operating expenses: Consulting fees G&A expenses Professional fees Salaries and wages Total operating expense Loss from operations Other income (expenses) Gain (loss) on derivative liability valuation Interest expenses Total other income/expenses Net loss before income taxes Income tax expense Net (loss) Weighted average shares outstanding - Basic Net (loss) per common shares - Basic Weighted average shares outstanding - Diluted Net (loss) per common shares - Diluted Beginning balance, amount Beginning balance, in shares Conversion of promissory notes to stock Conversion of promissory notes to stock (in shares) Common stock issued for services Common stock issued for services (in shares) Preferred shares returned to treasury cancelled Common stock warrants issued by cashless exercise Common stock warrants issued by cashless exercise, Shares Derivative settlements Net loss Ending balance, amount Ending balance, in shares Statement of Cash Flows [Abstract] Cash Flows From Operating Activities Net profit (loss) Adjustments to reconcile net income to net cash provided from operating activities: Amortization of debt discount and deferred financing costs New derivatives recorded as loan fees Change in derivative liability Liability for unissued shares due to agreements Decrease (increase) in operating assets Inventory Prepaid expenses Other assets Accounts payable Accrued interest Deferred revenue Sales tax payable Net cash provided( used by) operating activities Cash Flows From Investing Activities Net cash used from investing activities Cash Flows From Financing Activities Proceeds from convertible notes payable, net Proceeds from (payments to) related parties, net Proceeds from promissory notes payable Net cash provided from financing activities Net increase (decrease) in cash Cash, beginning of year Cash, end of year Supplemental Disclosures of Cash Flow Information: Stock issued for debt conversion Accounting Policies [Abstract] BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Going Concern [Abstract] GOING CONCERN Notes to Financial Statements PREPAID EXPENSES Convertible Notes Payable CONVERTIBLE NOTE PAYABLE Derivative Liabilities DERIVATIVE LIABILITIES Equity [Abstract] PREFERRED STOCK COMMON STOCK Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Income Tax Disclosure [Abstract] INCOME TAXES Commitments and Contingencies Disclosure [Abstract] COMMITMENTS Subsequent Events [Abstract] SUBSEQUENT EVENTS Organization and Description of Business Financial Statement Presentation Fiscal year end Use of Estimates Cash Equivalents Revenue recognition and related allowances Accounts Receivable and Allowance for Doubtful Accounts Inventories Warranty Advertising and marketing costs Fair Value Measurements Income taxes Basic and Diluted Loss Per Share New Accounting Pronouncements Summary of the fair value of our derivative liabilities Schedule of Prepaid Expenses Convertible Notes Payable Schedule of Notes payable Derivative Liabiities Schedule of fair value of the conversion feature convertible note Common Stock Schedule of Warrants Activity Common stock voting rights, description Cash equivalent term (In days) Advertising and Marketing Costs Common Stock, Reverse Stock Split Fair Value of Liability Original Note Amount Derivative, Inception Date Derivative, Maturity Date Derivative, Variable Interest Rate Notes payable Debt discount Financing costs./Original issue discount Notes payable, net of discount Proceeds from New Convertible Notes Notes Converted Debt Discount Loan Fees Interest Expenses Convertible Note Interest Derivative Liabiities Balance, beginning of period Initial recognition of derivative liability Conversion of derivative instruments to Common Stock Mark-to-Market adjustment to fair value Balance, end of period Statistical Measurement [Axis] Expected dividends Expected volatility Expected term Risk free interest rate Common Stock Price Exercise price Preferred Stock, Shares Authorized Preferred Stock, par value Voting Rights Stock-based compensation Common Stock issued for Services, shares Issue Date No. Of Warrants Exercise Price per Share Remaining Life Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table] Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items] Related Party Transactions (Textual) Per month consulting fees Accounts payable - related parties Stock based compensation Annual fee, description Unissued shares Unissued shares value Restricted Common stock issued for debt Fair value of common stock issued Gain (loss) on settlement of debt Stock Issued During Period, Value, Issued for Services Agreement term Quarterly salary payment Common stock per share Payment of board meeting Annual salary Operating loss carry-forwards Operating losses expire year Income tax rate Net operating loss carry-forwards Long-term Purchase Commitment [Table] Long-term Purchase Commitment [Line Items] Commitments (Textual) Investor relations agreement, description Shares issued Fair market value grant total Agreement services payable Convertible per share Fair market value per share Common stock shares issued Common stock value issued Additional shares issued Payment for advisor fee Accured Consulting fees APG Capital #2 [Member] Amortization Of Debt Discount And Deferred Financing Costs Auctus Fund #2 [Member] Auctus Fund #3 [Member] Auctus Fund #4 [Member] Auctus Fund #5 [Member] Auctus Fund #6 [Member] Auctus Fund #7 [Member] Auctus Fund #8 [Member] Auctus Fund #9 [Member] Number of days to classify liquid investment as Cash Equivalents. Stock issued during the period. Common Stock Text [Block] Common stock warrants issued by cashless exercise Common stock warrants issued by cashless exercise, Shares Consultant Agreement [Member] Consulting fees during the year Consulting fees per month. Conversion of derivative instruments to Common Stock Convertible Note Interest Convertible Note [Text Block] Derivative Liabilities [Text Block] Director one member. EMA Financial #2 [Member] EMA Financial #3 [Member] EMA Financial #4 [Member] Emerging Corp Capital #2 [Member] Emerging Corp Capital [Member] Exercise Price Fair value of stock issued during the period. Going concern. The entire disclosure for going concern. Increase Decrease in Sales tax payable Initial recognition of derivative liability Investor Relations Agreement [Member] Liability for Unissued Shares Loss on Derivative Liability. Mark-to-Market Adjustment to fair Value Mr. Edward Aruda [Member] New Derivatives Recorded as Loan fees. Original Issue Discount Payment of board meeting. Power Up Lending #8 [Member] Preferred shares returned to treasury cancelled Prepaid Expenses [Text Block] Quarterly payment salary. Schedule of Prepaid Expenses [Table Text Block] Stock unissued during period shares. Stock unissued during period value. Liability For Unissued Shares Due To Consulting Agreement. Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Warrant2Member Warrant3Member Warrant4Member Warrant5Member Warrant6Member Warrant7Member Assets, Current Assets Liabilities, Current Liabilities Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Nonoperating Income (Expense) Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expense Increase (Decrease) in Accounts Payable Increase (Decrease) in Accrued Interest Receivable, Net Increase (Decrease) in Deferred Revenue IncreaseDecreaseInSalesTaxPayable Net Cash Provided by (Used in) Financing Activities Cash, Period Increase (Decrease) Cash Equivalents, at Carrying Value EX-101.PRE 11 vtnl-20190930_pre.xml XBRL PRESENTATION FILE XML 12 R17.htm IDEA: XBRL DOCUMENT v3.19.3
SUBSEQUENT EVENTS
9 Months Ended
Sep. 30, 2019
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS
11. SUBSEQUENT EVENTS

 

None.

XML 13 R13.htm IDEA: XBRL DOCUMENT v3.19.3
COMMON STOCK
9 Months Ended
Sep. 30, 2019
Notes to Financial Statements  
COMMON STOCK
7. COMMON STOCK

 

On March 15, 2018, the Company announced that its Board of Directors has determined that it is in the best interests of the Corporation to initiate a program  to reacquire certain shares of stock from its stockholders, and to thereafter retire said shares as non-voting Treasury stock. The Corporation has approved a Share Repurchase Program (the “Program”) to accomplish this. The Corporation hereby will make an offer of redemption to its shareholders in accordance with the terms of the Program. The specific timing, price and size of purchases will depend on prevailing stock prices, general economic and market conditions, and other considerations. The Program does not obligate the Company to acquire any particular amount of stock, and the Program may be suspended or discontinued at any time at the Company’s discretion. The Company discontinued this program on June 30, 2019.

 

On March 27, 2018, the Company approved the issuance of 7,248 shares of the Company’s common stock for services provided by a consultant, in the form of stock awards which shall vest as of the date of grant. The shares were valued at the fair market value on the date of grant totaling $39,139, which has been expensed as stock-based compensation as part of consulting expenses.

 

On April 30, 2018, the Company filed a Certificate of Amendment to increase the number of authorized common shares from 25,000,000,000 to 50,000,000,000 with a par value of $0.001.

 

During the year ended December 31, 2018, the holders of convertible notes converted a total of $560,907 of principal, accrued interest, note fees and penalties into 1,201,212  shares of common stock. The common stock was valued at $2,519,708 based on the market price of the Company’s stock on the date of conversion. The issuance extinguished $1,958,802 worth of derivative liabilities, and $(1,083,929) was recorded as additional paid in capital.

 

On April 22, 2019, the Majority Preferred Series B Shareholders of the Company, owning a majority of the Company’s voting securities, approved a resolution authorizing the Company to amend the Articles of Incorporation to accomplish the Reverse Split of the Corporation’s issued and outstanding shares of 1 for 3,000 of Common Stock having a par value of $0.001 per share. The Company filed a Certificate of Amendment with an effective date of September 16, 2019.

 

During the nine months ended September 30, 2019, the holders of convertible notes converted a total of $64,220 of principal and accrued interest, and $1,500 in note fees into 444,281  shares of common stock. The common stock was valued at $308,870 based on the market price of the Company’s stock on the date of conversion. The issuance extinguished $121,575 worth of derivative liabilities and $1,267,126 was recorded as additional paid in capital.

 

As of September 30, 2019 and December 31, 2018 there were 1,942,319 and 1,498,038  shares issued and outstanding, respectively.

 

Warrants

 

The following table summarizes the activity related to warrants of the Company as of September 30, 2019:

 

Issue   Number of   Exercise Price   Remaining Life
Date   Warrants   per Share   (Years)
6/19/2017   17   0.03   2.72
6/4/2018   16,667   0.001   3.71
8/13.18   12,500   0.001   3.87
10/11/2018   8,333   0.001   4.03
12/20/2018   8,583   0.001   4.22
4/12/2019   19,000   0.001   4.53
7/22/2019   15,500,000   0.001   4.81

 

During the three months ended September 30, 2019, the Company issued 15,500,000 warrants, with an exercise price of $.001 in connection with a convertible note originating on July 22, 2019. If the market price of one share of common stock is greater than the Exercise Price, the holder may elect to receive warrant shares pursuant to cashless exercise. The warrants vest immediately and expire five years from the date of issuance.

 

During the three months ended September 30, 2018, the Company issued 12,500 warrants, with an exercise price of $.001 in connection with a convertible note originating on August 13, 2018. If the market price of one share of common stock is greater than the Exercise Price, the holder may elect to receive warrant shares pursuant to cashless exercise. The warrants vest immediately and expire five years from the date of issuance.

 

During the three months ended September 30, 2019 and 2018, there were no warrants exercised.

 

During the nine months ended September 30, 2019, the Company issued an aggregate of 15,519,000 warrants, with an exercise price of $.001 in connection with convertible notes executed on April 12, 2019 and July 22, 2019. If the market price of one share of common stock is greater than the Exercise Price, the holder may elect to receive warrant shares pursuant to cashless exercise. The warrants vest immediately and expire five years from the date of issuance.

 

During the nine months ended September 30, 2018, the Company issued an aggregate of 29,167 warrants, with an exercise price of $.001 in connection with convertible notes executed on June 4, 2018 and August 13, 2018. If the market price of one share of common stock is greater than the Exercise Price, the holder may elect to receive warrant shares pursuant to cashless exercise. The warrants vest immediately and expire five years from the date of issuance.

 

During the nine months ended September 30, 2019 and 2018, the Company issued 0 and 66,508, respectively, shares of common stock through a cashless exercise of the warrants.

 

We account for common stock purchase warrants as derivative liabilities and debt issuance costs on the balance sheet at fair value, and changes in fair value during the periods presented in the statement of operations, which is revalued at each balance sheet date subsequent to the initial issuance of the warrant.

XML 14 R7.htm IDEA: XBRL DOCUMENT v3.19.3
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
9 Months Ended
Sep. 30, 2019
Accounting Policies [Abstract]  
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
1. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Organization and Description of Business

 

Vet Online Supply Inc. (the “Company”) is a Florida corporation incorporated on May 31, 2014. The Company engages in the online sale of its own holistic product line for pets, as well as targeting the larger Big-Box Pet retail suppliers, and during the first quarter of 2018, discontinued its legacy veterinarian supplies lines. The company discontinued its legacy line of products to increase margins and profitability with its own brand-name holistic products. These new holistic pet products are designed to help with arthritis, compromised immune systems, stress responses, aggression and digestive issues and may also be useful in treating acute ailments like sprains and strains, torn ligaments, bone breaks and even during post-operative care to reduce swelling, pain and stiffness. The Company’s web-based eCommerce platform with our products is on our website, www.vetonlinesupplies.com. The website gives our potential clients the ability to purchase quality pet products by placing their order any time of day at their convenience.

 

Distribution channels include its existing online retail sales platform and fulfillment, and direct sales through its global manufacturing sales representative network. Although selling pet products online is not entirely new to the company, we anticipate that this medium will continue to grow as our brand continues to achieve recognition. We believe that by providing high quality holistic pet products at competitive prices and to customers online, Vet Online Supply hopes to become a ‘go-to’ solution for pet owners everywhere. In addition, online vs. catalogue has the benefit of, among other things, search tools and accounts that remember previous purchases, and expedited ordering.

 

On April 22, 2019, the Company approved the authorization of a 1 for 3,000 reverse stock split of the Company’s outstanding shares of common stock. The Company’s financial statements have been retroactively adjusted for this stock split for all periods presented.

 

On July 1, 2019, the Company filed a Certificate of Amendment to increase the number of authorized Series A Preferred Stock to 30,000,000, with a par value of $0.001. Each share of Preferred Series A Stock shall have a value of $10 per share and will convert into common stock at the closing price of the common stock on the date of conversion. The Series A stock shall have no voting rights on corporate matters, unless and until the Series A shares are converted into Common Shares, at which time they will have the same voting rights as all Common Shareholders have; their consent shall not be required for taking any corporate action.

 

To date, our activities have been limited to formation, the raising of equity capital, and the initial stages of implementation of our business plan. We filed a Form S-1 Registration Statement with the U.S. Securities and Exchange Commission, received a notice of effect and trade on the OTC Markets, PINK under the symbol VTNL. We are continuing to explore additional sources of capital. We anticipate incurring operating losses as we continue to implement our business plan.

 

Financial Statement Presentation

 

The audited financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).

 

Fiscal year end

 

The Company has selected December 31 as its fiscal year end.

 

Use of Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported therein. Due to the inherent uncertainty involved in making estimates, actual results reported in future periods may be based upon amounts that differ from these estimates.

 

Cash Equivalents

 

The Company considers all highly liquid investments with maturities of 90 days or less from the date of purchase to be cash equivalents.

 

Revenue Recognition and Related Allowances

 

The Company adopted ASU No. 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”) as amended, as of January 1, 2018 with no material impact. The Company primarily generates net revenue through product sales to distributors and to retail customers on its website. Revenue is recognized upon transfer of control of promised products to customers which is generally upon shipment in an amount that reflects the consideration we expect to receive in exchange for those products or services. Revenue is recognized net of allowances for returns and any taxes collected from customers, which are subsequently remitted to governmental authorities.

 

Accounts Receivable and Allowance for Doubtful Accounts

 

Accounts receivable are stated at the amount that management expects to collect from outstanding balances. Bad debts and allowances are provided based on historical experience and management’s evaluation of outstanding accounts receivable. Management evaluates past due or delinquency of accounts receivable based on the open invoices aged on due date basis. The allowance for doubtful accounts at September 30, 2019 and December 31, 2018 is $0.

 

Inventories

 

The Company is a manufacturer of premium CBD infused holistic pet products and as such will maintain inventory on site. The company directly drop ships to customers when ordered. The Company has wholesale distributors that purchase products in bulk inventory.

 

Warranty

 

The Company is a manufacturer of products which are shipped to our customers directly from the company and as a result, there are costs that may be incurred by the Company under the terms of the limited warranty provided by the company directly to the purchasers. We provide provisions for obligations which may arise under manufacturer’s warranties and therefore incur liabilities. We warranty the product for packaging and shipping.

 

Advertising and Marketing Costs

 

The company provides website online marketing of its products, as well as wholesalers who market the product. The company also utilises various public press releases to provide public information about its product line and future products under development. Advertising and marketing costs are expensed as incurred for the three and nine months ended September 30, 2019 were $200 and $4,000, respectively. ($5,850 – December 31, 2018).

 

Fair Value of Financial Instruments

 

Fair value is defined as the price that would be received upon sale of an asset or paid upon transfer of a liability in an orderly transaction between market participants at the measurement date and in the principal or most advantageous market for that asset or liability. The fair value should be calculated based on assumptions that market participants would use in pricing the asset or liability, not on assumptions specific to the entity. In addition, the fair value of liabilities should include consideration of non-performance risk including our own credit risk.

 

In addition to defining fair value, the standard expands the disclosure requirements around fair value and establishes a fair value hierarchy for valuation inputs is expanded. The hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of the three levels and which is determined by the lowest level input that is significant to the fair value measurement in its entirety.

 

These levels are:

 

Level 1 - inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.

 

Level 2 - inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

 

Level 3 - inputs are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. The fair values are therefore determined using model-based techniques that include option pricing models, discounted cash flow models, and similar techniques.

 

Financial assets and liabilities measured at fair value on a recurring basis:

 

    Input   September 30, 2019     December 31, 2018  
    Level   Fair Value     Fair Value  
Derivative Liability   3   $ 1,322,116     $ 1,426,982  
Total Financial Liabilities       $ 1,322,116     $ 1,426,982  

 

In management’s opinion, the fair value of convertible notes payable and advances payable is approximate to carrying value as the interest rates and other features of these instruments approximate those obtainable for similar instruments in the current market. Unless otherwise noted, it is management’s opinion that the Company is not exposed to significant interest, exchange or credit risks arising from these financial instruments. As of September 30, 2019 and December 31, 2018, the balances reported for cash, accounts receivable, prepaid expenses, accounts payable, and accrued liabilities, approximate the fair value because of their short maturities.

 

Income taxes

 

 The Company has adopted SFAS No. 109 – “Accounting for Income Taxes”. ASC Topic 740 requires the use of the asset and liability method of accounting for income taxes. Under the asset and liability method of ASC Topic 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.

 

Basic and Diluted Loss Per Share

 

In accordance with ASC Topic 280 – “Earnings Per Share”, the basic loss per common share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding. Diluted loss per common share is computed similar to basic loss per common share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive.

 

Recent Accounting Pronouncements

 

In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), which replaces existing revenue recognition guidance. The updated guidance requires companies to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, the new standard requires that reporting companies disclose the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The Company adopted the standard on January 1, 2018, using a modified retrospective approach, with the cumulative effect of initially applying the standard recognized in retained earnings at the date of adoption.

XML 15 R3.htm IDEA: XBRL DOCUMENT v3.19.3
BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares
Sep. 30, 2019
Dec. 31, 2018
Common stock, par value $ 0.001 $ 0.001
Common stock, authorized 50,000,000,000 50,000,000,000
Common stock, issued 1,942,319 1,498,038
Common stock, outstanding 1,942,319 1,498,038
Series A Preferred Stock [Member]    
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, authorized 30,000,000 30,000,000
Preferred stock, issued 0 0
Preferred stock, outstanding 0 0
Series B Preferred Stock [Member]    
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, authorized 10,000,000 10,000,000
Preferred stock, issued 1,000 1,000
Preferred stock, outstanding 1,000 1,000
XML 16 R30.htm IDEA: XBRL DOCUMENT v3.19.3
DERIVATIVE LIABIITIES (Details Narrative) - Liabilities, Total [Member]
9 Months Ended
Sep. 30, 2019
$ / shares
Expected dividends 0.00%
Common Stock Price $ 0.0001
Minimum [Member]  
Expected volatility 185.70%
Expected term 1 month 13 days
Risk free interest rate 1.71%
Exercise price $ 0.00005
Maximum [Member]  
Expected volatility 568.21%
Expected term 5 years
Risk free interest rate 2.44%
Exercise price $ 0.03
XML 17 R34.htm IDEA: XBRL DOCUMENT v3.19.3
RELATED PARTY TRANSACTIONS (Details) - USD ($)
1 Months Ended 3 Months Ended 4 Months Ended 9 Months Ended 10 Months Ended
Mar. 27, 2018
May 16, 2017
Apr. 07, 2017
Apr. 03, 2017
Sep. 30, 2017
Jun. 19, 2017
Mar. 28, 2017
Sep. 30, 2019
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Oct. 15, 2017
Sep. 30, 2019
Sep. 30, 2018
Nov. 13, 2017
Dec. 31, 2018
Related Party Transactions (Textual)                                
Consulting fees               $ 13,000 $ 165,180       $ 39,228 $ 771,773    
Accounts payable - related parties               $ 82,032         82,032     $ 29,267
Stock based compensation             $ 96,000                  
Stock-based compensation $ 39,139                              
Stock Issued During Period, Value, Issued for Services                   $ 486 $ 38,653   $ 39,139    
Mr Edward Aruda [Member]                                
Related Party Transactions (Textual)                                
Consulting fees                         40,000      
Per month consulting fees                         5,000      
Stock based compensation     $ 21,000                          
Gain (loss) on settlement of debt                         14,760      
Investor Relations Agreement [Member]                                
Related Party Transactions (Textual)                                
Stock-based compensation   $ 825                            
Consultant Agreement [Member]                                
Related Party Transactions (Textual)                                
Stock-based compensation   67,500                            
Stock Issued During Period, Value, Issued for Services   $ 15,000                            
Consultant Agreement [Member] | Mr. Matthew C. Scott, Director [Member]                                
Related Party Transactions (Textual)                                
Consulting fees                         75,000      
Stock based compensation                         140,000      
Annual fee, description       Entered into a consulting agreement with Mr. Scott for a term of one year, where under Mr. Scott shall receive an annual fee of $100,000 payable in quarterly installments                        
Unissued shares       2,000,000                        
Unissued shares value       $ 140,000                     $ 25,000  
Restricted Common stock issued for debt                             25,000,000  
Fair value of common stock issued                             $ 1,200,000  
Gain (loss) on settlement of debt                             1,150,000  
Stock Issued During Period, Value, Issued for Services                             $ 50,000  
Agreement term       1 year                        
Consultant Agreement [Member] | Mr. Samuel Berry, Director [Member]                                
Related Party Transactions (Textual)                                
Consulting fees                       $ 50,000 16,667      
Stock based compensation         $ 50,000                      
Restricted Common stock issued for debt         1,000,000             75,000,000        
Fair value of common stock issued                       $ 1,200,000        
Gain (loss) on settlement of debt                       1,150,000        
Stock Issued During Period, Value, Issued for Services         $ 50,000             $ 50,000        
Quarterly salary payment           $ 12,500                    
Payment of board meeting                         $ 500      
Annual salary           $ 50,000                    
Restricted Stock [Member] | Consultant Agreement [Member] | Mr. Samuel Berry, Director [Member]                                
Related Party Transactions (Textual)                                
Common stock per share           $ 0.05                    
XML 18 R29.htm IDEA: XBRL DOCUMENT v3.19.3
DERIVATIVE LIABIITIES (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2019
Sep. 30, 2019
Dec. 31, 2018
Disclosure Derivative Liabiities Details Abstract      
Balance, beginning of period $ 1,426,982 $ 1,426,982 $ 625,214
Initial recognition of derivative liability   165,563 5,441,395
Conversion of derivative instruments to Common Stock $ (121,575) (121,575) (1,958,802)
Mark-to-Market adjustment to fair value   (148,854) (2,680,825)
Balance, end of period   $ 1,322,116 $ 1,426,982
XML 19 R25.htm IDEA: XBRL DOCUMENT v3.19.3
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - Fair Value, Measurements, Recurring [Member] - Derivative [Member] - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Fair Value of Liability $ 1,322,116 $ 1,426,982
Fair Value, Inputs, Level 3 [Member]    
Fair Value of Liability $ 1,322,116 $ 1,426,982
XML 20 R21.htm IDEA: XBRL DOCUMENT v3.19.3
CONVERTIBLE NOTES PAYABLE (Tables)
9 Months Ended
Sep. 30, 2019
Disclosure Convertible Notes Payable Tables Abstract  
Schedule of Notes payable

As of September 30, 2019 and December 31, 2018, notes payable were comprised of the following:

 

    Original   Original   Due   Interest   Conversion   September 30,     December 31,  
    Amount   Note Date   Date   Rate   Rate   2019     2018  
APG Capital #2    31,500   6/25/2018   6/25/2019   24%   Variable     31,500       31,500  
Auctus Fund #2    84,000   1/10/2018   10/10/2018   24%   Variable     31,285       47,373  
Auctus Fund #3    175,000   2/6/2018   11/6/2018   24%   Variable     175,000       175,000  
Auctus Fund #4    90,000   3/6/2018   12/6/2018   24%   Variable     90,000       90,000  
Auctus Fund #5    100,000   6/14/2018   3/14/2019   24%   Variable     100,000       100,000  
Auctus Fund #6    75,000   8/13/2018   5/13/2019   24%   Variable     75,000       75,000  
Auctus Fund #7    25,000   10/11/2018   7/11/2019   24%   Variable     25,000       25,000  
Auctus Fund #8    25,750   12/20/2018   9/20/2019   24%   Variable     25,750       25,750  
Auctus Fund #9    57,000   4/12/2019   1/12/2020   12%   Variable     57,000        
Auctus Fund #10    31,000   7/22/2019   7/22/2020   12%   Variable     31,000        
EMA Financial #2    50,000   12/15/2017   12/15/2018   24%   Variable     8,474       8,474  
EMA Financial #3    100,000   3/5/2018   3/5/2019   24%   Variable     73,305       83,499  
EMA Financial #4    25,000   10/10/2018   7/10/2019   24%   Variable     25,000       25,000  
Emerging Corp #1    83,333   2/12/2018   2/11/2019   22%   Variable     74,933       74,933  
Emerging Corp #2    110,000   10/31/2018   10/31/2019   12%   Variable     110,000       110,000  
Power Up Lending #8    33,000   6/25/2018   4/15/2019   12%   Variable           33,000  
                          933,247       904,529  
Debt discount     (97,416 )     (313,258 )
Financing costs/Original issue discount     (9,011 )     (36,047 )
Notes payable, net of discount   $ 826,820     $ 555,224  
ZIP 21 0001641751-19-000027-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001641751-19-000027-xbrl.zip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end XML 22 R24.htm IDEA: XBRL DOCUMENT v3.19.3
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Jul. 02, 2019
Apr. 22, 2019
Sep. 30, 2019
Sep. 30, 2019
Dec. 31, 2018
Accounting Policies [Abstract]          
Common stock voting rights, description On July 1, 2019, the Company filed a Certificate of Amendment to increase the number of authorized Series A Preferred Stock to 30,000,000, with a par value of $0.001. Each share of Preferred Series A Stock shall have a value of $10 per share and will convert into common stock at the closing price of the common stock on the date of conversion. The Series A stock shall have no voting rights on corporate matters, unless and until the Series A shares are converted into Common Shares, at which time they will have the same voting rights as all Common Shareholders have; their consent shall not be required for taking any corporate action.        
Cash equivalent term (In days)       90 days  
Advertising and Marketing Costs     $ 200 $ 4,000 $ 5,850
Common Stock, Reverse Stock Split   On April 22, 2019, the Company approved the authorization of a 1 for 3,000 reverse stock split of the Company’s outstanding shares of common stock. The Company’s financial statements have been retroactively adjusted for this stock split for all periods presented.      

XML 23 R20.htm IDEA: XBRL DOCUMENT v3.19.3
PREPAID EXPENSES (Tables)
9 Months Ended
Sep. 30, 2019
Notes to Financial Statements  
Schedule of Prepaid Expenses
    September 30,     December 31,  
    2019     2018  
Prepaid expenses   $     $ 3,000  
XML 25 R28.htm IDEA: XBRL DOCUMENT v3.19.3
CONVERTIBLE NOTES PAYABLE (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2019
Mar. 31, 2019
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Proceeds from New Convertible Notes           $ 73,250 $ 774,500  
Notes Converted   $ 308,870 $ 168,378 $ 385,197 $ 1,597,924 64,220 406,330  
Debt Discount           (97,416)   $ (313,258)
Interest Expenses $ 126,202   374,760     487,137 1,088,949  
Convertible Notes [Member]                
Notes Converted           59,282 390,478  
Debt Discount           14,750 127,833  
Loan Fees           352,879 976,978  
Interest Expenses 48,741   23,461     132,495 52,495  
Convertible Note Interest $ 0   $ 6,964     $ 4,938 $ 15,852  
XML 26 R6.htm IDEA: XBRL DOCUMENT v3.19.3
STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash Flows From Operating Activities    
Net profit (loss) $ (545,151) $ (3,945,356)
Adjustments to reconcile net income to net cash provided from operating activities:    
Amortization of debt discount and deferred financing costs 352,879 976,978
New derivatives recorded as loan fees 70,313 4,058,576
Change in derivative liability (148,855) (2,127,690)
Common stock issued for services 39,139
Liability for unissued shares due to agreements 25,000
Decrease (increase) in operating assets    
Inventory 585 (38,332)
Prepaid expenses 3,000
Other assets (156)
Accounts payable 2,269 108,041
Accrued interest 133,995 111,972
Deferred revenue (82)
Sales tax payable 16 35
Net cash provided( used by) operating activities (131,187) (791,637)
Cash Flows From Investing Activities    
Net cash used from investing activities
Cash Flows From Financing Activities    
Proceeds from convertible notes payable, net 73,250 774,500
Proceeds from (payments to) related parties, net 52,765 9,918
Proceeds from promissory notes payable
Net cash provided from financing activities 126,015 784,418
Net increase (decrease) in cash (5,172) (7,219)
Cash, beginning of year 10,640 16,820
Cash, end of year 5,468 9,601
Supplemental Disclosures of Cash Flow Information:    
Stock issued for debt conversion $ 64,220 $ 406,330
XML 27 R2.htm IDEA: XBRL DOCUMENT v3.19.3
BALANCE SHEETS (Unaudited) - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Current assets    
Cash $ 5,468 $ 10,640
Inventory 17,375 17,960
Prepaid expenses 3,000
Other current assets 156
Total current assets 22,999 31,600
TOTAL ASSETS 22,999 31,600
Current liabilities    
Accounts payable 569,519 567,250
Convertible notes payable, interest 189,143 61,586
Convertible notes payable, net of discount 826,820 555,224
Deferred revenue 82
Derivative liabilities 1,322,116 1,426,982
Liability for unissued shares 150,825 150,825
Related party liabilities 82,032 29,267
Sales tax payable 51 35
Total current liabilities 3,140,506 2,791,251
Total liabilities 3,140,506 2,791,251
Commitments and Contingencies
Stockholders' equity (deficit)    
Common stock, $0.001 par value; 50,000,000,000 authorized 1,942,319 shares issued and outstanding at September 30, 2019 1,498,038 shares issued and outstanding at December 31, 2018 [1] 1,942 1,498
Additional paid in capital 6,858,915 6,672,064
Accumulated deficit (9,978,365) (9,433,214)
Total stockholder's deficit (3,117,507) (2,759,651)
TOTAL LIABILITIES & EQUITY 22,999 31,600
Series A Preferred Stock [Member]    
Stockholders' equity (deficit)    
Preferred stock, Series A: $0.001 par value; 30,000,000 shares authorized 0 shares issued and outstanding at September 30, 2019 and December 31, 2018; Preferred stock, Series B: $0.001 par value; 10,000,000 shares authorized 1,000 shares issued and outstanding at September 30, 2019 1,000 shares issued and outstanding at December 31, 2018
Series B Preferred Stock [Member]    
Stockholders' equity (deficit)    
Preferred stock, Series A: $0.001 par value; 30,000,000 shares authorized 0 shares issued and outstanding at September 30, 2019 and December 31, 2018; Preferred stock, Series B: $0.001 par value; 10,000,000 shares authorized 1,000 shares issued and outstanding at September 30, 2019 1,000 shares issued and outstanding at December 31, 2018 $ 1 $ 1
[1] All common share amounts and per share amounts in the financial statements reflect the one-for-three thousand reverse stock split that was made effective on April 22, 2019. See Note 7.
XML 28 R16.htm IDEA: XBRL DOCUMENT v3.19.3
COMMITMENTS
9 Months Ended
Sep. 30, 2019
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS
10. COMMITMENTS AND CONTINGENCIES

 

  (1). IR Agreement

 

On March 28, 2017, the Company entered into an investor relations agreement with a third party, whereby the third party will provide advertising, promotional and marketing services for the Company between April 1, 2017 and July 1, 2017. In consideration of the foregoing services performed by the third party, the Company will pay a fee of 640 restricted shares on or before April 1, 2017. In addition, the third party will remain the owner of at least 1% of the company’s outstanding shares for a 1-year period. On April 1, 2018, the Company shall issue additional shares as necessary to bring the total number of shares paid to the third party to equal 1% of the outstanding shares of common stock as of 4/1/2018. In the event the Company does not issue the shares as required under this provision, the Company will be subject to a penalty of $5,000 per month until the shares are issued.

 

640 shares were issued on March 28, 2017 and valued at the fair market value on the date of grant totaling $96,000, which amount has been expensed as stock-based compensation as part of consulting expenses.

 

7,248 shares were issued on March 27, 2018 and valued at the fair market value on the date of grant totaling $39,139, which amount has been expensed as stock-based compensation as part of consulting expenses.

 

In respect to the investor relations agreement, 5 additional shares have been allocated for issuance effective May 16, 2017, and $825 has been expensed as stock-based compensation as part of consulting expenses due to 500 shares of common stock issued to a consultant.

 

The 5 shares were not issued as of September 30, 2019, and $825 is recorded on the balance sheet as liabilities for unissued shares.

 

  (2). Consultant Agreement

 

On January 24, 2018, the Company entered into a Consulting Agreement with BAS1. The Company has agreed to pay BAS1 a fee of $10,000 for a 30-day marketing awareness program.

 

As of September 30, 2019, the Company paid of $7,500 to the advisor in respect to this agreement.

 

  (3). Distribution Agreement

 

On February 23, 2018, the Company entered into an Exclusive Agreement for Distribution with a west coast distributor, whereby the distributor will exclusively distribute all Pet CDB Products owned by the Company. Furthermore, the distributor will purchase $3,000,000  of product at negotiable prices for a period of 24 months for distribution. As of September 30, 2019, this agreement is in affect.

 

On April 3, 2018, the Company agreed to enter in to a 12-month exclusive agreement with a west coast distributor, whereas the distributor has agreed to purchase $6.5M on Oral Pet Sprays from Vet Online Supply Inc. during the next 12 months. Vet Online Supply is allowing an exclusive agreement to purchase and place our CBD Pet products in California marijuana dispensaries through April 3, 2019. On April 3, 2019, the Company chose not to extend the agreement.

 

  (4). Consultant Agreement

 

On March 1, 2018, the Company executed a Consulting Agreement whereby the Consultant will receive a retainer of $50,000 per month for nine months to revise an online retail website, Private-Label product contract and distribution for veterinarian supplies and holistic based pet products.

 

On March 15, 2018, the Company agreed to engage in an additional contract with the consultant for $200,000.

 

On October 1, 2018, the Company executed an additional Consulting Agreement whereby the Consultant will receive a fee of $350,000  to expand the business product sales, marketing and new product development, develop new distribution channels, and the development of a new subsidiary providing services in Cryptocurrency. This involves negotiating contracts, raising capital with new funding partners, and establishing the criteria to expand the Company’s business model.

 

During the nine months ended of September 30, 2019 and 2018, the Company paid $550 and $337,500, respectively, to the advisor in respect of these agreements.

 

As of September 30, 2019, the Company paid of $448,050 to the advisor in respect of these agreements. The balance due on these agreements is $151,950 and is due on or before December 31, 2019.

 

  (5). Consultant Agreement

 

On August 1, 2018, the Company entered into a National Sales Rep Agreement for a period of three years, to recruit and manage new sales representatives. In consideration of services performed, the Company will pay a commission of 25% of gross proceeds to be paid in cash, and 10% of gross proceeds to be paid in restricted common stock. In addition, the Company has agreed to pay a fee of $25,000 in the form of restricted common stock upon signing of the Agreement.

 

The Company recorded $25,000 in respect to the value of unissued shares as liabilities for unissued shares and expensed $25,000 as stock-based compensation as part of consulting expenses. At September 30, 2019 the shares remained unissued.

XML 29 R12.htm IDEA: XBRL DOCUMENT v3.19.3
PREFERRED STOCK
9 Months Ended
Sep. 30, 2019
Equity [Abstract]  
PREFERRED STOCK
6. PREFERRED STOCK

 

On March 28, 2017, the Company filed an amendment to its articles of incorporation designating 20,000 shares of its authorized preferred stock, par value $0.001 as Series B Voting Preferred Stock. The Series B Voting Preferred Stock shall have the right to vote the shares on any matter requiring shareholder approval on the basis of 4 times the votes of all the issued and outstanding shares of common stock, as well as any issued and outstanding preferred stock.

 

On March 1, 2018, 1,000 shares of Series B Voting Preferred Stock were issued to Daniel Rushford.

 

On October 25, 2018, the Company’s Board of Directors authorized the creation of 2,000,000 shares of Series A Preferred Stock with a par value of $0.001, and on October 30, 2018 a Certificate of Designation was filed with the Florida Secretary of State. Upon written notice to the Corporation, the holder of Series A Preferred stock may convert their shares into ten (10) shares of fully paid and nonassessable shares of Common Stock of the Corporation. The holders shall have no voting rights on corporate matters, unless and until they convert their Series A shares into Common Shares, at which time they will have the same voting rights as all Common Shareholders have; their consent shall not be required for taking any corporate action.

 

On July 1, 2019, the Company filed a Certificate of Amendment to increase the number of authorized Series A Preferred Stock to 30,000,000, with a par value of $0.001. Each share of Preferred Series A Stock shall have a value of $10 per share and will convert into common stock at the closing price of the common stock on the date of conversion. The Series A stock shall have no voting rights on corporate matters, unless and until the Series A shares are converted into Common Shares, at which time they will have the same voting rights as all Common Shareholders have; their consent shall not be required for taking any corporate action.

 

As of September 30, 2019, 30,000,000 Series A Preferred shares and 10,000,000 Series B Preferred shares were authorized, of which 0 Series A shares were issued and outstanding, (0 shares as of December 31, 2018) and 1,000 Series B shares were issued and outstanding (1,000 shares as of December 31, 2018).

XML 31 R31.htm IDEA: XBRL DOCUMENT v3.19.3
PREFERRED STOCK (Details) - $ / shares
Oct. 25, 2018
Mar. 28, 2017
Sep. 30, 2019
Jul. 02, 2019
Dec. 31, 2018
Mar. 01, 2018
Series B Preferred Stock [Member]            
Preferred stock, issued     1,000   1,000  
Preferred Stock, Shares Authorized   20,000 10,000,000   10,000,000  
Preferred Stock, par value   $ 0.001 $ 0.001   $ 0.001  
Voting Rights   The Series B Voting Preferred Stock shall have the right to vote the shares on any matter requiring shareholder approval on the basis of 4 times the votes of all the issued and outstanding shares of common stock, as well as any issued and outstanding preferred stock.        
Series A Preferred Stock [Member]            
Preferred stock, issued     0   0  
Preferred Stock, Shares Authorized 2,000,000   30,000,000 30,000,000 30,000,000  
Preferred Stock, par value $ 0.001   $ 0.001 $ 0.001 $ 0.001  
Voting Rights The holders shall have no voting rights on corporate matters, unless and until they convert their Series A shares into Common Shares, at which time they will have the same voting rights as all Common Shareholders have; their consent shall not be required for taking any corporate action.          
Daniel Rushford | Series B Preferred Stock [Member]            
Preferred stock, issued           1,000
XML 32 R35.htm IDEA: XBRL DOCUMENT v3.19.3
INCOME TAXES (Details)
9 Months Ended
Sep. 30, 2019
USD ($)
Income Tax Disclosure [Abstract]  
Operating loss carry-forwards $ 9,978,365
Operating losses expire year Dec. 31, 2034
Income tax rate 21.00%
Net operating loss carry-forwards $ 2,095,457
XML 33 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.3 html 196 257 1 true 44 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://vetonlinesupplies.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - BALANCE SHEETS (Unaudited) Sheet http://vetonlinesupplies.com/role/BalanceSheets BALANCE SHEETS (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - BALANCE SHEETS (Unaudited) (Parenthetical) Sheet http://vetonlinesupplies.com/role/BalanceSheetsParenthetical BALANCE SHEETS (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - STATEMENT OF OPERATIONS (Unaudited) Sheet http://vetonlinesupplies.com/role/StatementOfOperations STATEMENT OF OPERATIONS (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - STATEMENT OF SHAREHOLDERS' EQUITY (Unaudited) Sheet http://vetonlinesupplies.com/role/StatementOfShareholdersEquity STATEMENT OF SHAREHOLDERS' EQUITY (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - STATEMENTS OF CASH FLOWS (Unaudited) Sheet http://vetonlinesupplies.com/role/StatementsOfCashFlows STATEMENTS OF CASH FLOWS (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://vetonlinesupplies.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 7 false false R8.htm 00000008 - Disclosure - GOING CONCERN Sheet http://vetonlinesupplies.com/role/GoingConcern GOING CONCERN Notes 8 false false R9.htm 00000009 - Disclosure - PREPAID EXPENSES Sheet http://vetonlinesupplies.com/role/PrepaidExpenses PREPAID EXPENSES Notes 9 false false R10.htm 00000010 - Disclosure - CONVERTIBLE NOTES PAYABLE Notes http://vetonlinesupplies.com/role/ConvertibleNotesPayable CONVERTIBLE NOTES PAYABLE Notes 10 false false R11.htm 00000011 - Disclosure - DERIVATIVE LIABILITIES Sheet http://vetonlinesupplies.com/role/DerivativeLiabilities DERIVATIVE LIABILITIES Notes 11 false false R12.htm 00000012 - Disclosure - PREFERRED STOCK Sheet http://vetonlinesupplies.com/role/PreferredStock PREFERRED STOCK Notes 12 false false R13.htm 00000013 - Disclosure - COMMON STOCK Sheet http://vetonlinesupplies.com/role/CommonStock COMMON STOCK Notes 13 false false R14.htm 00000014 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://vetonlinesupplies.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 14 false false R15.htm 00000015 - Disclosure - INCOME TAXES Sheet http://vetonlinesupplies.com/role/IncomeTaxes INCOME TAXES Notes 15 false false R16.htm 00000016 - Disclosure - COMMITMENTS Sheet http://vetonlinesupplies.com/role/Commitments COMMITMENTS Notes 16 false false R17.htm 00000017 - Disclosure - SUBSEQUENT EVENTS Sheet http://vetonlinesupplies.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 17 false false R18.htm 00000018 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://vetonlinesupplies.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 18 false false R19.htm 00000019 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://vetonlinesupplies.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://vetonlinesupplies.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies 19 false false R20.htm 00000020 - Disclosure - PREPAID EXPENSES (Tables) Sheet http://vetonlinesupplies.com/role/PrepaidExpensesTables PREPAID EXPENSES (Tables) Tables http://vetonlinesupplies.com/role/PrepaidExpenses 20 false false R21.htm 00000021 - Disclosure - CONVERTIBLE NOTES PAYABLE (Tables) Notes http://vetonlinesupplies.com/role/ConvertibleNotesPayableTables CONVERTIBLE NOTES PAYABLE (Tables) Tables http://vetonlinesupplies.com/role/ConvertibleNotesPayable 21 false false R22.htm 00000022 - Disclosure - DERIVATIVE LIABIITIES (Tables) Sheet http://vetonlinesupplies.com/role/DerivativeLiabiitiesTables DERIVATIVE LIABIITIES (Tables) Tables 22 false false R23.htm 00000023 - Disclosure - COMMON STOCK (Tables) Sheet http://vetonlinesupplies.com/role/CommonStockTables COMMON STOCK (Tables) Tables http://vetonlinesupplies.com/role/CommonStock 23 false false R24.htm 00000024 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://vetonlinesupplies.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://vetonlinesupplies.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables 24 false false R25.htm 00000025 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://vetonlinesupplies.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://vetonlinesupplies.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables 25 false false R26.htm 00000026 - Disclosure - PREPAID EXPENSES (Details) Sheet http://vetonlinesupplies.com/role/PrepaidExpensesDetails PREPAID EXPENSES (Details) Details http://vetonlinesupplies.com/role/PrepaidExpensesTables 26 false false R27.htm 00000027 - Disclosure - CONVERTIBLE NOTES PAYABLE (Details) Notes http://vetonlinesupplies.com/role/ConvertibleNotesPayableDetails CONVERTIBLE NOTES PAYABLE (Details) Details http://vetonlinesupplies.com/role/ConvertibleNotesPayableTables 27 false false R28.htm 00000028 - Disclosure - CONVERTIBLE NOTES PAYABLE (Details Narrative) Notes http://vetonlinesupplies.com/role/ConvertibleNotesPayableDetailsNarrative CONVERTIBLE NOTES PAYABLE (Details Narrative) Details http://vetonlinesupplies.com/role/ConvertibleNotesPayableTables 28 false false R29.htm 00000029 - Disclosure - DERIVATIVE LIABIITIES (Details) Sheet http://vetonlinesupplies.com/role/DerivativeLiabiitiesDetails DERIVATIVE LIABIITIES (Details) Details http://vetonlinesupplies.com/role/DerivativeLiabiitiesTables 29 false false R30.htm 00000030 - Disclosure - DERIVATIVE LIABIITIES (Details Narrative) Sheet http://vetonlinesupplies.com/role/DerivativeLiabiitiesDetailsNarrative DERIVATIVE LIABIITIES (Details Narrative) Details http://vetonlinesupplies.com/role/DerivativeLiabiitiesTables 30 false false R31.htm 00000031 - Disclosure - PREFERRED STOCK (Details) Sheet http://vetonlinesupplies.com/role/PreferredStockDetails PREFERRED STOCK (Details) Details http://vetonlinesupplies.com/role/PreferredStock 31 false false R32.htm 00000032 - Disclosure - COMMON STOCK (Details Narrative) Sheet http://vetonlinesupplies.com/role/CommonStockDetailsNarrative COMMON STOCK (Details Narrative) Details http://vetonlinesupplies.com/role/CommonStockTables 32 false false R33.htm 00000033 - Disclosure - COMMON STOCK (Details) Sheet http://vetonlinesupplies.com/role/CommonStockDetails COMMON STOCK (Details) Details http://vetonlinesupplies.com/role/CommonStockTables 33 false false R34.htm 00000034 - Disclosure - RELATED PARTY TRANSACTIONS (Details) Sheet http://vetonlinesupplies.com/role/RelatedPartyTransactionsDetails RELATED PARTY TRANSACTIONS (Details) Details http://vetonlinesupplies.com/role/RelatedPartyTransactions 34 false false R35.htm 00000035 - Disclosure - INCOME TAXES (Details) Sheet http://vetonlinesupplies.com/role/IncomeTaxesDetails INCOME TAXES (Details) Details http://vetonlinesupplies.com/role/IncomeTaxes 35 false false R36.htm 00000036 - Disclosure - COMMITMENTS (Details Narrative) Sheet http://vetonlinesupplies.com/role/CommitmentsDetailsNarrative COMMITMENTS (Details Narrative) Details http://vetonlinesupplies.com/role/Commitments 36 false false All Reports Book All Reports vtnl-20190930.xml vtnl-20190930.xsd vtnl-20190930_cal.xml vtnl-20190930_def.xml vtnl-20190930_lab.xml vtnl-20190930_pre.xml http://fasb.org/us-gaap/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/srt/2019-01-31 true true XML 34 R26.htm IDEA: XBRL DOCUMENT v3.19.3
PREPAID EXPENSES (Details) - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Notes to Financial Statements    
Prepaid expenses $ 3,000
XML 35 R22.htm IDEA: XBRL DOCUMENT v3.19.3
DERIVATIVE LIABIITIES (Tables)
9 Months Ended
Sep. 30, 2019
Derivative Liabiities  
Schedule of fair value of the conversion feature convertible note

The following table represents the Company’s derivative liability activity for the embedded conversion features for the periods ending September 30, 2019 and December 31, 2018:

 

    September 30,     December 31,  
    2019     2018  
Balance, beginning of period   $ 1,426,982     $ 625,214  
Initial recognition of derivative liability     165,563       5,441,395  
Conversion of derivative instruments to Common Stock     (121,575 )     (1,958,802 )
Mark-to-Market adjustment to fair value     (148,854 )     (2,680,825 )
Balance, end of period   $ 1,322,116     $ 1,426,982  
XML 36 R33.htm IDEA: XBRL DOCUMENT v3.19.3
COMMON STOCK (Details) - Warrant [Member]
9 Months Ended
Sep. 30, 2019
$ / shares
shares
Issue Date Jun. 19, 2017
No. Of Warrants | shares 17
Exercise Price per Share | $ / shares $ 0.03
Remaining Life 2 years 8 months 19 days
Issue Date Jun. 04, 2018
No. Of Warrants | shares 16,667
Exercise Price per Share | $ / shares $ 0.001
Remaining Life 3 years 8 months 16 days
Issue Date Aug. 13, 2018
No. Of Warrants | shares 12,500
Exercise Price per Share | $ / shares $ 0.001
Remaining Life 3 years 10 months 13 days
Issue Date Oct. 11, 2018
No. Of Warrants | shares 8,333
Exercise Price per Share | $ / shares $ 0.001
Remaining Life 4 years 11 days
Issue Date Dec. 20, 2018
No. Of Warrants | shares 8,583
Exercise Price per Share | $ / shares $ 0.001
Remaining Life 4 years 2 months 19 days
Issue Date Apr. 12, 2019
No. Of Warrants | shares 19,000
Exercise Price per Share | $ / shares $ 0.001
Remaining Life 4 years 6 months 11 days
Issue Date Jul. 22, 2019
No. Of Warrants | shares 15,500,000
Exercise Price per Share | $ / shares $ 0.001
Remaining Life 4 years 9 months 22 days
XML 37 R18.htm IDEA: XBRL DOCUMENT v3.19.3
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
9 Months Ended
Sep. 30, 2019
Accounting Policies [Abstract]  
Organization and Description of Business

Organization and Description of Business

 

Vet Online Supply Inc. (the “Company”) is a Florida corporation incorporated on May 31, 2014. The Company engages in the online sale of its own holistic product line for pets, as well as targeting the larger Big-Box Pet retail suppliers, and during the first quarter of 2018, discontinued its legacy veterinarian supplies lines. The company discontinued its legacy line of products to increase margins and profitability with its own brand-name holistic products. These new holistic pet products are designed to help with arthritis, compromised immune systems, stress responses, aggression and digestive issues and may also be useful in treating acute ailments like sprains and strains, torn ligaments, bone breaks and even during post-operative care to reduce swelling, pain and stiffness. The Company’s web-based eCommerce platform with our products is on our website, www.vetonlinesupplies.com. The website gives our potential clients the ability to purchase quality pet products by placing their order any time of day at their convenience.

 

Distribution channels include its existing online retail sales platform and fulfillment, and direct sales through its global manufacturing sales representative network. Although selling pet products online is not entirely new to the company, we anticipate that this medium will continue to grow as our brand continues to achieve recognition. We believe that by providing high quality holistic pet products at competitive prices and to customers online, Vet Online Supply hopes to become a ‘go-to’ solution for pet owners everywhere. In addition, online vs. catalogue has the benefit of, among other things, search tools and accounts that remember previous purchases, and expedited ordering.

 

On April 22, 2019, the Company approved the authorization of a 1 for 3,000 reverse stock split of the Company’s outstanding shares of common stock. The Company’s financial statements have been retroactively adjusted for this stock split for all periods presented.

 

On July 1, 2019, the Company filed a Certificate of Amendment to increase the number of authorized Series A Preferred Stock to 30,000,000, with a par value of $0.001. Each share of Preferred Series A Stock shall have a value of $10 per share and will convert into common stock at the closing price of the common stock on the date of conversion. The Series A stock shall have no voting rights on corporate matters, unless and until the Series A shares are converted into Common Shares, at which time they will have the same voting rights as all Common Shareholders have; their consent shall not be required for taking any corporate action.

 

To date, our activities have been limited to formation, the raising of equity capital, and the initial stages of implementation of our business plan. We filed a Form S-1 Registration Statement with the U.S. Securities and Exchange Commission, received a notice of effect and trade on the OTC Markets, PINK under the symbol VTNL. We are continuing to explore additional sources of capital. We anticipate incurring operating losses as we continue to implement our business plan.

Financial Statement Presentation

Financial Statement Presentation

 

The audited financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).

Fiscal year end

Fiscal year end

 

The Company has selected December 31 as its fiscal year end.

Use of Estimates

Use of Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported therein. Due to the inherent uncertainty involved in making estimates, actual results reported in future periods may be based upon amounts that differ from these estimates.

Cash Equivalents

Cash Equivalents

 

The Company considers all highly liquid investments with maturities of 90 days or less from the date of purchase to be cash equivalents.

Revenue recognition and related allowances

Revenue Recognition and Related Allowances

 

The Company adopted ASU No. 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”) as amended, as of January 1, 2018 with no material impact. The Company primarily generates net revenue through product sales to distributors and to retail customers on its website. Revenue is recognized upon transfer of control of promised products to customers which is generally upon shipment in an amount that reflects the consideration we expect to receive in exchange for those products or services. Revenue is recognized net of allowances for returns and any taxes collected from customers, which are subsequently remitted to governmental authorities.

Accounts Receivable and Allowance for Doubtful Accounts

Accounts Receivable and Allowance for Doubtful Accounts

 

Accounts receivable are stated at the amount that management expects to collect from outstanding balances. Bad debts and allowances are provided based on historical experience and management’s evaluation of outstanding accounts receivable. Management evaluates past due or delinquency of accounts receivable based on the open invoices aged on due date basis. The allowance for doubtful accounts at September 30, 2019 and December 31, 2018 is $0.

Inventories

Inventories

 

The Company is a manufacturer of premium CBD infused holistic pet products and as such will maintain inventory on site. The company directly drop ships to customers when ordered. The Company has wholesale distributors that purchase products in bulk inventory.

Warranty

Warranty

 

The Company is a manufacturer of products which are shipped to our customers directly from the company and as a result, there are costs that may be incurred by the Company under the terms of the limited warranty provided by the company directly to the purchasers. We provide provisions for obligations which may arise under manufacturer’s warranties and therefore incur liabilities. We warranty the product for packaging and shipping.

Advertising and marketing costs

Advertising and Marketing Costs

 

The company provides website online marketing of its products, as well as wholesalers who market the product. The company also utilises various public press releases to provide public information about its product line and future products under development. Advertising and marketing costs are expensed as incurred for the three and nine months ended September 30, 2019 were $200 and $4,000, respectively. ($5,850 – December 31, 2018).

Fair Value Measurements

Fair Value of Financial Instruments

 

Fair value is defined as the price that would be received upon sale of an asset or paid upon transfer of a liability in an orderly transaction between market participants at the measurement date and in the principal or most advantageous market for that asset or liability. The fair value should be calculated based on assumptions that market participants would use in pricing the asset or liability, not on assumptions specific to the entity. In addition, the fair value of liabilities should include consideration of non-performance risk including our own credit risk.

 

In addition to defining fair value, the standard expands the disclosure requirements around fair value and establishes a fair value hierarchy for valuation inputs is expanded. The hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of the three levels and which is determined by the lowest level input that is significant to the fair value measurement in its entirety.

 

These levels are:

 

Level 1 - inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.

 

Level 2 - inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

 

Level 3 - inputs are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. The fair values are therefore determined using model-based techniques that include option pricing models, discounted cash flow models, and similar techniques.

 

Financial assets and liabilities measured at fair value on a recurring basis:

 

    Input   September 30, 2019     December 31, 2018  
    Level   Fair Value     Fair Value  
Derivative Liability   3   $ 1,322,116     $ 1,426,982  
Total Financial Liabilities       $ 1,322,116     $ 1,426,982  

 

In management’s opinion, the fair value of convertible notes payable and advances payable is approximate to carrying value as the interest rates and other features of these instruments approximate those obtainable for similar instruments in the current market. Unless otherwise noted, it is management’s opinion that the Company is not exposed to significant interest, exchange or credit risks arising from these financial instruments. As of September 30, 2019 and December 31, 2018, the balances reported for cash, accounts receivable, prepaid expenses, accounts payable, and accrued liabilities, approximate the fair value because of their short maturities.

Income taxes

Income taxes

 

 The Company has adopted SFAS No. 109 – “Accounting for Income Taxes”. ASC Topic 740 requires the use of the asset and liability method of accounting for income taxes. Under the asset and liability method of ASC Topic 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.

Basic and Diluted Loss Per Share

Basic and Diluted Loss Per Share

 

In accordance with ASC Topic 280 – “Earnings Per Share”, the basic loss per common share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding. Diluted loss per common share is computed similar to basic loss per common share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive.

New Accounting Pronouncements

Recent Accounting Pronouncements

 

In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), which replaces existing revenue recognition guidance. The updated guidance requires companies to recognize revenue in a way that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, the new standard requires that reporting companies disclose the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The Company adopted the standard on January 1, 2018, using a modified retrospective approach, with the cumulative effect of initially applying the standard recognized in retained earnings at the date of adoption.

XML 38 R4.htm IDEA: XBRL DOCUMENT v3.19.3
STATEMENT OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Income Statement [Abstract]        
Net sales $ 156 $ 1,295 $ 1,521 $ 4,309
Cost of goods sold 73 675 920 2,200
Gross profit (loss) 83 620 601 2,109
Operating expenses:        
Consulting fees 13,000 165,180 39,228 771,773
G&A expenses 3,357 7,323 16,482 53,528
Professional fees 10,749 8,400 54,446 75,329
Salaries and wages 9,000 9,000 27,000 27,000
Total operating expense 36,106 189,903 137,156 927,630
Loss from operations (36,023) (189,283) (136,555) (925,521)
Other income (expenses)        
Gain (loss) on derivative liability valuation (100,370) 814,310 78,541 (1,930,886)
Interest expenses (126,202) (374,760) (487,137) (1,088,949)
Total other income/expenses (226,572) 439,550 (408,596) (3,019,835)
Net loss before income taxes (262,595) 250,267 (545,151) (3,945,356)
Income tax expense
Net (loss) $ (262,595) $ 250,267 $ (545,151) $ (3,945,356)
Weighted average shares outstanding - Basic [1] 1,942,319 888,127 1,874,134 670,913
Net (loss) per common shares - Basic $ (0.1352) $ 0.2818 $ (0.29088) $ (5.8806)
Weighted average shares outstanding - Diluted [1] 2,301,072
Net (loss) per common shares - Diluted $ 0.1088
[1] All common share amounts and per share amounts in the financial statements reflect the one-for-three thousand reverse stock split that was made effective on April 22, 2019. See Note 7.
XML 39 R8.htm IDEA: XBRL DOCUMENT v3.19.3
GOING CONCERN
9 Months Ended
Sep. 30, 2019
Going Concern [Abstract]  
GOING CONCERN
2. GOING CONCERN

 

The Company has experienced net losses to date, and it has not generated sufficient revenue from operations to meet our operational overhead. We will need additional working capital to service debt and for ongoing operations, which raises substantial doubt about our ability to continue as a going concern. Management of the Company is preparing a strategy to meet operational shortfalls which may include equity funding, short term or long-term financing or debt financing, to enable the Company to reach profitable operations. Historically, the Company’s sole officer and director has provided short term loans to meet working capital shortfalls. We have recently entered into financing agreements with various third parties to meet our capital needs in fiscal 2019.

 

The accompanying financial statements do not include any adjustments related to the recoverability or classification of asset-carrying amounts or the amounts and classification of liabilities that may result should the Company be unable to continue as a going concern.

XML 40 R14.htm IDEA: XBRL DOCUMENT v3.19.3
RELATED PARTY TRANSACTIONS
9 Months Ended
Sep. 30, 2019
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS
8. RELATED PARTY TRANSACTIONS

 

Mr. Matthew C. Scott, Director

 

On April 1, 2017, the Company expanded its board of directors to include Matthew C. Scott. Concurrently, the Company entered into a consulting agreement with Mr. Scott for a term of one year, whereby Mr. Scott shall receive an annual fee of $100,000 payable in quarterly installments. Furthermore, effective April 1, 2017 the Company agreed to issue Mr. Scott 667 shares of restricted common stock for his services as a director. The shares upon issue will be held by the Company for a term of six months and are cancelable should Mr. Scott not serve in his capacity as director for a minimum term of six months.

 

The Company recorded $140,000 in share-based compensation in respect of the 667 shares issuable based on the fair market value on April 1, 2017, which has been recorded on the balance sheet as liabilities for unissued shares. Furthermore, a total of $140,000 has been expensed in the year ending December 31, 2017 as stock-based compensation as part of consulting expenses. As of the date of this report, the shares have not been issued.

 

On October 15, 2017, the Board of Directors of the Company approved the issuance of 25,000 restricted common shares to Matthew Scott to satisfy accrued fees of $50,000, pursuant his agreement dated April 1, 2017. The shares were issued on November 13, 2017 and were valued at $1,200,000, based on the market value on the date the shares were approved for issuance, and $1,150,000 was recorded as a loss on settlement of debt of the statement of operations.

 

On April 1, 2018, the Company agreed to renew the Consulting Agreement dated April 1, 2017 for one year.

 

On November 8, 2018, Mr. Scott resigned as a Director and agreed to forfeit all stock and outstanding debts owed to him pursuant to his Consulting Agreement. The Company recorded a reduction of $210,000 to accounts payable and unissued shares with a corresponding entry to additional paid in capital.

 

Mr. Samuel Berry, Director

 

On June 19, 2017, the Company entered into a Consulting Agreement with Mr. Samuel Berry. Mr. Berry will receive an annual salary of $50,000, payable in quarterly installments at $12,500 per quarter.

 

On June 19, 2017 the Board of Directors appointed Mr. Samuel Berry as Director. For accepting the position of Director, Mr. Berry will receive 333 Shares of the Company’s common stock. Additionally, Mr. Berry will be paid $500 for each board meeting for which he is physically present.

 

The Company recorded $50,000 in respect to the value of 333 unissued shares as liabilities for unissued shares and expensed $50,000 as stock-based compensation as part of consulting expenses in the period ended September 30, 2017. As of the date of this report, the shares have not been issued.

 

On October 15, 2017, the Board of Directors of the Company approved the issuance of 25,000  restricted common to Samuel Berry to satisfy consulting fees of $50,000, pursuant his agreement dated June 19, 2017. The shares were issued on November 13, 2017 and were valued at $1,200,000 based on the market value on the date the shares were approved for issuance, and $1,150,000 was recorded as a loss on settlement of debt on the statement of operations.

 

On June 19, 2019, the Company agreed to renew the Consulting Agreement dated June 19, 2017 for one year .

 

During the nine months ended September 30, 2019, the Company accrued $37,500 in consulting fees in connection to his agreement and made payments of $1,000.

 

On July 22, 2019, the Company appointed Samuel Berry as the Chief Financial Officer of the company. Mr. Berry was appointed as a Director on June 19, 2017. For accepting the position of CFO, Mr. Berry will receive $45,000 annual salary. On September 1, 2019, the agreement was voided, and therefore no fees were accrued.

 

Daniel Rushford, President, CEO, Secretary, Treasurer and Director

 

On August 28, 2017, the Company entered into an Employment Agreement with Mr. Daniel Rushford with regard to being appointed as the new Chief Executive Officer, President, Secretary, Treasurer and Member of the Board of Directors. Mr. Rushford will receive a monthly salary of $2,000 to be paid at the end of each month. Unpaid amounts will accrue annual interest of 6%. The term of the Consulting Agreement is for two years; renewable upon mutual consent.

 

On November 13, 2017, the Company issued 8,333 restricted common shares for $25,000 in share-based compensation that were valued at $95,000 based on the market value on the date of issuance, and $70,000 was recorded as a loss on settlement of debt. 

 

On January 2, 2018, the Company approved an increase in salary to $3,000 per month.

 

During the nine months ended September 30, 2019, the Company accrued wages and interest of $27,265 in connection with his agreement and made payments of $8,000.

XML 41 R10.htm IDEA: XBRL DOCUMENT v3.19.3
CONVERTIBLE NOTES PAYABLE
9 Months Ended
Sep. 30, 2019
Convertible Notes Payable  
CONVERTIBLE NOTE PAYABLE
4. CONVERTIBLE NOTES PAYABLE

 

As of September 30, 2019 and December 31, 2018, notes payable were comprised of the following:

 

    Original   Original   Due   Interest   Conversion   September 30,     December 31,  
    Amount   Note Date   Date   Rate   Rate   2019     2018  
APG Capital #2    31,500   6/25/2018   6/25/2019   24%   Variable     31,500       31,500  
Auctus Fund #2    84,000   1/10/2018   10/10/2018   24%   Variable     31,285       47,373  
Auctus Fund #3    175,000   2/6/2018   11/6/2018   24%   Variable     175,000       175,000  
Auctus Fund #4    90,000   3/6/2018   12/6/2018   24%   Variable     90,000       90,000  
Auctus Fund #5    100,000   6/14/2018   3/14/2019   24%   Variable     100,000       100,000  
Auctus Fund #6    75,000   8/13/2018   5/13/2019   24%   Variable     75,000       75,000  
Auctus Fund #7    25,000   10/11/2018   7/11/2019   24%   Variable     25,000       25,000  
Auctus Fund #8    25,750   12/20/2018   9/20/2019   24%   Variable     25,750       25,750  
Auctus Fund #9    57,000   4/12/2019   1/12/2020   12%   Variable     57,000        
Auctus Fund #10    31,000   7/22/2019   7/22/2020   12%   Variable     31,000        
EMA Financial #2    50,000   12/15/2017   12/15/2018   24%   Variable     8,474       8,474  
EMA Financial #3    100,000   3/5/2018   3/5/2019   24%   Variable     73,305       83,499  
EMA Financial #4    25,000   10/10/2018   7/10/2019   24%   Variable     25,000       25,000  
Emerging Corp #1    83,333   2/12/2018   2/11/2019   22%   Variable     74,933       74,933  
Emerging Corp #2    110,000   10/31/2018   10/31/2019   12%   Variable     110,000       110,000  
Power Up Lending #8    33,000   6/25/2018   4/15/2019   12%   Variable           33,000  
                          933,247       904,529  
Debt discount     (97,416 )     (313,258 )
Financing costs/Original issue discount     (9,011 )     (36,047 )
Notes payable, net of discount   $ 826,820     $ 555,224  

 

During the nine months ending September 30, 2019, the Company received proceeds from new convertible notes of $73,250. The Company recorded no payments on their convertible notes, and conversions of $59,282 of convertible note principal. The Company recorded loan fees on new convertible notes of $14,750, which increased the debt discounts recorded on the convertible notes during the nine months ending September 30, 2018. All of the Company’s convertible notes have a conversion rate that is variable, and therefore, the Company has accounted for their conversion features as derivative instruments (see Note 5). The Company also recorded amortization of $352,879 on their convertible note debt discounts and loan fees. As of September 30, 2019, the convertible notes payable are convertible into 21,183,475,536  shares of the Company’s common stock.

 

During the nine months ending September 30, 2018, the Company received proceeds from new convertible notes of $774,500. The Company recorded no payments on their convertible notes, and conversions of $390,478 of convertible note principal. The Company recorded penalties of $47,727, of which $32,762 was converted into the Company’s common stock. The Company recorded loan fees on new convertible notes of $127,833, which increased the debt discounts recorded on the convertible notes during the nine months ending September 30, 2018. All of the Company’s convertible notes have a conversion rate that is variable, and therefore, the Company has accounted for their conversion features as derivative instruments (see Note 5). The Company also recorded amortization of $976,978 on their convertible note debt discounts and loan fees.  

 

During the three months ended September 30, 2019 and 2018, the Company recorded interest expense of $48,741 and $23,461, respectively, on its convertible notes payable. During the three months ended September 30,2019 and 2018, the Company recorded conversions of $0 and $6,964, respectively of convertible note interest.

 

During the nine months ended September 30, 2019 and 2018, the Company recorded interest expense of $132,495 and $52,495, respectively, on its convertible notes payable. During the nine months ended September 30, 2019 and 2018, the Company recorded conversions of $4,938 and $15,852, respectively of convertible note interest.  As of September 30, 2019 and 2018, the accrued interest balance was $189,143 and $42,876, respectively.

 

As of September 30, 2019, we have not attained profitable operations and are dependent upon obtaining financing to pursue any extensive acquisitions and activities.

XML 42 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 43 R32.htm IDEA: XBRL DOCUMENT v3.19.3
COMMON STOCK (Details Narrative) - USD ($)
1 Months Ended
Mar. 27, 2018
Mar. 28, 2017
Sep. 30, 2019
Dec. 31, 2018
Apr. 30, 2018
Equity [Abstract]          
Common stock, authorized     50,000,000,000 50,000,000,000 50,000,000,000
Stock-based compensation $ 39,139        
Common Stock issued for Services, shares 7,248 1,920,000      
XML 44 R36.htm IDEA: XBRL DOCUMENT v3.19.3
COMMITMENTS (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 4 Months Ended 9 Months Ended 10 Months Ended
Mar. 27, 2018
Jun. 19, 2017
May 16, 2017
Apr. 07, 2017
Apr. 03, 2017
Sep. 30, 2017
Jun. 19, 2017
Mar. 28, 2017
Sep. 30, 2019
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Oct. 15, 2017
Sep. 30, 2019
Sep. 30, 2018
Nov. 13, 2017
Commitments (Textual)                                
Stock-based compensation $ 39,139                              
Shares issued 7,248             1,920,000                
Fair market value grant total               $ 96,000                
Agreement services payable                     $ 486 $ 38,653   $ 39,139  
Accured Consulting fees                 $ 13,000 $ 165,180       39,228 771,773  
Mr Edward Aruda [Member]                                
Commitments (Textual)                                
Fair market value grant total       $ 21,000                        
Accured Consulting fees                           40,000    
Consultant Agreement [Member]                                
Commitments (Textual)                                
Stock-based compensation     $ 67,500                          
Agreement services payable     $ 15,000                          
Convertible per share     $ 0.01                          
Fair market value per share     $ 0.055                          
Common stock shares issued     1,500,000                          
Common stock value issued     $ 82,500                          
Payment for advisor fee                             $ 14,475  
Consultant Agreement [Member] | Mr. Samuel Berry, Director [Member]                                
Commitments (Textual)                                
Shares issued             1,000,000                  
Fair market value grant total           $ 50,000                    
Agreement services payable           $ 50,000             $ 50,000      
Annual salary             $ 50,000                  
Payment of board meeting                           500    
Accured Consulting fees                         $ 50,000 16,667    
Consultant Agreement [Member] | Mr. Matthew C. Scott, Director [Member]                                
Commitments (Textual)                                
Fair market value grant total                           140,000    
Agreement services payable                               $ 50,000
Unissued shares         2,000,000                      
Unissued shares value         $ 140,000                     $ 25,000
Annual fee, description         Entered into a consulting agreement with Mr. Scott for a term of one year, where under Mr. Scott shall receive an annual fee of $100,000 payable in quarterly installments                      
Accured Consulting fees                           $ 75,000    
Investor Relations Agreement [Member]                                
Commitments (Textual)                                
Stock-based compensation     $ 825                          
Investor relations agreement, description               In consideration of the foregoing services performed by the third party, the Company will pay a fee of 1,920,000 restricted shares on or before April 1, 2017. In addition, the third party will remain the owner of at least 1% of the company's outstanding shares for a 1 year period. On April 1, 2018, the Company shall issue additional shares as necessary to bring the total number of shares paid to the third party to equal 1% of the outstanding shares of common stock as of 4/1/2018. In the event the Company does not issue the shares as required under this provision, the Company will be subject to a penalty of $5,000 per month until the shares are issued.                
Common stock shares issued     1,500,000                          
Additional shares issued     15,000                          
Restricted Stock [Member] | Mr. Matthew C. Scott, Director [Member]                                
Commitments (Textual)                                
Shares issued         2,000,000                      
Restricted Stock [Member] | Consultant Agreement [Member] | Mr. Samuel Berry, Director [Member]                                
Commitments (Textual)                                
Common stock value issued   $ 1,200,000                            
XML 45 R9.htm IDEA: XBRL DOCUMENT v3.19.3
PREPAID EXPENSES
9 Months Ended
Sep. 30, 2019
Notes to Financial Statements  
PREPAID EXPENSES
3. PREPAID EXPENSES

 

    September 30,     December 31,  
    2019     2018  
Prepaid expenses   $     $ 3,000  

 

Prepaid fees represent amounts paid in advance for future contractual benefits to be received. Contracting expenses paid in advance are recorded as a prepaid asset and then amortized to the statements of operations when services are rendered, or over the life of the contract using the straight-line method.

 

During the nine months ended September 30, 2019, the Company reclassed prepaid employee wages that were paid during the year ended December 31, 2018.

XML 46 R15.htm IDEA: XBRL DOCUMENT v3.19.3
INCOME TAXES
9 Months Ended
Sep. 30, 2019
Income Tax Disclosure [Abstract]  
INCOME TAXES
9. INCOME TAXES

 

Deferred income taxes are determined using the liability method for the temporary differences between the financial reporting basis and income tax basis of the Company’s assets and liabilities. Deferred income taxes are measured based on the tax rates expected to be in effect when the temporary differences are included in the Company’s tax return. Deferred tax assets and liabilities are recognized based on anticipated future tax consequences attributable to differences between financial statement carrying amounts of assets and liabilities and their respective tax bases.

 

Operating loss carry forwards generated during the period from May 25, 2014 (date of inception) through September 30, 2019 of approximately $9,978,365 will begin to expire in 2034. The Company applies a statutory income tax rate of 21%. Accordingly, deferred tax assets related to net operating loss carry-forwards total approximately $2,095,457 at September 30, 2019.

 

All tax years since inception are open to examination by the Internal Revenue Service.

XML 47 R11.htm IDEA: XBRL DOCUMENT v3.19.3
DERIVATIVE LIABILITIES
9 Months Ended
Sep. 30, 2019
Derivative Liabilities  
DERIVATIVE LIABILITIES
5. DERIVATIVE LIABILITIES

 

The following table represents the Company’s derivative liability activity for the embedded conversion features for the periods ending September 30, 2019 and December 31, 2018:

 

    September 30,     December 31,  
    2019     2018  
Balance, beginning of period   $ 1,426,982     $ 625,214  
Initial recognition of derivative liability     165,563       5,441,395  
Conversion of derivative instruments to Common Stock     (121,575 )     (1,958,802 )
Mark-to-Market adjustment to fair value     (148,854 )     (2,680,825 )
Balance, end of period   $ 1,322,116     $ 1,426,982  

 

During the nine months ended September 30, 2019 and 2018, the Company recorded derivative liabilities for embedded conversion features related to convertible notes payable of $165,563 and $5,049,659, respectively.

During the nine months ended September 30, 2019 and 2018, in conjunction with convertible notes payable principal and accrued interest being converted into common stock of the Company, derivative liabilities were reduced by $121,575 and $1,733,419, respectively.

 

For the nine months ended September 30, 2019 and 2018, the Company performed a final mark-to-market adjustment for the derivative liability related to the convertible notes and the carrying amount of the derivative liability related to the conversion feature and recognized a gain on the derivative liability valuation of $148,854 and $2,127,690, respectively.

 

During the three months ended September 30, 2019 and 2018, the Company recorded derivative liabilities for embedded conversion features related to convertible notes payable of $57,365 and $183,148, respectively.

 

During the three months ended September 30, 2019 and 2018, in conjunction with convertible notes payable principal and accrued interest being converted into common stock of the Company, derivative liabilities were reduced by $0 and $99,317, respectively.

 

For the three months ended September 30, 2019 and 2018, the Company performed a final mark-to-market adjustment for the derivative liability related to the convertible notes and the carrying amount of the derivative liability related to the conversion feature and recognized a loss(gain) on the derivative liability valuation of $75,555 and $(888,709), respectively.

 

The Company uses the Black-Scholes option pricing model to estimate fair value for those instruments convertible into common shares at inception, at conversion or extinguishment date, and at each reporting date. During the nine months ended September 30, 2019, the company used the following assumptions in their Black-Scholes model: (1) risk free interest rate 1.71% - 2.44%, (2) term of 0.12 years – 5 years, (3) expected stock volatility of 185.7% - 568.21%, (4) expected dividend rate of 0%, (5) common stock price of $0.0001, and (6) exercise price of $0.00005 - $0.03.

 

These instruments were not issued with the intent of effectively hedging any future cash flow, fair value of any asset, liability or any net investment in a foreign operation. The instruments do not qualify for hedge accounting, and as such, all future changes in the fair value will be recognized in earnings until such time as the instruments are exercised, converted or expire.

XML 48 R19.htm IDEA: XBRL DOCUMENT v3.19.3
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended
Sep. 30, 2019
Accounting Policies [Abstract]  
Summary of the fair value of our derivative liabilities

Financial assets and liabilities measured at fair value on a recurring basis:

 

    Input   September 30, 2019     December 31, 2018  
    Level   Fair Value     Fair Value  
Derivative Liability   3   $ 1,322,116     $ 1,426,982  
Total Financial Liabilities       $ 1,322,116     $ 1,426,982  
XML 49 R5.htm IDEA: XBRL DOCUMENT v3.19.3
STATEMENT OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($)
Preferred Stock
Common Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Beginning balance, amount at Dec. 31, 2017 $ 1 $ 223 [1] $ 19 $ 3,904,473 $ (4,864,606) $ (959,890)
Beginning balance, in shares at Dec. 31, 2017 1,000 223,070 [1]        
Conversion of promissory notes to stock $ 435 [1] 1,597,489 1,597,924
Conversion of promissory notes to stock (in shares) [1]   435,214        
Common stock issued for services $ 7 [1] 38,646 38,653
Common stock issued for services (in shares) [1]   7,158        
Preferred shares returned to treasury cancelled [1] (19) 19
Common stock warrants issued by cashless exercise $ 67 [1] (67)
Common stock warrants issued by cashless exercise, Shares [1]   66,508        
Net loss [1] (3,954,104) (3,954,104)
Ending balance, amount at Mar. 31, 2018 $ 1 $ 732 [1] 5,540,560 (8,818,710) (3,277,417)
Ending balance, in shares at Mar. 31, 2018 1,000 731,950 [1]        
Beginning balance, amount at Dec. 31, 2017 $ 1 $ 223 [1] 19 3,904,473 (4,864,606) (959,890)
Beginning balance, in shares at Dec. 31, 2017 1,000 223,070 [1]        
Conversion of promissory notes to stock           406,330
Common stock issued for services           39,139
Net loss           (3,945,356)
Ending balance, amount at Sep. 30, 2018 $ 1 $ 918 [1] 6,094,435 (8,809,962) (2,714,608)
Ending balance, in shares at Sep. 30, 2018 1,000 917,959 [1]        
Beginning balance, amount at Dec. 31, 2017 $ 1 $ 223 [1] 19 3,904,473 (4,864,606) (959,890)
Beginning balance, in shares at Dec. 31, 2017 1,000 223,070 [1]        
Derivative settlements           (1,958,802)
Ending balance, amount at Dec. 31, 2018 $ 1 $ 1,498 [1] 6,672,064 (9,433,214) $ (2,759,651)
Ending balance, in shares at Dec. 31, 2018 1,000 1,498,038 [1]       1,498,038
Beginning balance, amount at Mar. 31, 2018 $ 1 $ 732 [1] 5,540,560 (8,818,710) $ (3,277,417)
Beginning balance, in shares at Mar. 31, 2018 1,000 731,950 [1]        
Conversion of promissory notes to stock $ 114 [1] 385,083 385,197
Conversion of promissory notes to stock (in shares) [1]   113,769        
Common stock issued for services $ 0 [1] 486 486
Common stock issued for services (in shares) [1]   90        
Net loss [1] (241,519) (241,519)
Ending balance, amount at Jun. 30, 2018 $ 1 $ 846 [1] 5,926,129 (9,060,229) (3,133,253)
Ending balance, in shares at Jun. 30, 2018 1,000 845,809 [1]        
Conversion of promissory notes to stock $ 72 [1] 168,306 168,378
Conversion of promissory notes to stock (in shares) [1]   72,150        
Net loss [1] 250,267 250,267
Ending balance, amount at Sep. 30, 2018 $ 1 $ 918 [1] 6,094,435 (8,809,962) (2,714,608)
Ending balance, in shares at Sep. 30, 2018 1,000 917,959 [1]        
Beginning balance, amount at Dec. 31, 2018 $ 1 $ 1,498 [1] 6,672,064 (9,433,214) $ (2,759,651)
Beginning balance, in shares at Dec. 31, 2018 1,000 1,498,038 [1]       1,498,038
Conversion of promissory notes to stock $ 444 [1] 308,426 $ 308,870
Conversion of promissory notes to stock (in shares) [1]   444,281        
Derivative settlements [1] (121,575) (121,575)
Net loss [1] (200,093) (200,093)
Ending balance, amount at Mar. 31, 2019 $ 1 $ 1,942 [1] 6,858,915 (9,633,307) (2,772,449)
Ending balance, in shares at Mar. 31, 2019 1,000 1,942,319 [1]        
Beginning balance, amount at Dec. 31, 2018 $ 1 $ 1,498 [1] 6,672,064 (9,433,214) $ (2,759,651)
Beginning balance, in shares at Dec. 31, 2018 1,000 1,498,038 [1]       1,498,038
Conversion of promissory notes to stock           $ 64,220
Common stock issued for services          
Derivative settlements           (121,575)
Net loss           (545,151)
Ending balance, amount at Sep. 30, 2019 $ 1 $ 1,942 [1] 6,858,915 (9,978,365) $ (3,117,507)
Ending balance, in shares at Sep. 30, 2019 1,000 1,942,319 [1]       1,942,319
Beginning balance, amount at Mar. 31, 2019 $ 1 $ 1,942 [1] 6,858,915 (9,633,307) $ (2,772,449)
Beginning balance, in shares at Mar. 31, 2019 1,000 1,942,319 [1]        
Net loss [1] (82,463) (82,463)
Ending balance, amount at Jun. 30, 2019 $ 1 $ 1,942 [1] 6,858,915 (9,715,770) (2,854,912)
Ending balance, in shares at Jun. 30, 2019 1,000 1,942,319 [1]        
Net loss [1] (262,595) (262,595)
Ending balance, amount at Sep. 30, 2019 $ 1 $ 1,942 [1] $ 6,858,915 $ (9,978,365) $ (3,117,507)
Ending balance, in shares at Sep. 30, 2019 1,000 1,942,319 [1]       1,942,319
[1] All common share amounts and per share amounts in the financial statements reflect the one-for-three thousand reverse stock split that was made effective on April 22, 2019. See Note 7.
XML 50 R1.htm IDEA: XBRL DOCUMENT v3.19.3
Document and Entity Information - shares
9 Months Ended
Sep. 30, 2019
Nov. 08, 2019
Document and Entity Information [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Sep. 30, 2019  
Current Fiscal Year End Date --12-31  
Entity File Number 000-55787  
Entity Registrant Name Vet Online Supply Inc  
Entity Central Index Key 0001641751  
Entity Primary SIC Number 5047  
Entity Tax Identification Number 47-0990750  
Entity Incorporation, State or Country Code FL  
Entity Address, Address Line One 6500 Live Oak Drive  
Entity Address, City or Town Kelseyville  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 95451  
City Area Code 415  
Local Phone Number 756-4057  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period false  
Entity Common Stock, Shares Outstanding   1,943,330
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2019  
XML 51 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} EXCEL 52 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 53 R27.htm IDEA: XBRL DOCUMENT v3.19.3
CONVERTIBLE NOTES PAYABLE (Details) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2019
Dec. 31, 2018
Notes payable $ 933,247 $ 904,529
Debt discount (97,416) (313,258)
Financing costs./Original issue discount (9,011) (36,047)
Notes payable, net of discount 826,820 555,224
APG Capital #2    
Original Note Amount $ 31,500  
Derivative, Inception Date Jun. 25, 2018  
Derivative, Maturity Date Jun. 25, 2019  
Derivative, Variable Interest Rate 24.00%  
Notes payable $ 31,500 31,500
Auctus Fund #2    
Original Note Amount $ 84,000  
Derivative, Inception Date Jan. 10, 2018  
Derivative, Maturity Date Oct. 10, 2018  
Derivative, Variable Interest Rate 24.00%  
Notes payable $ 31,285 47,373
Auctus Fund #3    
Original Note Amount $ 175,000  
Derivative, Inception Date Feb. 06, 2018  
Derivative, Maturity Date Nov. 06, 2018  
Derivative, Variable Interest Rate 24.00%  
Notes payable $ 175,000 175,000
Auctus Fund #4    
Original Note Amount $ 90,000  
Derivative, Inception Date Mar. 06, 2018  
Derivative, Maturity Date Dec. 06, 2018  
Derivative, Variable Interest Rate 24.00%  
Notes payable $ 90,000 90,000
Auctus Fund #5    
Original Note Amount $ 100,000  
Derivative, Inception Date Jun. 14, 2018  
Derivative, Maturity Date Mar. 14, 2019  
Derivative, Variable Interest Rate 24.00%  
Notes payable $ 100,000 100,000
Auctus Fund #6    
Original Note Amount $ 75,000  
Derivative, Inception Date Aug. 13, 2018  
Derivative, Maturity Date May 13, 2019  
Derivative, Variable Interest Rate 24.00%  
Notes payable $ 75,000 75,000
Auctus Fund #7    
Original Note Amount $ 25,000  
Derivative, Inception Date Oct. 11, 2018  
Derivative, Maturity Date Jul. 11, 2019  
Derivative, Variable Interest Rate 24.00%  
Notes payable $ 25,000 25,000
Auctus Fund #8    
Original Note Amount $ 25,750  
Derivative, Inception Date Dec. 20, 2018  
Derivative, Maturity Date Sep. 20, 2019  
Derivative, Variable Interest Rate 24.00%  
Notes payable $ 25,750 25,750
Auctus Fund #9    
Original Note Amount $ 57,000  
Derivative, Inception Date Apr. 12, 2019  
Derivative, Maturity Date Jan. 12, 2020  
Derivative, Variable Interest Rate 12.00%  
Notes payable $ 57,000
Auctus Fund #10    
Original Note Amount $ 31,000  
Derivative, Inception Date Jul. 22, 2019  
Derivative, Maturity Date Jul. 22, 2020  
Derivative, Variable Interest Rate 12.00%  
Notes payable $ 31,000
EMA Financial #2    
Original Note Amount $ 50,000  
Derivative, Inception Date Dec. 15, 2017  
Derivative, Maturity Date Dec. 15, 2018  
Derivative, Variable Interest Rate 24.00%  
Notes payable $ 8,474 8,474
EMA Financial #3    
Original Note Amount $ 100,000  
Derivative, Inception Date Mar. 05, 2018  
Derivative, Maturity Date Mar. 05, 2019  
Derivative, Variable Interest Rate 24.00%  
Notes payable $ 73,305 83,499
EMA Financial #4    
Original Note Amount $ 25,000  
Derivative, Inception Date Oct. 10, 2018  
Derivative, Maturity Date Jul. 10, 2019  
Derivative, Variable Interest Rate 24.00%  
Notes payable $ 25,000 25,000
Emerging Corp Capital #1    
Original Note Amount $ 83,333  
Derivative, Inception Date Feb. 12, 2018  
Derivative, Maturity Date Feb. 11, 2019  
Derivative, Variable Interest Rate 22.00%  
Notes payable $ 74,933 74,933
Emerging Corp Capital #2    
Original Note Amount $ 110,000  
Derivative, Inception Date Oct. 31, 2018  
Derivative, Maturity Date Oct. 31, 2019  
Derivative, Variable Interest Rate 12.00%  
Notes payable $ 110,000 110,000
Power Up Lending #8    
Original Note Amount $ 33,000  
Derivative, Inception Date Jun. 25, 2018  
Derivative, Maturity Date Apr. 15, 2019  
Derivative, Variable Interest Rate 12.00%  
Notes payable $ 33,000
XML 54 R23.htm IDEA: XBRL DOCUMENT v3.19.3
COMMON STOCK (Tables)
9 Months Ended
Sep. 30, 2019
Disclosure Common Stock Tables Abstract  
Schedule of Warrants Activity

The following table summarizes the activity related to warrants of the Company as of September 30, 2019:

 

Issue   Number of   Exercise Price   Remaining Life
Date   Warrants   per Share   (Years)
6/19/2017   17   0.03   2.72
6/4/2018   16,667   0.001   3.71
8/13.18   12,500   0.001   3.87
10/11/2018   8,333   0.001   4.03
12/20/2018   8,583   0.001   4.22
4/12/2019   19,000   0.001   4.53
7/22/2019   15,500,000   0.001   4.81